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Abstract 
Infections caused by Candida species (candidosis) have greatly increased 
over recent years, mainly due to the escalation of the AIDS epidemic, population 
ageing, increasing number of immunocompromised patients and the more 
widespread use of indwelling medical devices.  Candida albicans is the main cause 
of candidosis, however, non-Candida albicans Candida (NCAC) species such as 
Candida glabrata, Candida tropicalis and Candida parapsilosis are now frequently 
identified as potential human pathogens.  This increased incidence of NCAC in 
human infection can be attributed to improved identification methods but might 
also be a reflection of the high level of resistance often exhibited by these species 
to certain antifungal agents.   
Candida species pathogenicity is facilitated by a number of virulence 
factors, most importantly adherence to medical devices and/or host cells, biofilm 
formation, and secretion of enzymes, such as proteases.  Despite intensive 
research to identify pathogenic factors in fungi, particularly in C. albicans, 
relatively little is known about the virulence determinants of NCAC species.  Thus, 
the work described in this thesis examined several of the most relevant virulence 
factors (adhesion, biofilm formation ability, tissue colonisation and invasion, and 
expression of hydrolytic enzymes) of clinical isolates of C. glabrata, C. tropicalis 
and C. parapsilosis recovered from different body sites (oral cavity and urinary 
and vaginal tracts). 
The study of NCAC biofilms, in terms of formation, structure, matrix 
composition, and metabolic activity, was the first goal of this research.  Total 
biomass quantification, showed that all NCAC strains were able to form biofilms, 
although this was less extensive for C. glabrata compared to C. parapsilosis and C. 
tropicalis.  Scanning electron microscopy (SEM) revealed structural differences for 
biofilms with respect to cell morphology and spatial arrangement.  Furthermore, 
C. parapsilosis matrices had large amounts of carbohydrates and low protein.  
Conversely, matrices extracted from C. tropicalis biofilms had low amounts of 
carbohydrates and protein.  Interestingly, the composition of C. glabrata biofilm 
matrices' was high in both protein and carbohydrate contents.  It was also evident 
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that there were intrinsic differences in terms of metabolic activity amongst 
biofilms of NCAC species, and no correlation was found concerning colony 
forming units (CFUs) and biofilm metabolic activities determined by XTT 
reduction.   
Another objective of the work described was to study the adhesion and 
biofilm formation ability of several clinical urinary isolates on to silicone in the 
presence of artificial urine (AU) and the role of Candida surface properties 
(hydrophobicity and zeta potential) in these events.  Silicone colonization by NCAC 
species in the presence of AU showed that, all urinary isolates were able to 
adhere to silicone, but in a species and strain dependent manner.  However, these 
differences in adhesion could not be correlated with cell surface properties 
(hydrophobicity and zeta potential).  Moreover, despite the high number of 
cultivable cells biofilms were not observed and confocal scanning laser 
microscopy (CLSM) showed an absence of extracellular polymeric material for all 
strains.  
The pathogenesis of C. parapsilosis and C. tropicalis was investigated using 
a commercially available reconstituted human oral epithelium (RHOE), in 
conjunction with CLSM observation and lactate dehydrogenase (LDH) 
determination.  Furthermore, the role of secreted aspartly proteinases (Saps) on 
invasion and damage of RHOE was evaluated by real-time polymerase chain 
reaction (PCR).  It was possible to observe that all C. tropicalis and C. parapsilosis 
strains were able to colonize the tissue, however, this was in a species- and strain-
dependent manner.  Candida parapsilosis revealed low invasiveness after 12 h of 
infection and extensive damage was evident after 24 h when assessed using 
histological examination and LDH determination.  Moreover, C. tropicalis was 
found to be highly invasive after 12 h of infection, with extensive tissue damage 
occurring also after 24h.  Real time-PCR of SAP genes showed that expression was 
strain dependent for both species.  Furthermore, the results suggested that the 
proteinases were not involved in invasion of RHOE by C. tropicalis and C. 
parapsilosis, but indicated a role for these enzymes in tissue damage caused by C. 
parapsilosis.   
Abstract/Sumário 
 
Finally, single and mixed infection of RHOE by C. glabrata or/and C. albicans 
were examined, using CLSM and peptide nucleic probes by in situ hybridization 
(PNA FISH).  It was found that the invasiveness of C. glabrata strains was 
enhanced in the presence of C. albicans. 
In summary, this work underlines both species and strain differences in 
terms of virulence factors associated with C. glabrata, C. parapsilosis and C. 
tropicalis.  Furthermore, there was clear evidence demonstrating the importance 
of the use of new techniques including CLSM and molecular analysis tools 
enabling the elucidation of the mechanisms of virulence.  By increasing our 
knowledge on Candida pathogenesis, potential therapeutic targets may well be 
identified that can be used as adjuvant for new therapies. 
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Sumário 
As infecções por Candida espécies (candidoses) têm aumentando 
drasticamente nos últimos anos, principalmente devido ao aumento da idade da 
população, ao crescente número de pacientes imunocomprometidos e ao elevado 
uso de dispositivos médicos.  Candida albicans é o principal agente causador de 
candidoses, contudo outras espécies de Candida não albicans (CNA) têm vindo a 
ser identificadas como potenciais agentes patogénicos, nomeadamente, Candida 
glabrata, Candida tropicalis e Candida parapsilosis.  Este aumento é também o 
reflexo da elavada resistência destas espécies a certos antifúngicos.  A 
patogenicidade de Candida está relacionada com o elevado número de factores 
de virulência, sendo os mais relevantes a capacidade de aderir a materiais 
médicos e/ou células do hospedeiro, a facilidade em formar biofilmes e a 
produção de enzimas, tais como as aspartil proteases (APs).  Apesar, de existirem 
diversos estudos desenvolvidos com o intuito de identificar factores de virulência 
em C. albicans, pouco se conhece sobre os factores de virulência em espécies de 
CNA.  Assim, este trabalho teve como objectivo principal o estudo dos factores de 
virulência mais relevantes (adesão, formação de biofilme, colonização e invasão 
de tecidos, e produção de hidrolases) de vários isolados clínicos de C. glabrata, C. 
tropicalis e C. parapsilosis provenientes de differentes partes do corpo humano 
(cavidade oral e tractos vaginal e urinário).  
O primeiro objectivo deste trabalho foi estudar a capacidade de estirpes de 
CNA formarem biofilmes, bem como a sua caracterização em termos de estrutura, 
composição da matriz e actividade metabólica.  A quantificação da biomassa total 
demonstrou que todas as estirpes em estudo são capazes de formar biofilme, 
contudo, verificou-se que C. glabrata produz menos biofilme comparativamente 
às estirpes de C. parapislosis e C. tropicalis.  A avaliação por microscopia 
electrónica de varrimento revelou diferenças significativas estruturais nos 
biofilmes no que respeita à morfologia das células e à sua disposição espacial.  A 
matriz dos biofilmes de C. parapsilosis apresentou elavada quantidade de 
polissacarídeos e baixa quantidade de proteínas. Contrariamente, as matrizes 
extraídas dos biofimes de C. tropicalis apresentaram reduzidas quantidades de 
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polissacarídeos e proteínas.  Curiosamente, os biofilmes de C. glabrata 
apresentaram elevada quantidade dos dois componentes em estudo. Com este 
trabalho, foi também possível concluir, que existem differenças intrínsecas em 
termos de actividade metabólica dos biofilmes em estudo e não foi encontrada 
correlação entre o número de células viáveis e a actividade celular determinada 
através da redução do XTT.   
Outro objectivo do trabalho aqui descrito consistiu no estudo da adesão e 
formação de biofilme de isolados urinários de CNA em silicone na presença de 
urina artificial (UA) e na avaliação do papel das propriedades superficiais 
(hidrofobiciadde e potencial zeta) das células nestes fenómenos.  Estes ensaios 
demonstraram que todas as estirpes são capazes de aderir ao silicone, contudo 
com elevada variabilidade dependendo da espécie e da estirpe.  Porém, os 
parâmetros físico-químicos das superfícies celulares avaliados não se 
correlacionaram com os valores de adesão obtidos.  Além disso, apesar da 
elevada viabilidade celular após 72h, estas estirpes não foram capazes de formar 
quantidade elevada de biofilme, como confirmado por microscopia de confocal 
laser (MCL), que mostrou ausência de matriz.   
A patogenicidade de C. tropicalis e C. parapsilosis foi estudada em epitélio 
oral reconstituído (EOR) por MCL e por quantificação da libertação da enzima 
lactato desidrogenase.  Avaliou-se também o papel das APs na capacidade 
invasiva e no dano causado ao epitélio por PCR em tempo real.  No que respeita à 
infecção, foi possível verificar que todas as estirpes de C. tropicalis e C. 
parapsilosis foram capazes de o colonizar, contudo numa extensão que varia com 
a espécie e com a estirpe.  Candida parapsilosis revelou-se pouco invasiva ao final 
de 12 h de infecção, mas causadora de elavado dano no tecido ao fim de 24 h.  
Por outro lado, C. tropicalis demonstrou ser altamente invasiva ao fim de 12 h e 
igualmente causadora de elevado dano no epitélio oral após as 24 h de infecção.  
Os estudos de expressão dos genes das APs, demonstram depender da estirpe 
para ambas as espécies.  Além disso, os resultados obtidos sugerem que as APs 
não têm um papel activo na invasão do epitélio em C. tropicalis e C. parapsilosis, 
mas sugerem envolvimento no dano causado por C. parapsilosis.   
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Por último, estudou-se a infeção simples e mista do EOR com C. glabrata e 
C. albicans, através de MCL e diferenciando as duas espécies com sondas de 
ácidos núcleicos por hibridação in situ.  A co-infecção de C. glabrata com C. 
albicans demostrou, que a invasão de C. glabrata é favorecida por C. albicans.   
Assim, este trabalho mostra existirem diferenças significativas entre 
espécies e estirpes no que respeita aos factores de virulência de C. glabrata, C. 
parapsilosis e C. tropicalis.  É também realçada a importância do uso de novas 
metodologias, tais como MCL e biologia molecular que permitam a elucidação e 
controlo dos mecanismos inerentes aos factores de virulência subjacentes às 
candidoses.  O aumento do conhecimento a respeito da patogenicidade de 
Candida é importante uma vez que poderá permitir a identificação de potenciais 
alvos terapêuticos e concomitantemente, o desenvolvimento de novas terapias 
alternativas.  
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Candida albicans is regarded as the most prevalent fungi involved in 
both human colonization and infection (candidosis).  Although, most cases 
of candidosis have been attribute to C. albicans, more recently, non-
Candida albicans Candida (NCAC) species (Candida tropicalis, Candida 
parapsilosis and Candida glabrata) have been identified as common 
pathogens.  This emergence is often associated to the advent of new 
medical procedures to treat cancer, the increase in invasive medical 
procedures, the incidence of HIV, and the widespread use of broad 
spectrum antibiotics.  The pathogenesis of candidosis is facilitated by a 
number of virulence factors, most importantly adherence to medical 
devices and/or host cells, biofilm formation, and secretion of enzymes, 
such as proteases.  Despite intensive research to identify pathogenic 
factors in fungi, particularly in C. albicans relatively, little is known about 
the virulence determinants of NCAC species. 
The primary event in Candida infection is the adherence of the 
microorganisms to a host and/or medical device surfaces, often leading to 
the formation of biofilms.  Therefore, an important aim of the present 
work was to study the biofilm of NCAC species in terms of its formation 
ability, structure, matrix composition and its metabolic activity.  A special 
focus is given to adhesion and biofilm formation of several clinical urinary 
isolates onto silicone in presence of artificial urine and the role of cells' 
surface properties (hydrophobicity and zeta potential) in these events.  
Secreted aspartly proteinases (Saps) are considered to be key 
enzymes that contribute to candidal infection by promoting damage of the 
host mucosa, thereby facilitating the invasion of the organism into the 
epithelium.  The pathogenesis of mucosal candidosis has been investigated 
in several studies using animal models, primarily in C. albicans.  
Furthermore, a commercially available reconstituted human oral 
epithelium (RHOE) has successfully been used to investigate in vitro 
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mechanisms of epithelium invasion by C. albicans.  Thus, another 
important goal of this work was the investigation of the pattern of 
colonization of RHOE by C. parapsilosis and C. tropicalis and the role of 
secretion of aspartly proteinases on invasion and tissue damage. 
Oral candidosis is a frequent problem, especially in immune 
compromised patients and recently C. glabrata has emerged as important 
pathogen of the oral mucosa alone or in mixed infections, often with C. 
albicans.  So, the last aim of this work was to examine single and mixed 
infection (C. glabrata with C. albicans) of RHOE by confocal laser scanning 
microscopy (CSLM), using in situ hybridization with peptide nucleic probes 
for selective staining both species.  
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This dissertation is divided in eight chapters.  Chapter I is a general 
introduction, in which the latest information concerning the biology, 
epidemiology and virulence factors of the C. glabrata, C. tropicalis and C. 
parapsilosis is presented.  The next seven chapters correspond to different parts 
of the experimental work performed.  
Chapter II initially addresses the study of biofilm formation ability of 
different clinical isolates of C. glabrata, C. tropicalis and C. parapsilosis and 
secondly, its characterization in terms of structure and matrix composition 
(protein and carbohydrate contents). 
In Chapter III a comparison between planktonic and biofilm cells concerning 
their metabolic activity is reported.  
Chapter IV evaluates the adhesion and biofilm formation abilities of 
different clinical urinary isolates of NCAC species onto silicone surfaces in the 
presence of artificial urine and the role of Candida cell surface properties 
(hydrophobicity and zeta potential) in these events.  
 
Chapters V and VI address the determination of the pattern of colonization 
and invasion of a reconstituted human oral epithelium (RHOE) model by C. 
parapsilosis and C. tropicalis strains, respectively, and its relation with the 
secretion of aspartyl proteinases (Saps).  A comparison of clinical strains obtained 
from different body sites was made in terms of colonization, invasion and SAP 
gene expression using RHOE, together with confocal laser scanning microscopy 
(CLSM) and real-time PCR.  
The aim of the work present in chapter VII was to assess single and mixed 
species infections of RHOE with C. glabrata/C. albicans and ascertain the role of C. 
glabrata in the infection using specifics peptide nucleic acid (PNA) probes by 
fluorescent in situ hybridization (FISH). 
Chapter VIII offers the major conclusions of the dissertation and the 
suggestions for future work.  
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The work presented in this chapter was based on the submitted review 
paper: 
Biology, epidemiology and virulence factors of Candida glabrata, Candida 
parapsilosis and Candida tropicalis.  
Sónia Silva, Melyssa Negri, Mariana Henriques, Rosário Oliveira, David W 
Williams and Joana Azeredo.  
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Abstract  
In recent years there has been a significant increase in the incidence 
of fungal infections in humans (Lass-Flörl, 2009).  These infections may 
either be superficial, affecting the skin, hair, nails and mucosal membranes, 
or systemic, involving major body organs (Rüping et al., 2008).  A number 
of factors have been implicated in this increased occurrence of fungal 
disease, but it is generally accepted that the more widespread provision of 
new medical practices, such as immunosuppressive therapy, invasive 
surgical procedures and use of broad spectrum antibiotics are highly 
significant (Samaranayake et al., 2002; Hargety et al., 2003; Kojic et al., 
2004).  
Of the fungi regarded as human pathogens, members of the genus 
Candida are the most frequently recovered from fungal infections.  The 
Candida genus contains over 150 heterogeneous species (Calderone, 2002) 
but only a minority of these are implicated in human candidosis.  
Additionally, it is known that approximately 65% of Candida species are 
unable to grow at a temperature of 37°C, thereby precluding these species 
from being successful pathogens or indeed commensals of humans 
(Calderone, 2002).   
Of the Candida species isolated from humans, Candida albicans is the 
most prevalent in both health and disease (Richards et al., 1999; Sobel et 
al., 2000; Samaranayake et al., 2002) conditions.  However, whilst 
mycological studies have shown that C. albicans represents over 80% of 
isolates from all forms of human candidosis (Samaranayake et al., 2002), in 
the last two decades the number of infections due to non-Candida albicans 
Candida (NCAC) species has increased significantly (Harris et al., 1999; 
Kauffman et al., 2000; Samaranayake et al., 2002; Manzano-Gayosso et al., 
2008; Ruan et al., 2008).  The apparent increased involvement of NCAC 
Chapter I 
 
4  
species in human candidosis may partly be related to improvements in 
diagnostic methods, such as the use of primary agars with ability to 
differentiate Candida species as well as the introduction of molecular 
techniques in the routine diagnosis of fungemia (Liguori et al., 2009).  
However, the high prevalence of NCAC species in disease could also be a 
reflection of their inherently higher level of antifungal drug resistance 
(González et al., 2008) compared with C. albicans, as this would promote 
their persistence, possibly to the detriment of C. albicans in mixed species 
infections treated with traditional antifungal agents.  
Unfortunately, compared with C. albicans there are relatively few 
investigations examining the virulence factors of NCAC species.  This 
general introduction therefore provides information on the current state of 
knowledge on the biology, epidemiology and virulence of C. glabrata, C. 
parapsilosis, and C. tropicalis which are three of the most frequent causes 
of candidosis after C. albicans.   
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Biology of non-Candida albicans Candida species  
The genus Candida comprises an extremely heterogeneous group of 
fungal organisms that can all grow as yeasts (Figure I.1), which were 
originally thought to reproduce only by asexual means.  Macroscopically, 
colonies of Candida species on the routinely used Sabouraud dextrose agar 
(SDA) are cream colored to yellowish.  Depending on the species, their 
texture may be pasty, smooth, glistening or dry, wrinkled and dull.  All 
species produce blastoconidia (Figure I.1 A), which may be round or 
elongated (Larone, 2002).  Moreover, members of the genus may also 
produce a filamentous type of growth such as true hyphae (Figure I.1 F) or 
more frequently, pseudohyphae (Figure I.1 C).  
 
 
 
Figure I.1 Epifluorescence photomicrograph of the different morphological 
growth forms of Candida albicans stained with calcofluor white: A) blastoconidia; 
B) reproduction by budding; C) pseudohyphae formation; D) yeast form; E) germ 
tube formation; F) hyphae formation.  *Internal cross walls (septa). 
 
 
The distinction between hyphae and pseudohyphae is related to the 
way in which they are formed.  Pseudohyphae are formed from yeast cells 
or from hyphae by budding (Figure I.1 B), but the new growth remains 
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attached to the parent cell and is elongate, resulting in filaments with 
constrictions at the cell-cell junctions.  There is no internal cross walls 
(septa) associated with pseudohyphae (Figure I.1 C).  In comparison, true 
hyphae are formed from yeast cells or even as branches of existing hyphae.  
The development of true hyphae is initiated by a ‘germ tube’ (Figure I.1 E) 
projection which can elongate and then branch with defined septa that 
divide the hyphae into separate cells (Figure I.1 F *).   
The Candida species, C. albicans and C. dubliniensis are truly 
polymorphic, due to their ability to form hyphae and/or pseudohyphae, 
and these particular species are also referred to as being germ tube 
positive, which is a diagnostic feature (Table I.1) (Calderone, 2002).  
 
 
Table I.1 Morphological characteristics of C. albicans, C. tropicalis, C. parapsilosis 
and C. glabrata species  
 
 
Species Germ 
tube 
Hyphae/Pseudohyphae 
(Dimorphism) 
Size of yeasts 
(µm) 
CHROM-agar 
reaction 
C. albicans + +/+ 4-6 × 6-10 Blue-green 
C. tropicalis - ±/+ 4-8 × 5-11 Dark blue 
C. parapsilosis - -/+ 2.5-4 × 2.5-9 White 
C. glabrata - -/- 1-4 White, Pink-
purple 
 
In contrast to other Candida species, C. glabrata is not polymorphic 
growing only as blastoconidia (Table I.1; Figure I.2 D).  Historically, this 
species was originally classified in the genus Torulopsis due to its lack of 
pseudohyphae formation.  However, in 1978 it was determined that the 
ability to form pseudohyphae was not a reliable distinguishing factor for 
members of the genus Candida and it was proposed that T. glabrata could 
be classified in the genus Candida, because of its human pathogenicity 
(Fidel et al., 1999).  With regards to C. parapsilosis, this species does not 
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produce true hyphae, but can generate pseudohyphae which are 
characteristically large and curved, and often referred to as ‘giant 
cells‘(Figure I.2 E, Larone, 2002; Trofa et al., 2008).  In contrast, on 
cornmeal tween 80 agar and at 25°C after 72 h, C. tropicalis can produce, 
oval blastospores, pseudohyphae and may also produce true hyphae 
(Figure I.2 F, Larone, 2002; Calderone, 2002; Yoshio et al., 2006). 
It should also be highlighted that C. glabrata cells (1-4 µm) are 
noticeably smaller than C. albicans (4-6 µm), C. tropicalis (4-8 µm), and C. 
parapsilosis (2.5-4 µm) blastoconidia (Calderone, 2002) (Table I.1).  On SDA 
(Figure I.2) C. glabrata forms glistening, smooth, and cream-colored 
colonies, which are relatively indistinguishable from those of other Candida 
species except for their relative size, which can be quite small (Figure I.2 A).  
Furthermore, C. parapsilosis when grown on SDA presents white, creamy, 
shiny, and smooth/wrinkled colonies (Figure I.2 B).  Moreover, on the same 
medium C. tropicalis forms colonies that are cream-colored with a slightly 
mycelial border (Figure I.2 C, Larone, 2002). 
 
 
 
Figure I.2 Candida species macroscopic colonies on SDA and microscopy structure 
on cornmeal tween 80 agar.  Macroscopic colonies:  C. glabrata (A); C. 
parapsilosis (B); C. tropicalis (C) and microscopic structure: C. glabrata (D); C. 
parapsilosis (E); C. tropicalis (F). 
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On CHROMagar™ Candida (CHROMagar, Paris, France), a relatively 
new differential agar medium, it is possible to distinguish a number of 
different Candida species by colour, as a result of distinct biochemical 
reactions.  On this chromogenic agar, C. glabrata colonies appear white, 
pink to purple, in contrast to C. albicans colonies which are blue-green, 
while C. parapsilosis appears white, and C. tropicalis dark blue (Table I.1). 
Concerning the biochemical reactions of Candida species, C. glabrata 
ferments and assimilates only glucose and trehalose, in contrast to C. 
albicans, which ferments and/or assimilates a high number of sugars 
excluding sucrose (Odds, 1988).  Candida tropicalis has the ability to 
ferment and assimilate sucrose and maltose (Martin, 1979).  Curiously, C. 
parapsilosis was firstly included as a species of Monilia, due to its inability 
to ferment maltose (Odds, 1988; Trofa et al, 2008).   
Regarding the genetic aspects of Candida, a critical distinguishing 
characteristic of C. glabrata is its haploid genome, in contrast to the diploid 
genome of C. albicans and several other NCAC species (Fidel et al., 1999).  
Genetically, C. tropicalis is most similar to C. albicans, and C. glabrata the 
least related (Butler et al., 2009).  It is through the advent of molecular 
genetics, that new identification methods for Candida have developed 
leading to the identification of new species together with their increased 
recognition in human infection.  Therefore, prior to 2005, C. parapsilosis 
was separated into three groups (I to III), and further studies revealed 
genomic differences that have led to the separation of these groups into 
closely related but distinct species, namely, C. parapsilosis, C. orthopsilosis, 
and C. metapsilosis (Gácser et al., 2007 a, b).  
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Epidemiology and risk factors for infection with non-
Candida albicans Candida species 
The high mortality rate associated with bacterial infections has 
declined with the early administration of empirical antibiotics, whilst 
concurrently systemic fungal infections have become increasingly 
important as causes of morbidity and mortality.  Candida species are 
amongst the most frequently recovered fungi from blood cultures in 
hospitalized patients (Pfaller et al., 1998).  In fact, an increasing incidence 
of fungal infections with Candida species has been noted in 
immunocompromised patients, including those patients in intensive care, 
post-surgical units, and suffering from cancer (Kiehn et al., 1980; 
Samaranayake et al., 2002; Hargety et al., 2003).  Candida species are most 
frequently isolated from the oral cavity, and vulvovaginal and urinary tracts 
and can be detected in approximately 31 to 55% of healthy individuals 
(Odds, 1988).  Historically, C. albicans has accounted for 70-80 % of clinical 
isolates, while other NCAC species occur only rarely (Odds, 1998).  Within 
the last 5-10 years NCAC species have emerged as opportunistic pathogens 
of humans and the reasons for this might relate to improved diagnostic 
methods or altered medical practices, as mentioned above.  Regardless of 
the basis of this change, recent epidemiological data reveal a mycological 
shift, and whilst C. albicans is still the most common causative agent, its 
incidence is declining with the frequency of other species such as C. 
glabrata, C. tropicalis and C. parapsilosis increasing (Chandra et al., 2001; 
Colombo et al., 2003; Basseti et al., 2006).    
Pfaller et al. (2007), in a study of the epidemiology of invasive 
candidosis, observed that collectively C. albicans, C. glabrata, C. tropicalis 
and C. parapsilosis, accounted for about 95% of identifiable Candida 
infections.  Moreover, in the 1980s, according to Kiehn et al (1980), C. 
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albicans constituted 68% of Candida isolates from sites other than blood in 
cancer patients, whilst C. tropicalis, C. parapsilosis and C. glabrata only 
accounted for 12%, 10% and 3.0% of isolates, respectively.  Table I.2 
highlights the more relevant epidemiologic studies published from 2000 to 
2010, concerning oral candidosis, candiduria and candidemia. 
Significantly in more recent studies, most cases of fungemia have 
been associated with NCAC species (Bassetti et al., 2006; Colombo et al., 
2007; Hasan et al., 2009; Chakrabarti et al., 2009).   
The incidence of C. glabrata is higher in adults than in children, and is 
lower in neonates (Krcmery et al., 2002).  In particular, C. parapsilosis 
appears to be a significant problem in neonates, transplant recipients and 
patients receiving parenteral nutrition (Trofa et al., 2008).  Furthermore, C. 
tropicalis is commonly associated with patients with neutropenia and 
malignancy (Colombo et al., 2007). 
For many years C. glabrata was considered a relatively non-
pathogenic saprophyte of the normal flora of healthy individuals and 
certainly not readily associated with serious infection in humans.  
However, following the widespread and increased use of 
immunosuppressive therapy together with broad-spectrum antibiotic 
therapies, the frequency of mucosal and systemic infections caused by C. 
glabrata has increased significantly (Hajjeh et al., 2004).  In the European 
Confederation of Medical Mycology (ECMM) survey, the incidence rates of 
candidosis infections attributed to these NCAC species were: 14% to C. 
glabrata and C. parapsilosis, and 7% to C. tropicalis (Tortorano et al., 2006).  
Recently, Chen et al. (2008) reported that C. glabrata was a causative 
agent of candiduria in Australia.  This is extremely important, since, 
compared with other NCAC species infection, the mortality rate associated 
with C. glabrata is the highest (Abi-Said et al., 1997; Krcmery, 1999).  
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Table I.2 Epidemiologic studies published during 2000-2010, concerning the distribution of Candida species 
isolates among various types of candidosis 
 
 
 
Candidosis 
 
References 
Year of 
observation 
Number 
of 
studies 
Region/ 
country 
Number of 
strains 
C. albicans 
(%) 
C. tropicalis 
(%) 
C. parapsilosis 
(%) 
C. glabrata 
(%) 
Oral 
Candidose 
Gravina et al., 2004 2003 62 Venezuela 43 42.3 12.8 14.9 2.1 
Luke et al., 2008 - 101 Argentine - 60.7 4.5 - 5.6 
Martins et  al., 2010 2005-2006 97 Portugal 53 79 4.8 6.5 4.8 
Candiduria 
Kauffman et al., 2000 - 861 USA 530 51.8 7.9 4.1 15.6 
Dorko et al., 2002 - - Slovakia 94 61.7 6.3 24.5 - 
Alvaréz-Lerma et al., 2004 1998-1999 1765 Spain 389 68.4 36 0.5 8.2 
Kobacyashi et al., 2004 - 205 Brazil 45 35.5 22.3 11.1 8.8 
Passos et al., 2005 - 153 Brazil 43 70 4.6 4.6 7 
Binelli et al., 2006 1999-2001 115 Brazil 23 52 43.5 - 17.3 
Chen et al, 2008 2006 54 Australia 65 85.2 - 4.4 27.8 
Candidemia 
Trick et al., 2002 1999 2358 USA - 59 10 11 12 
Bassetti et al., 2006 1999-2003 182 Italy 182 40 9 23 15 
Tortorano et al., 2006 1997-1999 569 Italy 473 53 6 15 13 
Colombo et al., 2007 - 7038 Brazil 282 38 48 23 9 
Costa-de-Oliveira et al., 2008 2004 117 Portugal - 35 - 26.5 - 
Hasan et al., 2009 - 51 USA 126 21 38 12 3 
Miranda et al., 2009 2004–2005 63 Brazil - 42 33 16 2 
Chakrabarti et al., 2009 - 140 India - 26.3 - - 10.5 
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Until recently, few studies had evaluated independent risk factors 
associated with nosocomial C. glabrata acquisition and subsequent 
infection.  Little is known about the hospital reservoirs of C. glabrata but, 
as with C. albicans, probable sources include a complex interaction of 
environmental and human reservoirs.  Two studies (Isenberg et al., 1989; 
Vasquez et al., 1993) have implicated hand carriage on hospital personnel 
as possible sources of infection.  Thus, C. glabrata may be similar to C. 
albicans and other nosocomial pathogens that are acquired, directly or 
indirectly, from contaminated environmental surfaces.  However, the role 
of carriage by personnel in dissemination of C. glabrata remains to be 
clarified.  Lately, the most frequent combination of mixed species infection 
by Candida species is C. glabrata and C. albicans, which has been found in 
approximately 70% of the patients with oral candidosis (Redding et al., 
2002).  
Candida parapsilosis, despite being initially considered a non-
pathogenic species, was primarily identified as the causative agent of a 
fatal case of endocarditis in an intravenous drug user in 1940 (Joachim et 
al., 1940).  Furthermore, over the past decade, the incidence of C. 
parapsilosis has dramatically increased.  In fact, reports indicate that C. 
parapsilosis is often the second most frequently isolated Candida species 
from blood cultures (Almirante et al., 2006; Colombo et al., 2007; Costa-de-
Oliveira et al., 2008).  Furthermore, C. parapsilosis is one of the fungi most 
frequently isolated from human hands (Bonassoli et al., 2005) and the 
second most commonly isolated Candida species from normally sterile 
body sites of hospitalized patients.  This species accounts for 15.5% of 
Candida isolates in North America, 16.3% in Europe, and 23.4% in Latin 
America, outranked only by C. albicans (51.5%, 47.8% and 36.5%, 
respectively) and C. glabrata (21.3%) in North America (Messer et al., 
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2003).  However, C. parapsilosis fungemia has a lower mortality rate (4%; 
Kossoff et al., 1998) compared with C. albicans and C. glabrata.   
The increase in the frequency of C. parapsilosis infections has been 
attributed to a variety of risk factors, including the organism’s selective 
growth capabilities in hyper alimentation solutions and its high ability to 
colonize intravascular devices and prosthetic materials.  Additionally, 
patients requiring prolonged used of a central venous catheter or 
indwelling device, such as cancer patients, are at an increased risk of 
infection with C. parapsilosis.  A recent study (Almirante et al., 2006) of 72 
patients in Spain, with invasive C. parapsilosis, identified vascular 
catheterization (97%), prior antibiotic therapy (91%), parental nutrition 
(54%), prior surgery (46%), prior immunosuppressive therapy (38%), 
malignancy (27%), transplant receipt (16%), neutropenia (12%), and prior 
colonization (11%) as risk factors for infections.  In a report of 64 episodes 
of C. parapsilosis candidemia from Brazilian hospitals, between 2002 and 
2003, the primary risk factors were neutropenia, the use of central venous 
catheters, and cancer chemotherapy (Brito et al., 2006).  The population at 
greatest risk for nosocomial infection with C. parapsilosis is that of 
extremely low birth weight neonates (Solomon et al., 1984; Voss et al., 
1994).  In fact, colonization of the skin or gastrointestinal tract is frequently 
a first step in the pathogenesis of invasive candidal disease, and neonates 
are especially prone to such infection given their compromised skin 
integrity, susceptibility to gastrointestinal tract infection, long term need 
for central venous catheter, and prolonged endotraccheal intubation 
(Benjamin et al., 2000).  Furthermore, C. parapsilosis has been isolated 
from approximately one-third of neonates with gastrointestinal 
colonization by Candida species (Saimain et al., 2001) and from 
oropharynges of 23% of healthy neonates (Contreras et al., 1994). 
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Candida tropicalis is one of the three most commonly isolated NCAC 
species (Álvarez-Lerma et al., 2004; Binelli et al., 2006; Colombo et al., 
2007; Hasan et al., 2009).  Usually, C. tropicalis is considered the third most 
frequently isolated NCAC species from blood and urine cultures (Kauffman 
et al., 2000; Álvarez-Lerma et al., 2004).  Moreover, in a recent 
epidemiology study conducted in 12 Brazilian medical centers, C. tropicalis 
was the second most often recovered Candida species, accounting for 33-
48% of all candidemia cases (Colombo et al., 2007; Miranda et al, 2009).  
Additionally, C. tropicalis is often found in patients admitted to intensive 
care units, especially in patients requiring prolonged catheterization, 
receiving broad-spectrum antibiotics, or with cancer (Kauffman et al., 
2000; Rho et al., 2004; Colombo et al., 2007; Nucci et al., 2007).  
Furthermore, C. tropicalis appears to display a higher potential for 
dissemination in the neutropenic host than C. albicans and other NCAC 
species.  According to Kontoyiannis et al. (2001), there are distinct 
differences in presentation and risk factors of C. tropicalis and C. albicans 
fungemia, with the former more persistent and leading to longer intensive 
care units stays during the course of their infection.  This may imply a 
higher virulence of C. tropicalis when compared with C. albicans.  In fact, 
some epidemiologic studies (Krcmery et al.,1999; Kontoyiannis et al., 2001; 
Eggimann et al., 2003; Colombo et al., 2007) documented that C. tropicalis 
was associated with higher mortality than other NCAC species and C. 
albicans.  This propensity of C. tropicalis for dissemination and the high 
mortality associated can be related to the virulence factors that this 
species exhibits (Krcmery et al., 2002; Negri et al., 2010a). 
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Virulence factors of non-Candida albicans Candida 
species 
The pathogenesis of invasive candidosis is facilitated by a number of 
virulence factors, including the ability to adhere to medical devices and/or 
host cells, biofilm formation, dimorphism, and secretion of hydrolytic 
enzymes such as proteases, phospholipases and lipases, and haemolysins.  
Despite, the intensive research to identify pathogenic factors in fungi, 
particularly in C. albicans, relatively little is known about the virulence 
determinants of NCAC species.  This issue is a major limitation in our ability 
to diagnose, treat, and prevent NCAC species infection. 
 
Adherence ability of non-Candida albicans Candida species 
The primary event in Candida infection is its adherence to host 
and/or medical device surfaces often leading to the formation of biofilms 
(Figure I.3 A; Crump et al., 2000; Chandra et al., 2001).  
 
 
 
Figure I.3 Stages of biofilm formation of Candida species on medical device 
surface.  (A) Initial adhesion to surface; (B) Formation of basal microcolony layers 
of Candida cells; (C) Mature biofilm of Candida constituted by cells and 
extracellular matrix. 
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Thus, adhesion is an extremely important virulence factor, and the 
extent of adhesion extension may be dependent on surface properties of 
both microorganisms and abiotic material, such as hydrophobicity, zeta 
potential, and surface roughness (Cai et al., 1994; Anil et al., 2001; 
Henriques et al., 2002; Sousa et al., 2009).  Furthermore, the switching 
between different colony morphologies is associated with alteration in cell 
wall architecture which in turn can influence cell-to-cell, cell-to-surface, 
and cell-to-host tissue adherence (Chaffin et al., 2008). 
As mentioned previously, the relatively non-pathogenic nature of C. 
glabrata in animal models suggests that it has few virulence attributes.  
However, its high mortality rate and rapid dissemination would indicate 
the opposite.  In a study with limited number of C. glabrata isolates, this 
organism displayed a degree of hydrophobicity comparable to C. albicans 
(Hazen et al., 1986).  Interestingly, while the hydrophobicity of C. albicans 
was extremely sensitive to specific growth conditions, numerous isolates of 
C. glabrata were relatively insensitive to those same growth conditions 
(Kikutaní et al., 1992).  In addition, Camancho et al. (2007) did not find a 
correlation between the hydrophobicity and adherence for Candida cells 
on siliconised latex catheters, demonstrating that cell hydrophobicity alone 
was not a predictor for the adhesion phenomenon.  Candida glabrata has 
been demonstrated to have a two-fold greater tendency to adhere to 
denture acrylic surfaces compared to C. albicans (Luo et al., 2002), and it 
was again shown that C. glabrata adhered to a higher extent to urinary 
epithelial cells than other NCAC species (Negri et al. 2010).  In contrast, in 
an in vitro assay of adherence to vascular endothelium, C. albicans was the 
most adherent species, while C. glabrata was the least adherent, followed 
by C. parapsilosis and C. tropicalis (Klotz et al., 1985).  Using a reconstituted 
human epithelium, a new model for studying microorganism’s colonization, 
Schaller et al. (2006) showed that C. glabrata was able to colonize but 
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unable to invade this epithelium.  An important factor correlated with the 
adhesion ability of Candida species is the presence of specific proteins on 
its cell-wall, namely adhesins.  In C. glabrata, a major group of adhesins is 
encoded by EPA (epithelial adhesin) gene family (De Las Penas et al., 2003).  
The overall structure of Epa proteins is similar to that of the Als (Agglutinin 
like sequence) proteins of C. albicans.  Although, there are few studies 
concerning C. glabrata Epa proteins, it is known that Epa1p is a Ca2+ 
dependent lectin that binds to N–acetyl lactosamine–containing glycol-
coconjugates (Comarck et al., 1999).  Furthermore, despite the large 
number of EPA genes, it has been shown that deletion of merely EPA1 
reduces adherence in vitro (De las Penas et al., 2003).  However, although 
EPA6 is not expressed in vitro, its expression increases during in vivo 
urinary infection, suggesting that C. glabrata is capable to adapt to 
different environmental conditions (Domergue et al., 2005).  
As reported for C. glabrata, Panagoda et al. (2001) shown that the 
initial adhesion of C. parapsilosis cells was associated with surface 
hydrophobicity.  In terms of epithelial and endothelial adhesion ability, few 
studies have been undertaken with C. parapsilosis.  The first study 
(Panagoda et al., 2001) comparing C. albicans and C. parapsilosis adhesion 
reported a greater ability (21%) of C. parapsilosis for buccal epithelial cell 
adherence with an increase of 14% in the extent of adhesion to acrylic. 
These studies suggest that the prevalence and severity of infection caused 
by C. parapsilosis associated with medical devices and/or host surfaces can 
be due to their high ability to colonize and survive on biomaterial surfaces 
even in unfavorable conditions.  Furthermore, a bioinformatics search of 
pathogen-specific gene families of Candida species revealed a number of 
genes for cell wall proteins in C. parapsilosis.  This study included genes for 
5 Als proteins and 6 Pga 30 (predicted GPI anchored protein 30) (Butler et 
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al., 2009), but unfortunately there has been no further work in studying 
the roles these proteins play in C. parapsilosis adhesion.   
Candida tropicalis has the ability to colonize urinary epithelial cells, 
silicone and latex catheter (Negri et al., submitted), however the extent of 
adhesion is strain dependent.  Concerning, proteins from C. tropicalis cell 
wall, at least 3 ALS genes were identified through southern and western 
blotting analysis with anti-Als antibody (Hoyer et al., 2001) however, to the 
authors’ knowledge no further work has been undertaken in this area.  
Apart from C. albicans, our knowledge of adhesion mechanisms in 
medical devices and human cells pathogenic fungi is still limited.  However, 
the cell wall is thought to play a crucial role for colonization and infection, 
and therefore, elucidation of its structure and composition would lead to a 
better understanding of the pathogenesis of NCAC infections, and also to 
an improvement of their treatment since some cell wall components may 
constitute valuable targets for antifungal drugs.  
 
Biofilm formation ability by non-Candida albicans Candida 
species 
Initial attachment of Candida to host or/and medical devices is 
followed by cell division, proliferation (Figure I.3 B), and subsequently 
biofilm development (Figure I.3 C) (Ramage et al., 2006).  Biofilms are 
described as surface associated communities of microorganisms embedded 
within an extracellular matrix.  It is now considered that biofilms represent 
the most prevalent growth forms of microorganisms (Al-Fattani et al., 
2006).   
Biofilm formation is a potent virulence factor for a number of 
Candida species, as it confers significant resistance to antifungal therapy by 
limiting the penetration of substances through the matrix and protecting 
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cells from host immune responses (Donlan et al., 2002; Mukherjee et al., 
2004).  Moreover, biofilms formed by C. albicans, C. parapsilosis, C. 
tropicalis, and C. glabrata isolates have been associated with higher 
mortality rates compared with isolates incapable of forming biofilms 
(Kumamoto, 2002).  Candida albicans biofilm formation is associated with 
the dimorphic switch from yeast to hyphal growth, and the biofilm 
structure involves, generally, two distinct layers: a thin, basal yeast layer 
and a thicker, less compact hyphal layer (Donlan et al., 2002).  It is assumed 
that the formation of mature biofilms and subsequent production of 
extracellular matrix is strongly dependent upon species, strain, and 
environmental conditions (pH, medium composition, oxygen) (Ramage et 
al., 2006; Jain et al., 2007).  Little is known about the matrix composition of 
NCAC species biofilms, but according to Baillie et al. (2000), C. albicans 
biofilm matrix is mainly composed of carbohydrate, protein, phosphorus, 
and hexosamines.  Many previous studies have focused on C. albicans 
biofilms, due its well-recognized virulence, whereas only few reports of 
NCAC species biofilms are available.  Shin et al. (2002) showed that biofilm 
formation by C. glabrata was reduced when compared with other NCAC 
species, when grown in rich culture media.  While extensive work has been 
performed concerning the C. albicans genes involved on biofilm formation, 
little is known about equivalent controlling genes in C. glabrata.   
Biofilms are readily formed by C. parapsilosis cells grown in media 
containing high glucose and lipid concentrations, which can be associated 
with the increased prevalence of bloodstream infections in patients 
receiving parental nutrition.  The selective preference of this species for 
plastic medical devices is of particular interest, as biofilm formation 
enhances the capacity of the organism to colonize catheters and 
intravascular cellular lines (Weems, 1992; Trofa et al., 2008).  In contrast to 
C. albicans, C. parapsilosis biofilms are thinner, less structured, and consist 
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exclusively of aggregate blastospores (Kuhn et al., 2002).  It is known that 
biofilms are affected by farnesol, a quorum-sensing molecule produced by 
C. albicans.  Martins et al. (2010) have reported that C. parapsilosis cells 
secrete farnesol, a finding that was in contrast to earlier studies by Trofa et 
al. (2008).  However, according to the latter, treatment with extracellular 
farnesol did arrest growth without an apparent effect on C. parapsilosis 
morphology.  Two recent studies documenting the generation of C. 
parapsilosis lipase knockout mutants found that these have a decreased 
ability to form biofilms.  Candida parapsilosis mutants produced 
significantly less biofilm than a wild type strain (Gácser et al., 2007), and 
the BCR (biofilm and cell wall regulator) gene was necessary for proper 
biofilm formation (Ding et al., 2007).  Notably, the biofilm deficient C. 
parapsilosis lipase mutants were less virulent in tissue culture infection 
models and in mice (Gácser et al., 2007).  Lattif et al. (2010) demonstrated 
that, similarly to C. parapsilosis, the two newly identified Candida species 
(C. orthopsilosis and C. metapsilosis) were able to form biofilms.  
Candida tropicalis clinical isolates have been classified as being 
strong biofilm formers (Negri et al., 2010 a, c).  Furthermore, Al-Fattani et 
al. (2006) showed that matrix material extracted from biofilms of C. 
tropicalis and C. albicans contained carbohydrates, proteins, hexosamine, 
phosphorus and uronic acid.  However, the major component in C. 
tropicalis biofilm matrices was hexosamine (27%).  The same authors also 
reported that these biofilms were partially detached after treatment with 
lipase type VII and chitinase, which contrasted with biofilms of C. albicans 
that were detached after treatment with proteinase K, chitinase, DNase I 
or B-N-aceytyglucosamidase.   
The studies described highlight the diversity found in terms of biofilm 
forming ability, structure, and matrix composition concerning C. glabrata, 
C. parapsilosis and C. tropicalis.  It must be emphasized that it is highly 
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important to continue these studies for elucidating such inherent 
differences and the possibility to identify and especially combat strains 
adapted to infection at particular body sites. 
 
Secreted enzymes by non-Candida albicans Candida species  
The secretion of enzymes (proteases and phospholipases), as well as 
haemolytic activity (Figure I.4), are recognized as important factors in 
tissue invasion by Candida and the ability to secrete these enzymes has 
been associated with high pathogenicity.   
 
 
 
Figure I.4 Photographs showing secreted enzymes by Candida species with an 
opaque halo of degradation around the colonies grown in a specific agar plate.  A) 
Proteinase activity on agar medium supplemented with BSA; B) Phospholipase 
activity on agar medium supplemented with egg; C) Heamolytic activity on agar 
medium supplemented with blood sheep and glucose . 
 
 
The function of hydrolytic enzymes is associated with the destruction 
of host tissues and recently, some authors described that Candida has 
been able to degrade hemoglobin using haemolysins in order to obtain 
iron, (Luo, et al., 2001, Naglik et al., 2004; Negri et al., 2010).  These 
enzymes are most frequently described for C. albicans, and little is known 
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about their production and secretion by NCAC species and subsequent role 
in pathogenecity.   
 
Secreted aspartyl proteinases (Saps) 
The secretion of aspartyl proteinases (Sap1p to Sap10p) is an 
important virulence determinant of C. albicans (Naglik et al., 1999; Hube et 
al., 2001; Monod et al., 2002).  Saps facilitate invasion and colonization of 
host tissues by disruption of the host mucosal membranes (Rüchel et al., 
1992) and by degrading important immunological and structural defence 
proteins (Pichová et al., 2001).   
Concerning C. glabrata, only a single study has shown that this 
species is capable of proteinase production, but the type of proteinase was 
not specified (Chakrabarti et al., 1991).  
In addition, when compared to C. albicans, C. parapsilosis has a low 
Sap activity (Kobayashi et al., 2004).  Only three SAP genes have been 
identified in C. parapsilosis (SAPP1-3), two of which remain largely 
uncharacterized (Merkerova et al., 2006).  The Sapp1p isoenzyme has 
however been biochemically characterized (Fusek et al., 1994; Pichová et 
al., 2001; Dostal et al., 2005) and SAPP2, produces a functional proteinase 
which constitutes about 20% of the Saps isolated from a culture 
supernatant (Fusek et al., 1993).  No studies have analyzed or 
characterized SAPP2 or Sapp3.  However, there is a trend relating Sap 
production and site isolation, since both vaginal and skin isolates of C. 
parapsilosis exhibit higher in vitro Sap activity than blood isolates (Cassone 
et al., 1995; Dagdeviren et al., 2005).   
As with C. albicans, in vitro studies reveal that C. tropicalis secretes 
high levels of Saps in a medium containing bovine serum albumin (BSA) as 
sole source of nitrogen (Figure I.4 A).  Furthermore, it is known that C. 
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tropicalis possesses at least four genes encoding Saps, and these are 
designated SAPT1 to SAPT4 (Togni et al., 1991; Zaugg et al., 2002).  To date, 
Sapt1p is the only enzyme that has been purified from culture supernatant, 
biochemically characterized and crystallized (Togni et al., 1991; Symersky 
et al., 1997).  The presence of aspartic proteinases secreted by C. tropicalis 
has also been reported on the surface of fungal elements penetrating 
tissues during disseminated infection and evading macrophages after 
phagocytosis of yeast cells (Borg et al., 1992, Rüchel et al., 1992).  
Recently, Naglik et al. (2008) and Lerman et al. (2008) have 
demonstrated that, SAP gene expression on oral environment was not 
correlated with invasion and tissue damage.   
 
Phospholipases and lipases  
In addition to Saps, enzymes categorized as phospholipases (PLs) are 
often considered to be factors in Candida pathogenicity.  PLs are enzymes 
that hydrolyze phospholipids into fatty acids.  According to the different 
and specific ester bonds cleaved, these enzymes have been classified into 
PLs A, B, C and D (Mukherjee et al., 2001).  The production of all classes of 
PLs has been described for Candida species and their production could 
contribute to host cell membrane damage which could promote cell 
damage or expose receptors to facilitate adherence (Ghannoum et al., 
2000; Kantarcioglu et al., 2002).  The most widely used diagnostic method 
for phospholipase determination is based on the growth on egg yolk agar 
media (Figure I.4 B).  Several studies indicate that NCAC species are able to 
produce extracellular phospholipases (Furlaneto-Maia, et al., 2007; 
Cafarchia, et al., 2008; Galan-Ladero, et al., 2010), or relative significantly 
smaller amounts of phospholipase compared to C. albicans (Ghannoum et 
al., 2000).  There have been contradictory findings, with some investigators 
reporting phospholipase activity in 51% of strains assayed (Ghannoum et 
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al., 2000) and others finding no PLs activity at all (Kantarcioglu et al., 2002).  
According to recent studies, whilst C. tropicalis appears to have a reduced 
ability to produce extracellular phospholipases, this production is strongly 
strain dependent (Cafarchia, et al., 2008; Furlaneto-Maia, et al., 2007; 
Galan-Ladero, et al., 2010; Negri et al., 2010).  Furthermore, contrary to 
the few studies on C. tropicalis and C. parapsilosis, no studies have been 
reported concerning C. glabrata PLs production (Kumar et al., 2009).  
Lipases are involved in both the hydrolysis and synthesis of 
triacylglycerols and are characterised by having stability at high 
temperatures and in organic solvents, and being resistant to proteolysis 
(Brockerhoff et al., 1974).  In C. albicans, 10 lipase genes have been 
identified (Hube et al., 2000).  In C. parapsilosis, two lipase genes, CpLIP1 
and CpLIP2 are reported with CpLIP2 known to encode for an active protein 
(Neugnot et al., 2002; Brunel et al., 2004).  Recently, Gácser et al. (2007) 
demonstrated that a lipase inhibitor significantly reduced tissue damage 
during C. parapsilosis infection of reconstituted human tissues and that 
CpLIP1-CpLIP2 mutants formed thinner and less complex biofilms.  They 
also had reduced growth in lipid rich media were more efficiently ingested 
and killed by macrophage like cells, and were less virulent in infections of 
reconstituted human oral epithelium.  Recent genomic DNA sequencing 
projects suggest that two additional CpLIP genes may exist in C. 
parapsilosis (Trofa et al., 2008).  Sequences similar to C. albicans (LIP1-10) 
were also detected in other pathogenic Candida species such as C. 
tropicalis but not in C. glabrata (Filler et al., 1991).  However, no relevant 
studies have been performed concerning the role of these genes on 
virulence of this species.  
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Haemolytic activity  
Pathogenic microorganisms can grow in the host by using haemin 
or hemoglobin as a source of iron.  The haemolysins are used by Candida 
species for degrading hemoglobin and extracting the elemental iron from 
host cells (Figure I.4 C).  Thus, haemolysins are key virulence factors 
enabling pathogen survival and persistence in the host (Manns et al. 1994; 
Watanabe et al,. 1999; Luo et al., 2001).  Furthermore, it is known that C. 
albicans possesses the ability to utilize iron to produce a factor which can 
release hemoglobin by lysing erythrocytes (Manns et al., 1994; Watanabe 
et al., 1999).  Production of this haemolytic factor may be regulated by the 
presence of glucose in the growth medium.  Furthermore, despite the 
activity being species and strain dependent, C. glabrata, C. parapsilosis and 
C. tropicalis are also capable of in vitro production of one or more types of 
haemolysins (in an absent, partial or total manner) (Luo et al., 2001).  
Although others authors observed that C. albicans, C. glabrata, C. tropicalis 
and C. parapsilosis are cable to product total haemolysins after 48 hours of 
incubation (Bonassoli et al., 2005; Furlaneto-Maia, et al., 2007; Kumar, et 
al., 2009; Negri et al., 2010).  Although haemolysins are known to be 
putative virulence factors contributing to pathogenicity in Candida species, 
the genetic expression of haemolytic activity of Candida is ill understood at 
present, but a study conducted for Luo et al. (2004) showed that HLP 
(haemolysin like protein) gene can be related with haemolytic activity of C. 
glabrata. 
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Concluding remarks 
 
Changes in the host are generally required for opportunistic 
pathogens to switch from harmless commensal microorganisms to 
potentially life-threatening human pathogens.  Opportunistic pathogens 
utilize several genes which play an important role in adhesion, biofilm 
formation, and enzymes secretion and are consequently involved in 
virulence.  Given these findings and the increase incidence of candidosis 
caused by NCAC species, especially, C. glabrata, C. parapsilosis and C. 
tropicalis and the unacceptable high morbidity and mortality, it is essential 
to increase our knowledge on the virulence factors associated with NCAC 
species.  Studies in this area will also contribute towards the identification 
of new targets for future therapeutics against these recently emerged 
pathogens.  
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Abstract 
Most cases of candidosis have been attributed to C. albicans, but recently, non-
Candida albicans Candida (NCAC) species have been identified as common pathogens.  
The ability of Candida species to form biofilms has important clinical repercussions due to 
their increased resistance to antifungal therapy and the ability of yeast cells within the 
biofilms to withstand host immune defenses.  Given this clinical importance of the biofilm 
growth form, the aim of this study was to characterize biofilms produced by three NCAC 
species, namely C. parapsilosis, C. tropicalis and C. glabrata.  The biofilm forming ability of 
clinical isolates of C. parapsilosis, C. tropicalis and C. glabrata recovered from different 
sources, was evaluated by crystal violet staining.  The structure and morphological 
characteristics of the biofilms were also assessed by scanning electron microscopy and the 
biofilm matrix composition analyzed for protein and carbohydrate content.  All NCAC 
species were able to form biofilms although these were less extensive for C. glabrata 
compared with C. parapsilosis and C. tropicalis.  It was evident that C. parapsilosis biofilm 
production was highly strain dependent, a feature not evident with C. glabrata and C. 
tropicalis.  Scanning electron microscopy revealed structural differences for biofilms with 
respect to cell morphology and spatial arrangement.  Candida parapsilosis biofilm 
matrices had large amounts of carbohydrate with less protein.  Conversely, matrices 
extracted from C. tropicalis biofilms had low amounts of carbohydrate and protein.  
Interestingly, C. glabrata biofilm matrix was high in both protein and carbohydrate 
content.  The present work demonstrates that biofilm forming ability, structure and matrix 
composition are highly species dependent with additional strain variability occurring with 
C. parapsilosis.  
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Introduction 
Invasive fungal infections, such as candidosis, represent a public 
health problem of major importance (Fridkin et al., 1996).  Candida species 
normally exist as commensals but they are opportunistic pathogens, with 
the ability to cause a variety of superficial and systemic infections (Odds, 
1998).  In the past ten years, the number of infections caused by Candida 
species has progressively increased (Samaranayake et al., 2002).  This 
emergence is often associated with the increasing incidence of human 
immunodeficiency virus (HIV) infection (Fanello et al., 2001), the rise in the 
elderly population base (Hargety et al., 2004), a higher number of 
immunocompromised patients and the more widespread use of indwelling 
medical devices (Kumamoto, 2002; Kojic et al., 2004).  Although most 
candidosis have been attributed to Candida albicans, more recently, non-
Candida albicans Candida (NCAC) species (Candida parapsilosis, Candida 
tropicalis and Candida glabrata) have been identified as common 
pathogens.  The prevalence of these species in human infection has been 
changing in recent years.  In the 1980s, according to Kiehn et al. (1980), C. 
albicans constituted 68% of Candida isolates from sites other than blood, 
in cancer patients, while C. tropicalis, C. parapsilosis and C. glabrata 
accounted only for 12.3, 10.3 and 3.0% of isolates, respectively.  Moreover, 
recently, 60% of the fungemia cases reported by Bassetti et al. (2006) were 
due to NCAC species.  Candida tropicalis has emerged as the second or 
third most common agent of candidemia, mainly in oncology patients 
(Weinberger et al., 2005; Nucci et al., 2007).  Moreover, the increased 
incidence of C. tropicalis as a causative agent of nosocomial urinary tract 
infections has been reported (Rho et al., 2004).  Candida parapsilosis is 
generally regarded as one of the less virulent yeast species, although it is 
now a frequent cause of candidemia.  Nosocomial outbreaks of C. 
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parapsilosis have also been described and have been attributed to transfer 
of yeast from the hands of healthcare workers (Bonassoli et al., 2005).  
Candida glabrata has recently emerged as an important nosocomial 
pathogen, yet little is known about its epidemiology (Hajjeh et al., 2004).  
Candida glabrata is of particular importance because of its innately high 
resistance to certain antifungal agents, specifically the azoles (Tsai et al., 
1997).  
One of the major contributions to Candida virulence is its versatility in 
adapting to a variety of different habitats and the formation of surface-
attached microbial communities known as biofilms (Costerton et al., 1995).  
Biofilm cells are organized into structured communities embedded within a 
matrix of extracellular material that is produced by the biofilm cells 
(Donlan et al., 2002).  Generally, the biofilm matrix composition includes 
(in addition to water), carbohydrates, proteins, phosphorus, glucose and 
hexosamines.  However, a large portion of the biofilm matrix still remains 
to be identified (Baillie et al., 2000).  The formation of Candida biofilms has 
important clinical repercussions because of their increased resistance to 
antifungal therapy and the protection afforded against host immune 
defenses (Donlan et al., 2002; Mukherjee et al., 2004).   
Many previous studies have focused on C. albicans biofilms (Hawser 
et al., 1995; Baillie et al., 1999, 2000; Chandra et al., 2001; Jin et al., 2003; 
Ramage et al., 2006) due to its well-recognized virulence, whereas only few 
studies of biofilms generated by all NCAC species have been reported 
(Hawser et al., 1994; Shin et al., 2002; Samaranayake et al., 2005; Al-
Fattani et al., 2006; Jain et al., 2007; Bizerra et al., 2008).  Thus, the aims of 
this work were firstly to assess biofilm formation ability of clinical isolates 
of C. glabrata, C. tropicalis and C. parapsilosis recovered from different 
body sites, and secondly, to characterize the biofilm structure and matrix 
composition in terms of protein and carbohydrate content. 
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Materials and methods 
Organisms  
A total of 18 clinical strains (Table II.1) of C. tropicalis, C. glabrata and 
C. parapsilosis, recovered from different body sites, were used in the 
course of this study. The majority of strains were recovered from vaginal 
and urinary tract samples were and were part of the collection at the 
Hospital of S. Marcos, Braga, Portugal.  Candida tropicalis 12 and 75 
(recovered from the vaginal tract), were obtained from the archive 
collection of the University of Maringá, Brazil.  All oral isolates were stock 
isolates of the biofilm group of the Centre of Biological Engineering, and 
were originally isolated from Clinic of Dentistry, Congregados, Portugal.  
Three reference strains of C. tropicalis, C. glabrata and C. parapsilosis from 
the American Type Culture Collection (ATCC) were also examined.  The 
identity of all isolates was confirmed using CHROMagar Candida 
(CHROMagar, Paris, France) and by PCR-based sequencing using specific 
primers (ITS1 and ITS4) against the 5.8s subunit gene reference.  Genomic 
DNA was extracted following previously described procedures (Scherer et 
al., 1987).  The PCRs products were sequenced using the ABI-PRISM Big 
Dye terminator cycle sequencing kit (Perkin Elmer, Applied Biosystems, 
Warrington, UK). 
 
Growth conditions 
For each experiment, strains were subcultured on sabouraud 
dextrose agar (SDA) (Merck, Darmstadt, Germany) for 48 h at 37°C.  Cells 
were then inoculated in sabouraud dextrose broth (SDB) (Merck) and 
incubated for 18 h at 37°C under agitation at 120 rev/min.  After 
incubation, the cells were harvested by centrifugation at 3000 g for 10 min 
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at 4°C and washed twice with ultra-pure sterile water.  Pellets were then 
suspended in SDB and the cellular density adjusted to 1x107 cells ml-1 using 
a Neubauer counting chamber. 
 
Biofilm biomass quantification  
Standardized cell suspensions (200 µl of containing 1x107 cells ml-1 in 
SDB) were placed into selected wells of 96-wells polystyrene microtiter 
plates (Orange Scientific, Braine-l`Alleud, Belgium) and incubated at 37°C 
on a shaker at 120 rev/min.  At 24 h, 100 µl of SDB medium was removed 
and an equal volume of fresh SDB added.  The preparations were then 
incubated for a further 48 h.  After this step, the medium was aspirated 
and non-adherent cells removed by washing the biofilms twice with sterile 
ultra-pure water.   
Biofilm forming ability was assessed through quantification of total 
biomass by crystal violet (CV) staining.  Thus, after washing, biofilms were 
fixed with 200 µl of methanol, which was removed after 15 min of contact.  
The microtiter plates were allowed to dry at room temperature, and 200 µl 
of CV (1% v/v) added to each well and incubated for 5 min.  The wells were 
then gently washed with sterile, ultra-pure water and 200 µl of acetic acid 
(33% v/v) added to release and dissolve the stain.  The absorbance of the 
obtained solution was read in triplicate in a microtiter plate reader (Bio-Tek 
Synergy HT, Izasa, Lisbon, Portugal) at 570 nm.  Experiments were repeated 
as part of three to five independent assays. 
 
Biofilm structure  
To examine the structure of biofilms by scanning electron microscopy 
2 ml of the standardized cell suspension (1x107 cells ml-1 in SDB) was 
introduced into 24-well polystyrene plates (Orange Scientific) and 
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incubated for 48 h at 37°C and 120 rev/min.  After 24 h, 1 ml of SDB 
medium was removed and an equal volume of fresh SDB added.  At 48 h, 
the medium was aspirated and non-adherent cells removed by washing the 
biofilms twice with sterile ultra-pure water.  Samples were dehydrated 
with alcohol (using 70% ethanol for 10 min, 95% ethanol for 10 min and 
100% ethanol for 20 min) and air dried for 20 min.  Samples were kept in a 
desiccator until the base of the wells was removed for analysis.  Prior to 
observation, the base of the wells were mounted onto aluminium stubs, 
sputter coated with gold and observed with an S-360 scanning electron 
microscope (Leo, Cambridge, USA). 
 
Biofilm matrix composition  
Extraction method 
Biofilms for analysis of matrix material were formed in 6-well 
polystyrene microtiter plates (Orange Scientific).  For this, inocula of 3 ml 
of yeast cell suspension (1x107 cells ml-1 in SDB) were added to each well 
and biofilms were formed as described previously.  After 48 h, the biofilm 
matrix was extracted using a slight modification to a previously described 
protocol (Azeredo et al., 2003).  Briefly, biofilm samples were scraped from 
the 6-well plates, resuspended with ultra-pure water, sonicated (Ultrasonic 
Processor, Cole-Parmer, Illinois, USA) for 30 s at 30 W, and then the 
suspension was vortexed for 2 min.  The suspension was centrifuged at 
3000 g for 10 min at 4°C and the supernatant filtered through a 0.2 µm 
nitrocellulose filter and stored at -20°C before analysis.  The pellets were 
dried at 60°C until a constant dry biofilm weight was determined.  The 
experiments were performed in triplicate and in three independent assays. 
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Quantification assays 
Protein and carbohydrate quantification 
The protein content of the biofilm matrix was measured using the 
BCA Kit (Bicinchoninic Acid, Sigma-Aldrich, St Louis, USA), using bovine 
serum albumin (BSA) as the standard.  
Total carbohydrate content of the biofilm matrix was estimated 
according to the procedure of Dubois et al. 1956, using glucose as 
standard.  
 
Statistical Analysis  
Results were compared using One-Way analysis of variance (ANOVA) 
by applying Levene´s test of homogeneity of variance and the Tukey 
multiple-comparisons test, using SPSS software (SPSS [Statistical Package 
for the Social Sciences], Inc., Chicago, USA).  All tests were performed with 
a confidence level of 95%.  
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Results  
Biofilm forming ability by non-Candida albicans Candida 
species  
Figure II.1 presents the results for biofilm quantification using CV 
staining.  It was evident that all NCAC species formed biofilms, although 
differences occurred depending on species or strain as in the case of C. 
parapsilosis.  Importantly, it was noticed that generally C. glabrata biofilms 
had less total biomass (average Abs=0.53±0.22) compared with C. 
parapsilosis (average Abs=1.14±0.43) and C. tropicalis (average 
Abs=1.31±0.08).  
 
 
 
Figure II.1 Absorbance values of crystal violet solutions (Abs CV) obtained from 48 h 
biofilms of non-Candida albicans Candida species formed in SDB (λ=570 nm) from 
different origins (■ oral, ■ urinary and □ vaginal).  Error bars represent standard deviation.  
*Strains that are significantly different (P<0.05) in each species.
 
Biofilms of non-Candida albicans Candida species 
 
47  
Candida glabrata strains had similar biofilm forming ability with no 
significant strain differences (P>0.05).  In contrast, C. parapsilosis strains 
were heterogeneous in terms of the level of biofilm formation.  Biofilms 
formed by C. parapsilosis AD yielded the highest level of absorbance 
(Abs=1.84±0.34) which were statistically higher than for C. parapsilosis 
534638 (P=0.004), 553877 (P<0.001) and ATCC 22019 (P<0.001).  Candida 
tropicalis strains exhibited a more homogeneous behaviour with all strains 
being high level biofilm formers (Abs values ≥ 0.75).  No statistical 
differences were found in the extent of biofilm formation for all the C. 
tropicalis strains (P>0.05), with the exception of strain 12, which had the 
highest biofilm forming ability (Abs=2.65±0.13) (P<0.001).  This strain 
produced a two-fold greater level of biofilm than other strains of C. 
tropicalis and C. parapsilosis, and a five-fold increase over C. glabrata 
strains.  
For each species, strains originating from the urinary tract generally 
yielded lower biofilm levels compared with those from other body sites.  In 
the case of C. parapsilosis, oral isolates were the highest biofilm producers 
and for the other NCAC species studied, the highest biofilm producers were 
vaginal isolates (C. glabrata 534784 and C. tropicalis 12).  
 
Structure of non-Candida albicans Candida species biofilms 
SEM analysis was used to examine biofilm structure and to determine 
Candida morphological characteristics (Figure II.2). 
Mature biofilms of C. parapsilosis and C. tropicalis strains consisted of 
a dense network of cells of a variety of morphologies.  Biofilms of C. 
parapsilosis strains AD, 553877 and ATCC 22019 were composed of both 
yeasts and pseudohyphae, although biofilms formed by other strains of the 
same species were devoid of pseudohyphae (Figure II.2 A).   
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Figure II.2 Scanning electron microscopy of non-Candida albicans Candida species biofilms 
formed in SDB at 48 hours. (A) C. parapsilosis, (B) C. tropicalis and (C) C. glabrata clinical 
isolate strains.  Arrows indicate the presence of hyphal morphologies.  The bar in the 
images corresponds to 20 µm.  Magnification ×1000. 
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Biofilms formed by C. tropicalis exhibited only yeasts morphology, 
with exception of strains AG1 and 12 which presented hyphal forms, with 
the latter appearing as especially long filaments (Figure II.2 B).  All biofilms 
of C. glabrata strains were comprised only of yeasts (Figure II.2 C).  
In the case of C. parapsilosis biofilm structure (Figure II.2 A), strains 
AD, AM2, 534638 and 513143 formed a multilayer and compact biofilm 
covering the entire surface.  In contrast, biofilms of strains 553877, 491861 
and ATCC 22019, consisted of non-contiguous cell aggregates.  The 
structure of C. tropicalis (Figure II.2 B) biofilms was also strain dependent 
with some strains (AG1, T2.2, 12, 75 and ATCC 750) producing thick 
biofilms of co-aggregated cells and others (strain 519468 and 544123) 
yielding a more discontinuous monolayer of yeasts anchored to surface.  
Candida glabrata (Figure II.2 C) revealed either a multilayer biofilm 
structure intimately packed (strains 562123 and 513100) or constituted by 
clusters of cells (strains D1, AE2, 534784, 585626 and ATCC 2001).  
The biofilm structures for isolates from the same clinical origin were 
similar for C. glabrata strains (Figure II.2 C).  Biofilms formed by the urinary 
isolates (562123 and 513100) displayed a highly compact layer covering the 
entire surface in a “carpet” like appearance.  Biofilms of oral isolates (D1 
and AE2) revealed smaller clusters compared to those in biofilms of vaginal 
isolates (534784 and 585626).  Biofilms of oral C. parapsilosis strains 
(Figure II.2 A) (AD and AM2) were very similar, presenting a multilayer 
structure.  In case of C. tropicalis (Figure II.2 B) urinary isolates (519468 and 
544123), the biofilms were also similar, presenting as discontinuous 
monolayer’s. 
 
Matrix biofilm composition  
Table II.1 shows the yield of total protein and carbohydrates 
extracted from biofilms formed by the NCAC species studied.   
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The results showed that, generally C. parapsilosis biofilm matrices 
had high amounts of carbohydrate (average mg/g biofilm dry weight = 
611.2±206) and relatively lower amounts of proteins (average mg/g biofilm dry 
weight = 50.9±21.4).  Strain differences were evident in terms of both protein 
and carbohydrate contents, with C. parapsilosis AM2 having a statistically 
higher carbohydrate and protein content in its biofilm matrix as compared 
with the all other C. parapsilosis strains, except strain 491861 (the highest 
protein content) and strain AD (similar to AM2 in carbohydrate content).  
In contrast, compared with the other species, the biofilm matrices of C. 
tropicalis strains had lower concentrations of both protein (average mg/g 
biofilm dry weight = 43.4±12.7) and carbohydrates (average mg/g biofilm dry weight = 
24.6±15.9).  Despite statistical differences being evident between C. 
tropicalis strains, the relatively low protein and carbohydrate matrix 
composition was a consistent finding for C. tropicalis. Interestingly, biofilm 
matrices of C. glabrata had relatively higher quantities of both protein 
(average mg/g biofilm dry weight = 226.7±58.6) and carbohydrate (average mg/g 
biofilm dry weight = 431.3±179.6) compared with the other species.  Indeed, 
protein levels were on average five times higher than those of C. 
parapsilosis and C. tropicalis. 
No correlation was found concerning the amount of carbohydrate 
and protein extracted from biofilm of NCAC species and the respective 
source of each clinical isolate.  However, the biofilm matrix of the vaginal 
clinical isolate, C. tropicalis 12, presented the highest amount of protein 
and carbohydrate of all clinical isolates of C. tropicalis.  For C. parapsilosis, 
oral isolates (AD and AM2) had the highest quantity of carbohydrates and 
the urinary isolate, C. parapsilosis 534638, the lowest protein and 
carbohydrate content.  
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Table II.1 Origin, reference and biofilm matrix composition of non-Candida albicans Candida species.  The values are means ± standard 
deviations 
 
* Significantly different (P<0.05) for each species.  
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Discussion 
Biofilm forming ability may confer NCAC species an ecological 
advantage, aiding survival as commensals and pathogens of humans by 
allowing them to evade host immune mechanisms, resisting antifungal 
treatment, and withstanding the competitive pressure from other 
microorganisms.  Biofilm formation in NCAC species, besides possibly being 
a key factor for the survival of these species, may also be responsible for 
them being particularly well adapted to colonization of tissues and 
indwelling devices.  
In the present study, the biofilm formation ability of different clinical 
isolates of NCAC species was evaluated and the results (Figure II.1) showed 
that all NCAC species studied (C. tropicalis, C. parapsilosis and C. glabrata), 
formed biofilms on polystyrene surfaces under the assayed conditions, 
although to different extents depending on the species and strain.  These 
results were in agreement with those of other authors, who reported that 
biofilm formation by Candida species occurs on a number of abiotic 
surfaces, including polystyrene (Hawser et al., 1994; Shin et al., 2002; 
Ramage et al., 2006; Parahitiyawa et al., 2006).  Significant statistical 
differences were found for biofilm production by the NCAC species in SDB 
medium.  In fact, C. glabrata strains were, in general, less able to form 
biofilms than C. parapsilosis and C. tropicalis strains.  These results are in 
accordance with Shin et al. (2002) who reported that biofilm positivity 
occurred most frequently in isolates of C. tropicalis, followed by C. 
parapsilosis and C. glabrata.  
It was noted that biofilm forming ability of C. parapsilosis species was 
highly strain dependent, which was less evident with both C. glabrata and 
C. tropicalis.  These observations corroborate previous reports for C. 
albicans whose growth and virulence attributes, together with biofilm 
formation (Hawser et al., 1994; Jin et al., 2003) have been shown to be 
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highly strain dependent.  Such findings undoubtedly reflect inherent 
physiological differences between strains and could have significance with 
respect to pathogenic potential.  
Despite the inherently destructive nature of SEM processing, the 
method provided useful information on biofilm structure and on the 
different cellular morphologies.  It is known that biofilm structure is 
dependent on environmental factors including growth conditions, nature 
of colonized surface (Hawser et al., 1994; Chandra et al., 2001; Jain et al., 
2007) and importantly from the perspective of this present study, the 
microbial species and strains involved (Hawser et al., 1994; Chandra et al., 
2001; Kuhn et al., 2002; Parahitiyawa et al., 2006; Jain et al., 2007).  SEM 
did indeed reveal structural and morphological differences for the biofilms 
of the studied NCAC species and strains.  Biofilms of C. glabrata (Figure II.2 
C) presented as a multilayered structure with blastoconidia intimately 
packed, for some strains, and for others as a biofilm composed of cell 
clusters.  As expected, there was a total absence of pseudohyphae and 
hyphae since C. glabrata is a non-hyphal species.  Recently, Zaw et al. 
(2007) also reported that after 48 h, the biofilms of aerobically grown C. 
glabrata generally revealed a multilayer structure packed with 
blastoconidia devoid of pseudohyphae and hyphae.  In the presented 
study, C. parapsilosis strains (Figure II.2 A) yielded a multilayer biofilm 
structure that was comprised of a dense network of yeasts and 
pseudohyphae.  Although few studies on the biofilm structure of C. 
parapsilosis strains have been reported, Kuhn et al. (2002) described that 
C. parapsilosis biofilms consisted of irregular groupings of blastoconidia on 
a basal blastoconidia layer.  Regarding C. tropicalis, its biofilms appeared as 
discontinuous layers of large blastoconidia anchored to the surface, which 
was in accordance with the findings of Bizerra et al. (2008).  The latter also 
reported that C. tropicalis biofilms formed in SDB medium, contained only 
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blastoconidia or generated a multilayer heterogeneous structure covering 
the entire surface as a thick biofilm.  In the present study, large quantities 
of hyphal elements were found in C. tropicalis 12 biofilms (vaginal clinical 
isolate).  It has been suggested (Baillie et al., 1999; Ramage et al., 2002) 
that the presence of such hyphae may have importance in the structural 
integrity of multilayered biofilms.  The present study reinforces and 
emphasizes a previous study where one C. tropicalis strain formed a thin 
layer of hyphae (in YNB) compared with other strains only presenting 
blastoconidia (Kuhn et al., 2002).  Parahitiyawa et al. (2006), reported that 
on polystyrene surfaces, C. tropicalis biofilms consisted of large 
coaggregated microcolonies of blastoconidia with a thick extracellular 
polymeric layer.  In fact, almost all microorganisms display structural 
heterogeneity within their biofilm architecture (Wimpenny et al., 2000).  
The present work indicates that this heterogeneity appears to be common 
in biofilms formed by C. glabrata, C. tropicalis and C. parapsilosis strains, 
revealing new important aspects on NCAC species biofilm ultrastructure.  
One of the most important characteristics of both bacterial and 
fungal biofilms is the presence and composition of the extracellular matrix 
(Donlan et al., 2002; Al-Fattani et al., 2006).  There is a general consensus 
that the biofilm matrix acts as a barrier to diffusion of antimicrobial agents, 
thereby limiting access of antimicrobials to organisms at the base of the 
biofilm (Al-Fattani et al., 2006).  In this study, biofilm matrices were 
analyzed for carbohydrate and protein content (Table II.1).  Significantly, 
consistent differences were found in the composition of biofilms of the 
NCAC species.  Matrices isolated from C. parapsilosis biofilms consisted of 
high amounts of carbohydrates and small amounts of proteins, whilst C. 
tropicalis biofilms were low in both carbohydrate and protein content.  
These results are in accordance with previous work (Al-Fattani et al., 2006) 
on C. tropicalis biofilm matrices which that they were mainly composed of 
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hexosamine, with smaller amounts of carbohydrate and proteins.  To the 
authors’ knowledge, this is the first report on the analysis of the biofilm 
matrices of C. parapsilosis and C. glabrata.  Interestingly, the matrices 
recovered from C. glabrata strains had higher amounts of both proteins 
and carbohydrates.  This is an interesting result, especially when related to 
potential virulence of this species whose infections yield both the highest 
mortality rate (Kcrmery, 1999) and resistance to antifungal agents (Tsai et 
al., 1997).  
The three different sources (body sites) for the clinical isolates 
represent very diverse ecological niches and differ in many biotic and 
abiotic factors.  Recent reports have demonstrated that blood isolates 
produce greater quantities of biofilm compared with oral isolates (Kumar 
et al., 2006).  In this current study, no correlation was found in terms of 
biofilm forming ability and matrix composition with the origin of the 
isolate.  However, biofilm structure analysis did highlight some interesting 
aspects.  For C. glabrata, the biofilm structure for isolates from the same 
origin did appear to be similar.  This was also true for C. tropicalis urinary 
tract isolates.  It could readily be hypothesized that for certain body sites, 
colonization requires a particular phenotype with respect to biofilm 
formation.  Such a biofilm phenotype might be genetically rather than 
environmentally governed, thus explaining why the biofilm structural 
differences could be detected in these in vitro studies.  Through elucidating 
such inherent differences, it might be possible to identify and specifically 
combat strains adapted for infection at particular body sites.  It must be 
emphasized, however, that further investigations with isolates from 
specific environments are required to confirm this hypothesis. 
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Abstract 
Candidosis have been attributed to C. albicans, however infections caused by non-
Candida albicans Candida (NCAC) species are increasingly being recognized.  The ability of 
Candida to grow as a biofilm is an important feature that promotes both infection and 
persistence in the host.  The biofilm` activity is significant since high activity might be 
associated with enhanced expression of putative virulence factors, whilst in contrast low 
activity has previously been suggested as a mechanism for resistance of biofilm cells to 
antimicrobials.  The aim of this study was to determine the metabolic activity of in vitro 
biofilms formed by different clinical isolates of NCAC species.   
The in situ total metabolic activity of C. parapsilosis, C. tropicalis and C. glabrata 
biofilms was determined using 2, 3-(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) 
carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay, and the number of cultivable 
cells was also established by CFU (colony forming unit) counts.  The biofilm structure was 
assessed by scanning electron microscopy (SEM).   
Results showed that total biofilm metabolic activity was species and strain 
dependent.  Candida glabrata exhibited the lowest biofilm metabolic activity despite 
having the highest number of biofilm cultivable cells.  Similarly, the metabolic activity of 
resuspended C. glabrata biofilm and planktonic cells was lower than that of the other 
species.  This study demonstrates the existence of intrinsic activity differences amongst 
NCAC species, which could have important implications in terms of species relative 
virulence.  Furthermore, the absence of an obvious correlation, between cultivable cells 
number and total biofilm activity raises the question about which parameter is the most 
appropriate for the in vitro assessment of biofilms and their potential clinical significance.  
 
 
Keywords: non-Candida albicans Candida species; biofilm activity, XTT reduction; 
cultivable cells 
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Introduction 
Candidosis is the most prevalent opportunistic fungal infection of 
humans and of particular significance into patients undergoing treatment 
for cancer (Kiehn et al., 1980), organ transplantation (Hargety et al., 2003) 
and receiving broad-spectrum antibiotics (Samaranayake, 1990).  
Candidosis is also one of the most common and persistent infections in 
HIV-infected individuals and AIDS patients (Samaranayake et al., 2002).   
Amongst Candida species, Candida albicans is the most commonly 
isolated and responsible for the majority of superficial and systemic 
infections (Odds, 1994).  However, many non-Candida albicans Candida 
(NCAC) species, such as Candida glabrata, Candida parapsilosis and 
Candida tropicalis have recently emerged as important pathogens in 
suitably debilitated individuals.  This fact is highlighted by recent 
epidemiology studies reporting that NCAC are currently estimated to be 
responsible for approximately 60% of fungemia (Colombo et al., 2003; 
Bassetti et al., 2006).  
A major virulence factor of Candida is its ability to adapt to a variety 
of different habitats and the consequent formation of surface-attached 
microbial communities known as biofilms (Costerton et al., 1995; Douglas, 
2003).  Candida biofilms can develop on natural host surfaces or on 
biomaterials used in indwelling medical devices.  Importantly, such biofilms 
are phenotypically distinct from their ‘free-living’ or planktonic forms, with 
biofilms exhibiting elevated resistance to host defences and administered 
antimicrobial agents (Baillie et al., 2000; Samaranayake et al., 2002; Hasan 
et al., 2009).  The clinical significance of biofilms is highlighted by recent 
estimates that over 65% of all hospital infections originate from these 
microbial communities (Mah et al., 2001).  As a consequence researchers 
are now recognising the importance of studying biofilm communities 
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rather than planktonic forms when characterising the pathogenic potential 
of microorganisms.  So far, a variety of methods have been described for 
both the in vitro production of biofilms and their subsequent 
characterization.  Indirect methods based on 96-well microtiter plate 
assays, which allow the simultaneous quantification of yeasts in a large 
number of biofilm samples have been recommended due to their simplicity 
and sensitivity (Hawser, 1996; Kuhn et al., 2002).  A frequently used 
approach to quantify biofilm cells activity has been the reduction assay of 
the tetrazolium salt 2, 3-(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT).  In this 
colorimetric method, XTT is reduced to an XTT formazan product by 
mitochondrial dehydrogenases of metabolically active cells.  The resulting 
colorimetric changes are considered to be proportional to the number of 
living cells and their metabolic activity (Hawser, 1996; Kuhn et al., 2002).   
Previous Candida biofilm studies have been mainly focused on C. 
albicans biofilms (Baillie et al., 1999; Hawser, 1996; Chandra et al., 2001; 
Jin et al., 2003; Henriques et al., 2006), with very few examining NCAC 
species (Hawser et al., 1994; Shin et al., 2002; Al-Fattani et al., 2006).  
Furthermore, the vast majority of candidal biofilm research has been 
focussed on the assessment of biofilm development either by biomass 
determination or by quantifying the number of cells in the biofilm.  The 
activity of the biofilm itself or its cellular composition has rarely been 
investigated (Kuhn et al., 2002).  This oversight is important given the fact 
that biofilm activity has significance in terms of pathogenicity as it is a likely 
indicator of growth, production of hydrolytic enzymes and, in the case of 
reduced activity, of possible resistance to antimicrobial activity.  Therefore, 
considering that the biofilm activity is a requirement in Candida infections, 
the aim of this study was to determine the metabolic activity of in vitro 
biofilms formed by different clinical isolates of NCAC species. 
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Materials and methods 
Organisms and growth conditions 
A total of 18 clinical strains (Table III.1) of C. parapsilosis (n=6), C. 
tropicalis (n=6) and C. glabrata (n=6) that had previously been recovered 
from oral, vaginal or urinary tract infections, were used in this study.  
Strains isolated from vaginal and urinary tract infections were kindly 
provided by the Hospital of São Marcos (Braga, Portugal).  Candida 
tropicalis strains 12 and 75 (recovered from the vaginal tract) were 
provided by the University of Maringá (Maringá, Brazil).  Oral isolates were 
originally isolated from patients attending the Clínica dos Congregados 
(Braga, Portugal).  Three reference strains, namely C. parapsilosis (ATCC 
22019), C. tropicalis (ATCC 750) and C. glabrata (ATCC 2001) were also 
included in this study.  The identity of all isolates was confirmed using 
CHROMagar®Candida (CHROMagar, Paris, France) and by PCR sequencing 
using specific primers (ITS1 and ITS4) targeting the 5.8S ribosomal RNA 
subunit gene (Williams et al., 1995).  
Before the experiments, all isolates were cultured on sabouraud 
dextrose agar (SDA; Merck, Germany) for 48 h at 37°C.  Cells were then 
subcultured in sabouraud dextrose broth (SDB; Merck, Germany) for 18 h 
at 37°C in an orbital shaker (120 rev/min).  Cells were then harvested by 
centrifugation at 3000 x g for 10 min at 4°C and washed twice in phosphate 
buffer saline (PBS pH 7, 0.1 M).  The cell pellets were finally resuspended in 
SDB and the cell concentration was adjusted using an improved Neubauer 
haemocytometer to a standardised level (1×107 or 1×108 cells ml-1) 
depending on the experiment. 
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Biofilm formation 
Biofilms were produced in 96-wells microtiter plates (Orange 
Scientific, Braine-l’ Alleud, Belgium).  Briefly, standardised inocula (200 µl 
of yeast cell suspension containing 1x107 cells ml-1 in SDB) were placed into 
selected wells and incubated at 37°C in an orbital shaker incubator at 120 
rev/min.  After 24 h, an aliquot of 100 µl of SDB medium was removed and 
an equal volume of fresh SDB added.  The microtiter plates were then 
incubated for further 48 h.  Experiments were performed in triplicate and 
on at least three separate occasions. 
 
Biofilm characterization 
In situ biofilm metabolic activity 
An XTT reduction assay (Hawser, 1996, 1998) was used to determine 
the in situ biofilm metabolic activity of the NCAC strains.  After biofilm 
formation, the culture medium was aspirated and the non-adherent cells 
were removed by washing the biofilms twice in PBS.  A 200 µl aliquot of a 
solution containing 100 µg/µl of XTT (2, 3-(2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) 
(Sigma-Aldrich, USA) and 10 µg µl-1 of PMS (phenazine methosulfate) 
(Sigma-Aldrich, USA) was then added to each pre-washed biofilm and also 
to the control wells (to measure background XTT levels).  The plates were 
then incubated for 3 h in the dark, at 37°C with agitation (120 rev/min).  
Colorimetric changes were measured at 490 nm using a microtiter plate 
reader (Bio-Tek® Synergy HT, Izasa, Portugal) and the absorbance values 
were standardised per unit area of well (absorbance/cm2).   
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Quantification of biofilm cultivable cells 
The number of cultivable biofilm cells was determined by counting 
colony forming units (CFUs) following biofilm cells resuspension.  Briefly, 
biofilms were first washed twice in PBS to remove loosely attached cells 
and the biofilm was then resuspended by repeated pipetting.  Complete 
removal of the biofilm was confirmed by subsequent crystal violet staining 
and spectrophotometric reading for inspection of the wells.  The 
resuspended biofilm (500 µl) was vigorously vortexed for 5 min to disrupt 
the biofilm matrix and serial decimal dilutions (in PBS) were plated onto 
SDA.  Agar plates were incubated for 24 h at 37°C, and the total CFUs per 
unit area (Log CFU/cm2) of microtiter plate well were enumerated.  
Experiments were repeated on three occasions with individual samples 
evaluated in triplicate.  
 
Biofilm structure  
Biofilm structure was examined by Scanning Electron Microscopy 
(SEM). Biofilms were formed by seeding 2 ml of the standardized cell 
suspension (1x107 cells ml-1 in SDB) into 24-well plates (Orange Scientific, 
Braine-l`Alleud, Belgium) and incubated for 48 h at 37°C and 120 rev/min. 
After 24 h, 1 ml of SDB medium was removed and an equal volume of fresh 
SDB added.  At 48 h, the medium was aspirated and non-adherent cells 
removed by washing the biofilms twice with sterile ultra-pure water. 
Samples were dehydrated with alcohol (using 70% ethanol for 10 min, 95% 
ethanol for 10 min and 100% ethanol for 20 min) and air dried for 20 min.  
Samples were kept in a desiccator until the base of the wells was removed 
for analysis.  Prior to observation, the base of the wells were mounted 
onto aluminium stubs, sputter coated with gold and observed with an S-
360 scanning electron microscope (Leo, Cambridge, USA). 
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Quantification of cellular metabolic activity  
Metabolic activity of biofilms cells 
Biofilms were removed from the microtiter plate wells as described 
previously and the cell concentration adjusted to 1×108 cells ml-1 using an 
improved Neubauer haemocytometer.  Cells from 1 ml of the standardised 
cell preparation by centrifugation (3000 x g), and the supernatant was 
discarded.  An aliquot of 1 ml of XTT solution (100 µg µl-1 of XTT and 10 µg 
µl-1 of PMS) was added to the yeast cells pellet.  The mixture was then 
incubated in the dark for 3 h at 37°C and 120 rev/min.  Colorimetric 
changes were measured as previously described and activity expressed as 
absorbance/1x108 cells.  Experiments were repeated on three occasions 
with individual samples evaluated in triplicate.  
 
Metabolic activity of planktonic cells  
Cells were inoculated in SDB for 18 h at 37°C under agitation (120 
rev/min) and then harvested by centrifugation (3000 x g for 10 min at 4°C) 
and washed twice in PBS.  After resuspension in PBS, the cell concentration 
was adjusted to 1 x 108 cells ml-1 and the cellular metabolic activity was 
measured as previously described for the resuspended biofilm cells. 
 
Statistical analysis 
Results were compared using a one-way analysis of variance 
(ANOVA) by applying Levene´s test of homogeneity of variance and the 
Tukey multiple-comparisons test, using SPSS software (SPSS [Statistical 
Package for the Social Sciences], Inc., Chicago, IL).  All tests were 
performed with a confidence level of 95%. 
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Results and discussion 
The primary aim of this study was to determine the total in situ 
biofilm activity of 21 strains of NCAC species using an XTT reduction assay 
(Figure III.1).   
 
 
 
Figure III.1 Absorbance values of XTT solutions per cm2 of biofilms formed in SDB 
for 48 h by different clinical isolates of C. parapsilosis, C. tropicalis and C. glabrata.  
Error bars represent standard deviation.  *Strains of the same species that are 
significantly different (P<0.05).  
 
 
It was clearly evident that biofilm metabolic activity was species and 
strain dependent.  Specifically, the overall mean metabolic activity of C. 
glabrata (Abs/cm2 = 0.19±0.05) biofilms was lower than for C. parapsilosis 
(Abs/cm2 = 0.33±0.15) and C. tropicalis (Abs/cm2 = 0.24±0.14).  Such intra 
species variation in terms of biofilm formation has previously been 
demonstrated albeit using parameters other than activity (Hawser, 1994; 
Shin et al., 2002).  It was interesting to note that in the case of C. 
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parapsilosis, both urinary tract isolates (534638 and 553877) had 
significantly (P<0.05) lower biofilm metabolic activity (Abs/cm2 = 
0.20±0.01; Abs/cm2 = 0.09±0.04) compared with the other C. parapsilosis 
strains.  Whether this finding relates to an inherent difference between 
strains from distinct pathological origins is unclear, and further 
investigation involving larger number of strains from these conditions is 
needed to clarify this point. 
There are several possible reasons for the observed species and strain 
differences in in situ biofilm metabolic activity.  A key factor would 
obviously be the relative number of metabolic active cells within the 
biofilm itself.  In order to analyse this, CFU counts for each biofilm were 
determined.  In contrast to what would perhaps be expected, there was no 
correlation between biofilm metabolic activity (Figure III.1) and CFU 
number (Figure III.2).  
 
 
 
Figure III.2 Logarithm of number cells of C. parapsilosis, C. tropicalis and C. 
glabrata per cm2 the biofilm formed in SDB after 48 h.  Error bars represent 
standard deviation. *Strains of the same species that are significantly different 
(P<0.05).  
 
Chapter III 
 
72  
It was evident that despite C. glabrata biofilms having the lowest 
metabolic activity, these biofilms had significantly (P>0.05) higher number 
of cultivable cells per unit area (Log CFU/cm2 = 9.16±0.59) when compared 
with C. tropicalis (Log CFU/cm2 = 7.34±0.72) and C. parapsilosis (Log 
CFU/cm2 = 7.82±0.09).  Furthermore, also the intra-strain variation 
observed for C. parapsilosis and C. tropicalis in terms of biofilm metabolic 
activity (Figure III.1) was not associated with differences in CFU numbers 
(Figure III.2).  
The observed discrepancy between in situ total biofilm activity and 
the number of cultivable cells does have important implications for biofilm 
studies, since it is often assumed that metabolic activity measurements 
provide a sufficient correlation to indirectly quantify biofilms (Hawser, 
1996; Chandra et al., 2001; Zaw et al., 2007).  This situation may be 
adequate when comparing a single strain type under different 
environmental conditions but is problematic when multiple strains and 
species are being compared (Kuhn et al., 2003). 
In terms of species and strain differences, consideration has to be 
given to inherent differences in the relative size, morphology, and 
biochemistry of cells.  It is known that C. glabrata cells are generally 
smaller (1-4 µm) than C. tropicalis (4-8 µm) and C. parapsilosis (2.5-4 µm) 
(Odds, 1998) and also have a narrower spectrum of carbohydrate 
utilisation (Kwon-Chung, et al., 1992; Fidel et al., 1999).  Unlike C. 
parapsilosis and C. tropicalis, C. glabrata (Figure III.3) is unable to generate 
filamentous forms which may also be expected to exhibit different 
metabolic activity, and thus contribute to species differences (Kuhn et al., 
2002).  Inherent species differences would be supported by the control 
experiments (Table III.1) where planktonic cultures illustrated similar 
differences between the species with C. glabrata again having lower 
cellular metabolic activity compared with the other two species.   
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Table III.1 Non-Candida albicans Candida strains used in this study, values of in situ total biofilm activity, relative biofilm activity and metabolic 
activity of biofilm and planktonic cells 
 
Species Strains Origin 
In situ total biofilm activity 
(Abs values/cm
2
) ± SD 
Relative biofilm activity 
(Abs values/10
8
 CFU) 
Cellular metabolic activity 
(Abs values/10
8
 cells) ± SD 
Biofilm cells Planktonic cells 
C. parapsilosis 
534638 
Urinary tract 
0.198 ± 0.01 0.518 0.548 ± 0.08 0.621 ± 0.05 
553877 0.099 ± 0.04 0.199  0.323 ± 0.04 0.474 ± 0.13 
AD 
Oral tract 
0.297 ± 0.07 0.055  0.387 ± 0.06 0.702 ± 0.19 
AM2 0.337 ± 0.13 0.116  0.587 ± 0.09 0.407 ± 0.09 
491861 
Vaginal 
0.405 ± 0.02 1.311  0.534 ± 0.11 0.554 ± 0.11 
513143 0.537± 0.04 1.677  0.496 ± 0.11 0.669 ± 0.11 
ATCC 22019 Reference 0.454 ± 0.09 1.134
 
0.221 ± 0.05 0.492 ± 0.05 
C. tropicalis 
519468 
Urinary tract 
0.115 ± 0.03 0.295 0.273 ± 0.01 0.702 ± 0.15 
544123 0.179 ± 0.02 1.059 0.283 ± 0.07 0.867 ± 0.07 
AG1 
Oral tract 
0.322 ± 0.05 1.094 0.345 ± 0.07 0.467 ± 0.04 
T2.2 0.259 ± 0.02 0.922 0.162 ± 0.02 0.585 ± 0.09 
12 
Vaginal 
0.185 ± 0.01 0.041 0.313 ± 0.02 0.298 ± 0.01 
75 0.137 ± 0.03 3.672 0.376 ± 0.07 0.323 ± 0.01 
ATCC 750 Reference 0.507 ± 0.09 16.80 0.665 ± 0.11 0.688 ± 0.02 
C. glabrata 
562123 
Urinary tract 
0.223 ± 0.04 0.006  0.228 ± 0.07 0.281 ± 0.09 
513100 0.129 ± 0.03 0.002 0.100 ± 0.02 0.149 ± 0.01 
D1 
Oral tract 
0.237 ± 0.09 0.006  0.179 ± 0.03 0.138 ± 0.07 
AE2 0.201± 0.08 0.052 0.167 ± 0.02 0.135 ± 0.04 
534784 
Vaginal 
0.172 ± 0.07 0.049 0.131 ± 0.03 0.079 ± 0.03 
585626 0.118 ± 0.05 0.031 0.084 ± 0.02 0.201 ± 0.06 
ATCC 2001 Reference 0.238 ± 0.06 0.084
 
0.181 ± 0.05 0.732 ± 0.14 
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Specifically, it was shown that C. glabrata biofilm cells had, on 
average, a lower metabolic activity (Abs/1x108cells = 0.15±0.03) than either 
C. tropicalis (Abs/1x108cells=0.35±0.16) or C. parapsilosis 
(Abs/1x108cells=0.45±0.15) cells (Table III.1).  There were, however, some 
discrepancies when comparing the relative strain hierarchy for metabolic 
activity for the planktonic and biofilm cultures.  A possible explanation for 
this relates to potential additional significant phenotypic differences 
occurring between the two lifestyles (Mukherjee et al., 2003; Ramage et 
al., 2005).  Perhaps the most important of these, are those factors that 
relate to the promotion, persistence and virulence of the organisms within 
the host environment.   
As biofilm cells are organised into structured communities embedded 
within an extracellular matrix, activity within biofilms would be dependent 
on nutrient access and availability of oxygen, together with removal of 
waste products.  These factors may vary because of inherent differences in 
the biofilms produced by the tested strains and species, with the resulting 
alteration in cellular and biofilm metabolic activity.  Indeed, evidences of 
variation in biofilm spatial arrangement is possible observed in Figure III.3.   
For instances (Figure III.3B), concerning C. tropicalis 12, which 
possess high number of CFU (Figure III.2) and low activity (Figure III.1), it is 
possible to verify that its biofilm is more cohesive than C. tropicalis 75, 
which presents lower CFU number (Figure III.2) as well as metabolic activity 
(Figure III.1).  The same was observed for C. glabrata (Figure 3III.A) and C. 
parapsilosis (Figure III.3C) biofilms.  Thus, an effect on the ability of XTT to 
diffuse into these ‘different’ biofilms is an aspect that also cannot be 
disregarded.  When total biofilm activity was normalised against 1x108 CFU 
of resuspended biofilm (Table III.1), it was evident that the relative biofilm 
activity of C. glabrata was 100 times less than C. tropicalis and 10 times 
lower than C. parapsilosis.   
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Figure III.3 Biofilm scanning electron microscopy images of two C. glabrata (A), C. 
tropicalis (B) and C. parapsilosis (C) strains formed in SDB for 48 h.  Magnification 
3000 x, bar 10 µm.  
 
 
Interestingly, this analysis highlights additional heterogeneity in 
terms of relative biofilm metabolic activity between C. parapsilosis and C. 
tropicalis.  Furthermore, the results indicate that, in general, biofilms 
formed by clinical isolates had a much lower relative activity compared to 
the corresponding reference strains, with the exception of C. parapsilosis 
ATCC 22019. 
In summary, this work underlines both species and strain differences 
in biofilm metabolic activity which in part reflects the inherent 
physiological differences between the organisms.  However, it has also to 
be considered that intrinsic biofilm factors may have a direct effect on the 
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responses obtained.  These findings may have significance concerning the 
pathogenic potential of the strains tested when extrapolated to in vivo 
situations, with the clinical isolates generally having a lower activity than 
the equivalent reference species.  Such a relatively low activity could 
promote persistence of the isolates within a clinical environment once the 
biofilm has become established.  Another important aspect raised by this 
study is that future research needs to consider which is the most 
appropriate parameter to investigate in vitro biofilm models since total 
biofilm activity or cultivable cells number do not necessarily reflect the 
behaviour of the biofilm itself. 
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Abstract 
Urinary tract infections (UTIs) are the most common nosocomial infections and 80% 
are related to the use of urinary catheters.  Furthermore, Candida species are responsible 
for around 15% of UTIs and an increasing involvement of non-Candida albicans Candida 
(NCAC) species (e.g. C. glabrata, C. tropicalis and C. parapsilosis) has been recognised.  
Given the fact that silicone is frequently used in the manufacture of urinary catheters, the 
aim of this work was to compare both the adhesion and biofilm formation on silicone of 
different urinary clinical isolates of NCAC species (i. e. C. glabrata, C. tropicalis and C. 
parapsilosis) in the presence of urine.  Several clinical isolates of NCAC species recovered 
from patients with UTIs, together with reference strains of each species, were examined.  
Adhesion and biofilm formation were performed in artificial urine and the biofilm biomass 
assessed by crystal violet staining.  Hydrophobicity and surface charge of cells was 
determined by measuring contact angles and zeta potential, respectively.  The number of 
viable cells in biofilms was determined by enumeration of CFU after appropriate culture.  
The biofilm structure was also examined by confocal laser scanning microscopy (CLSM). 
The results showed that all isolates adhered to silicone in a species- and strain-dependent 
manner with C. parapsilosis showing the lowest and C. glabrata the highest levels of 
adhesion.  However, these differences in adhesion abilities cannot be correlated with 
surface properties since all strains examined were hydrophilic and exhibited a similar zeta 
potential.  Despite a higher number of cultivable cells being recovered after 72 h of 
incubation, stronger biofilm formation was not observed and CLSM showed an absence of 
extracellular polymeric material for all isolates examined.  In summary, this work 
demonstrates that all tested NCAC species were able to adhere to and survive on silicone 
in the presence of urine.  Furthermore, C. glabrata strains presented higher colonization 
abilities compared with C. tropicalis and C. parapsilosis strains, a fact that might explain 
the larger role of C. glabrata colonization and disseminated infections in hospitalized and 
catheterized patients. 
 
Keywords: urinary tract infections; silicone; urine; non-Candida albicans 
Candida species, adhesion, biofilm 
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Introduction 
Nosocomial infections constitute a serious public health problem, as 
they are a major cause of morbidity and mortality, and cause an increased 
time of hospitalization with associated enhanced healthcare costs (Tamura 
et al., 2003).  Urinary tract infection (UTI) is one of the most common types 
of nosocomial infections (Schaberg et al., 1991, Tamura et al., 2003) and 
more than 80% of nosocomial UTIs are related to the use of medical 
devices such as urinary catheters (Febré et al., 1999; Harris et al, 1999; 
Douglas, 2002; Chow et al., 2008).  Furthermore, Candida species are 
responsible for around 80% of fungal infections in the hospital 
environment and 10-15% of UTIs are caused by these microorganisms 
(Amer et al., 2004).  Although, the majority of infections are caused by 
Candida albicans (Richards et al., 1999; Sobel et al., 2000), non-Candida 
albicans Candida (NCAC) species including Candida glabrata (Harris et al., 
1999; Manzano-Gayosso et al., 2008), Candida tropicalis (Kauffman et al., 
2000) and Candida parapsilosis (Ruan et al., 2008) are emerging as 
important nosocomial pathogens with a predilection for the urinary tract.  
Candida species are commensal microorganisms that become 
pathogenic when the defence mechanisms of the host is weakened, and 
these organisms then have the ability to cause a variety of superficial and 
systemic infections (Kojic et al., 2004).  The primary event in Candida 
infection is the adherence of the microorganism to a host and/or medical 
device surface, often leading to the formation of biofilms (Crump et al., 
2000; Chandra et al., 2001a).  Once established, Candida biofilms serve as a 
persistent reservoir of infection and, in addition, offer great tolerance to 
antifungal agents (Chandra et al., 2001b; Ramage et al., 2001; 
Samaranayake et al., 2005).  
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Predisposition to the development of fungal infections is mediated by 
multiple factors (Douglas, 2003) and it is now recognized that implanted 
devices have a profound clinical impact due to Candida-associated biofilms 
(Douglas, 2002).  Thus, the main aim of this work was to compare both the 
adhesion and biofilm formation ability of different urinary clinical isolates 
of NCAC species (i.e. C. glabrata, C. tropicalis and C. parapsilosis) onto 
silicone in the presence of urine.  
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Materials and methods 
Organisms 
A total of six urinary isolates of C. parapsilosis (534638 and 553877), 
C. tropicalis (519468 and 544123) and C. glabrata (562123 and 513100) 
were used in the course of this study.  Three reference strains, namely C. 
parapsilosis (ATCC 22019), C. tropicalis (ATCC 750) and C. glabrata (ATCC 
2001) were also examined.  Strains isolated from UTIs were gifted from the 
collection of the Hospital of São Marcos, (Braga, Portugal).  The identity of 
all isolates was confirmed using CHROMagar Candida and by PCR 
sequencing using specific primers (ITS1 and ITS4) targeting 5.8S rRNA 
subunit gene (Williams et al., 1995).  Genomic DNA was extracted 
according to previously described procedures (Scherer et al., 1987).  PCR 
products were sequenced using the ABI PRISM Big Dye Terminator Cycle 
Sequencing kit (Perkin Elmer, Applied Biosystems).  
 
Medium and growth conditions 
All Candida isolates were subcultured on sabouraud dextrose agar 
(SDA; Merck) for 48 h at 37°C, followed by culture in sabouraud dextrose 
broth (SDB, Merck) for 18 h at 37°C in an orbital shaker (120 rev/min).  
Cells were then harvested by centrifugation at 3000 g for 10 min at 4°C and 
washed twice with PBS (pH 7, 0.1 M).  The cell pellets were finally 
resuspended in artificial urine (AU) and cell concentration was adjusted 
using an improved Neubauer haemocytometer to 1×107 cells ml-1.  AU (pH 
5.8) was prepared with slight modification to that previously described 
(Shin et al., 2002; Jain et al., 2007).  The composition of the AU used in this 
study was, CaCl2 (0.65 g l
-1), MgCl2 (0.65 g l
-1), NaCl (4.6 g l-1), Na2SO4 (2.3 g 
l-1), Na3C3H5O(CO2)3 (0.65 g l
-1), Na2C2O4 (0.02 g l
-1), KH2PO4 (2.8 g l
-1), KCl 
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(1.6 g l-1), NH4Cl (1.0 g l
-1), urea (25.0 g l-1), creatinine (1.1 g l-1) and 
dextrose 0.3%.  
 
Silicone 
Coupons (1 × 1 cm2) were cut from a 1 mm layer of silicone (Neves & 
Neves, Trofa, Portugal).  This material was chosen due to its similarity to 
the material used in indwelling devices, including urinary catheters.  All 
coupons were cleaned by immersion in ultrapure water, followed by 
immersion in 50% (v/v) ethanol for 4 h.  After rinsing with ultrapure water 
and air-driyng, the coupons were autoclaved for 15 min at 121°C.   
 
Candida surface properties  
Contact angle measurement 
Hydrophobicity was evaluated through contact angle measurements 
and using the approach of van Oss et al. (1987, 1989).  The measurements 
were made on Candida cell lawns deposited on membrane filters, after 2 h 
of equilibrium in AU pH 5.8, prepared according to Busscher et al. (1984).  
For this, suspensions of 5 ml of 108 cells ml-1 were filtered and deposited 
over solidified agar plates (2% agar and 10% glycerol) and dried at 37°C for 
3–4 h to standardize the humidity level.  Contact angles were measured by 
the sessile drop technique on the cell lawns using a contact angle 
measurement apparatus (model OCA 15 PLUS, DATAPHYSICS).  The 
measurements were performed at room temperature, using three 
different liquids: water, formamide and 1-bromonaphtalene.  Each assay 
was performed in triplicate and at least 20 contact angles per sample were 
measured. 
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Zeta potential measurement 
The electric charge of the Candida strains under study was evaluated 
by zeta potential determination, after 2 h of equilibrium in AU pH 5.8 
(1×107 cells ml-1).  Measurements were performed with a 
microelectrophoresis cell (DLS Nanosizer; Malvern).  The applied voltage 
was 200 V, and each average value consisted of 25 recordings.  
 
Adhesion assays 
For the adhesion assays, silicone coupons were placed into 12-well 
microtiter plates (Orange Scientific) and 1 ml of the standardized cell 
suspension (1×107 cells ml-1 in AU) was added.  For controls, silicone 
coupons were similarly processed but in the absence of Candida cells.  The 
microtiter plates were incubated for 2 h at 37°C in an orbital shaker (120 
rev/min).  Following incubation, silicone coupons were placed into new 12-
well culture plates and washed once with ultrapure water to remove non-
adhered cells.  The cells were then fixed with 1 ml of 100% (v/v) methanol, 
which was removed after 15 min of contact.  The silicone coupons were 
then allowed to air dry at room temperature, and 1 ml of 1% (v/v) crystal 
violet (CV) was added and incubated for 5 min to stain the adhered cells.  
The silicone coupons were then gently washed twice with ultrapure water 
to remove the excess of CV and were allowed to dry at room temperature.  
Coupons were visualized under light microscopy (Olympus BX51) 
coupled to a DP71 digital camera (Olympus) for acquisition of images 
(original magnification×400).  At this magnification, each captured image 
was equivalent to 1.7×2.2 cm2.  For each surface analysed, at least 20 
images were obtained across the entire silicone surface.  The number of 
adhered cells per image was determined by image analysis using 
automated enumeration software (Sigma Scan Pro, Systat Software).  The 
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results were then expressed as the number of cells per unit area of silicone 
(number cells cm-2).  All experiments were performed in triplicate and in 
three to five independent assays. 
 
Biofilm formation assays 
For biofilm formation assays, silicone coupons were placed in 12-well 
microtiter plates (Orange Scientific) and 1 ml of standardized cell 
suspension (1×107 cells ml-1 in AU) was added.  The microtiter plates were 
incubated for 4, 8, 12, 24, 48 and 72 h at 37°C in an orbital shaker (120 
rev/min).  Every 24 h, 500 µl AU was removed and an equal volume of 
fresh AU added.  For controls, silicone coupons were similarly processed 
but in the absence of Candida.  Biofilm formation was assessed by total 
biomass quantification using CV staining (Stephanovic et al., 2000; Silva et 
al., 2009).  Thus, after the defined times of incubation, the medium was 
aspirated and non-adherent cells removed by washing the silicone coupons 
with sterile water.  The biofilm was then fixed with 1 ml of 100% (v/v) 
methanol, which was removed after 15 min of contact.  The silicone 
coupons were allowed to dry at room temperature, and 1 ml of CV (1% v/v) 
was added to each well and incubated for 5 min.  The silicone coupons 
were gently washed with sterile water and 1 ml of acetic acid (33% v/v) 
was added to release the CV from cells.  The A570 of the obtained solution 
was read in triplicate in a microtiter plate reader (Bio-Tek Synergy HT, 
Izasa).  The final absorbance was standardized according to the area of 
silicone (absorbance cm-2).  Experiments were performed in triplicate and 
repeated in three to five independent assays. 
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Candida viability assays 
The number of cultivable cells was determined by CFU enumeration.  
Briefly, after 4 and 72 h of biofilm formation (as described previously), 
silicone coupons were washed once in PBS (0.1M, pH 7) to remove loosely 
attached cells.  Coupons of silicone were then immersed in 3 ml of PBS 
(0.1M, pH 7) in new 6-well tissue culture plates and sonicated (Ultrasonic 
Processor, Cole-Parmer) for 45 s at 30 W.  Complete removal of adhered 
cells was confirmed by CV staining (as described previously).  The obtained 
suspensions were vortexed vigorously for 5 min and then serial decimal 
dilutions (in PBS) were subcultured onto SDA and incubated for 24 h at 
37ºC for c.f.u enumeration (log CFU cm-2).  Experiments were repeated in 
three occasions with individual samples evaluated in triplicate. 
 
Confocal laser scanning microscopy (CLSM)  
After 72 h of biofilm formation, silicone coupons were washed once 
with PBS (0.1M, pH 7), incubated for 40 min at 37°C in 1 ml of PBS 
containing the fluorescent stains FUN 1 (10 µM, Molecular Probes-
Invitrogen) and concanavalin A Alexa Fluor 488 conjugate (25 µg ml-1 in 
PBS, Molecular Probes-Invitrogen) and observed by CLSM.   
FUN1 (excitation wavelength=543 nm and emission=560 nm) is 
converted to orange-red cylindrical intravacuolar structures by 
metabolically active cells, while concanavalin A (excitation wavelength=488 
and emission=505 nm) binds to glucose and mannose residues with the 
emission of green fluorescence.  Stained silicone coupons were observed 
with a Leica TCS SP2 AOBS spectral confocal microscope. 
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Statistical analysis  
Results were compared using one-way analysis of variance (ANOVA) 
by applying Levene´s test of homogeneity of variance and the Tukey 
multiple-comparisons test, using SPSS software.  All tests were performed 
with a confidence level of 95%. 
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Results 
Hydrophobicity and zeta potential of non-Candida albicans 
Candida species   
Candida cell surface physico-chemical characteristics are presented in 
Table IV.1.  
 
Table IV.1 Water contact angle (Ɵ), values of the polar components of surface 
tension (Ɣ+, Ɣ-), degree of hydrophobicity (ΔGSWS) and zeta potential (ζ) of non-
Candida albicans Candida strains assayed 
 
 
* 
Statistically different from the other strains (P<0.05).  
Ϯ Strains that are statistically similar (P>0.05) but different from (P<0.05) those of other 
species. 
 
The hydrophobicity of the yeast cell surfaces (∆Gsws) expresses the 
free energy of interaction between two identical surfaces (s) immersed in 
water (w), as proposed by van Oss et al. 1995.  Water contact angles were 
Species Strain  () ± SD ˠ+ (mJm-2) 
 
ˠ- (mJm-2) 
 
∆Gsws (mJm−2) 
 
ζ (mV) ± SD 
C. parapsilosis 
534638 19.4 ± 2.7 4.4 51.1 24.4 - 2.2 ± 0.0 
553877 17.3 ± 1.2 3.4 51.8 26.3 - 1.4 ± 0.0 
ATCC 22019 17.7 ± 2.5 3.6 51.6 25.8 -2.7 ± 0.5 
C. tropicalis 
519468 20.7 ± 1.3 3.7 49.0 23.2 -2.6 ± 0.1 
544123 24.0 ± 1.3 8.4* 47.2* 15.5* -2.6 ± 0.6 
ATCC 750 20.5 ± 2.3 4.5 49.8 23.0 -3.8 ± 0.7 
C. glabrata 
562123 17.4 ± 2.4 3.4 50.6 25.1 -4.1 ± 0.6
∆
 
513100 19.2 ± 2.4 4.9 51.3 23.7 - 4.1 ± 0.9
∆
 
ATCC 2001 19.6 ± 2.2  3.1 53.0 28.4 -4.2 ± 0.6
∆
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used as a qualitative indication of cell surface hydrophobicity, with values 
below 65° indicating a hydrophilic surface (Vogler, 1998). 
Similar water contact angle values were obtained for all NCAC strains, 
ranging from 17.3° ± 1.2 (C. parapsilosis 553877) to 24.0° ± 1.3 (C. tropicalis 
544123), indicating that the different strains were of similar cell surface 
hydrophobicity (P>0.05) which were positive therefore indicating 
hydrophilic surfaces.  Regarding surface tension components, all strains 
showed higher values of the electron donor parameter (γ-) comparing to 
the electron acceptor parameter (γ+).  Candida tropicalis 544123 showed, 
again, the highest value of electron acceptance while C. glabrata ATCC 
2001 revealed the lowest value of the electron donor parameter.  
Table IV.1 summarizes the zeta potential values obtained for 
different NCAC strains when immersed in AU pH 5.8.  All strains had a 
negative zeta potential value, ranging from -4.2 ± 0.6 mV to -1.4 ± 0.0 mV.  
Furthermore, C. glabrata strains presented the most negative values, 
which were statistically lower than C. parapsilosis and C. tropicalis strains 
(P<0.05).   
 
Adhesion of non-Candida albicans Candida species to silicone  
Figure IV.1 presents the results of the extent of adhesion of NCAC 
species (i.e. C. glabrata, C. tropicalis and C. parapsilosis) to silicone in the 
presence of AU.  It was evident that all NCAC strains adhered to silicone, 
although differences were observed according to species and strains.  
Strain variation was particularly evident for C. parapsilosis, with C. 
parapsilosis 534638 displaying the highest number of cells adhered to 
silicone (2.2x106 ± 7.5x105 cells cm-2).   
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Figure IV.1 Number of cells of non-candida albicans Candida species per unit area 
adhered to silicone after 2 h in the presence of AU.  Error bars represent standard 
deviation.  *Statistically different from the other strains of the same species 
(P<0.05);  ∆statistically different from all strains of other species (P<0.05).  
 
 
This was significantly higher than C. parapsilosis 553877 (P=0.024) 
and the reference strain C. parapsilosis ATCC 22019 (P=0.023).  Compared 
with C. tropicalis and C. glabrata, C. parapsilosis adhered to the silicone 
coupons at a significantly lower (P<0.05) level.  Strains of C. glabrata 
adhered at equivalent levels to silicone (P>0.05), with the highest number 
of adhered cells (6.2x106 cells cm-2) evident for C. glabrata 562123.  
Candida tropicalis strains equally showed similar adhesion levels with little 
inter-strain difference (P>0.05).   
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Biofilm formation of non-Candida albicans Candida species on 
silicone  
Biofilm quantification was performed through total biomass 
quantification by CV staining.  Figure IV.2 shows the analysis of biofilm 
development (4, 8, 12, 24, 48 and 72 h of incubation) for C. parapsilosis, C. 
tropicalis and C. glabrata strains, on silicone in the presence of AU.   
 
 
 
Figure IV.2 Abs (570 nm) of CV solutions obtained from biofilms of non-Candida 
albicans Candida species formed on silicone in the presence of AU.  (A) C. 
parapsilosis; (B) C. tropicalis; and (C) C. glabrata strains.  Error bars represent 
standard deviation.  
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It was evident that biofilms of C. glabrata had a higher total biomass 
than those of C. parapsilosis and C. tropicalis at all measured time points 
(P<0.05).  Candida tropicalis and C. parapsilosis strains produced biofilm 
biomass of similar levels (P>0.05), whilst C. glabrata strains exhibited a 
more heterogeneous behaviour under the test conditions.  No statistical 
differences were observed between biomass values obtained at 4 and 72 h 
in the case of C. tropicalis and C. parapsilosis strains (P>0.05).  In contrast, 
biomass values for C. glabrata 513100 and ATCC 2001 strains decreased 
significantly after 48 h of incubation (P<0.05).  
Silicone coupons incubated for 72 h were also examined by 
fluorescence CLSM (Figure IV.3).   
 
 
 
Figure IV.3 CLSM images of non-Candida albicans Candida species 72 h growth on 
a silicone surface in the presence of urine.  Arrows indicate the presence of 
hyphal morphologies.  Magnification × 600. 
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The intense green fluorescence, resulting from concanavalin A 
binding to polysaccharides, outlines the live and dead cell wall of yeasts, 
while the red/orange colour, due to FUN 1 staining, identifies active cells.  
Thus, confocal images showed an absence of extracellular polymeric 
material (green coloration) at the last period of incubation (cells separated 
by regions lacking fluorescence), though this is not surprising, since the 
concentration of polymers within the matrix is typically low.  The observed 
area of red/orange fluorescence, confirmed the presence of higher 
amounts of metabolically active cells after 72 h adhesion on silicone in the 
presence of urine.  Furthermore, C. parapsilosis and C. tropicalis strains 
presented filamentous morphologies which were not evident with C. 
glabrata strains.   
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Discussion 
UTI is the most common type of nosocomial infection and is 
frequently associated with the use of indwelling urinary catheters (Febré et 
al., 1999).  Candida species are responsible for around 15% of UTIs (Amer 
et al., 2004) and there is an increasingly recognised involvement of NCAC 
species (Harris et al., 1999; Kauffman et al., 2000; Krcmery et al., 2002; 
Ruan et al., 2008).  Silicone rubber is the biomaterial frequently used to 
manufacture urinary catheters, and given the involvement of NCAC in UTIs, 
this present study aimed to assess the ability of NCAC species to colonize 
silicone in the presence of AU.   
All NCAC species (i.e. C. glabrata, C. parapsilosis and C. tropicalis), 
were able to adhere to silicone (Figure IV.1), which is in agreement with 
other studies examining Candida species adherence to silicone rubber 
(Busscher et al., 1997; Tamura et al., 2003).  However, it is important to 
note that C. glabrata strains adhered to a higher extent compared with C. 
parapsilosis and C. tropicalis.  In fact, C. glabrata strains have frequently 
been isolated from patients with candiduria (Harris et al., 1999; Manzano-
Gayosso et al., 2008) and recognized as potentially pathogenic in 
hospitalized and catheterized patients (Fidel et al., 1999).  As previously 
reported (Trofa et al., 2008), C. parapsilosis is not a frequent etiological 
agent of UTIs.  This was also evident in a recent epidemiological study of 
100 candiduria cases (between 1999 and 2004) in a paediatric hospital in 
Brazil.  In this study, C. parapsilosis was only isolated on four occasions 
compared with 56 for C. albicans, 20 for C. tropicalis and 11 for C. glabrata 
(da Silva et al., 2007).  Furthermore, despite the apparently reduced ability 
to adhere to silicone, C. parapsilosis strains exhibited a higher degree of 
intra-species heterogeneity compared with the two other species 
examined (Figure VI.1).  This intra-species variation by C. parapsilosis in its 
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adherence to different biomaterials has been reported previously (Cassone 
et al., 1995; Panagoda et al., 2001; Trofa et al., 2008).  Such findings 
undoubtedly reflect inherent physiological differences between species 
and strains and could have significance with respect to pathogenic 
potential.   
It is well known that cell surface properties, such as hydrophobicity 
and zeta potential, play an important role in adhesion of microorganisms 
to the surface of medical devices (Cai et al., 1994; Anil et al., 2001; 
Henriques et al., 2002).  As a result, we investigated the relationship 
between adhesion and hydrophobicity and zeta potential parameters.  The 
results showed that the water contact angle values obtained for the 
different Candida species were very similar, which differs from results 
previously reported by Anil et al. (2001), who demonstrated that 
hydrophobic behaviour varied amongst different C. albicans strains, 
although grown in different conditions.  Furthermore, this work showed 
that C. parapsilosis, C. tropicalis and C. glabrata strains were all hydrophilic 
and this fact does not affect the adherence abilities.  In addition, all the 
tested strains analysed had similar contact water angle values and this was 
despite C. glabrata exhibiting significantly higher adherence to silicone.  
Camacho et al. (2007) also did not find a correlation between 
hydrophobicity and adherence for Candida species on siliconized latex 
urinary catheters, demonstrating that cell hydrophobicity alone was not a 
predictor for the adhesion phenomenon.  Since Candida cells and silicone 
(Sousa et al., 2009) are negatively charged, it was expected that adhesion 
of strains with greater negative zeta potentials would be hindered by 
electrostatic repulsion.  Interestingly, the highest number of adhered cells 
was found for C. glabrata strains, which actually had the higher negative 
values of zeta potential, thus, highlighting that zeta potential is also not 
primarily responsible for adherence potential.  Additionally, according to 
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several authors (Verran et al., 1997; Carlen et al., 2001), micro-organism 
adhesion is dependent on the surface roughness of the substratum.  
Depending on the extent of surface roughness, areas suitable for the 
physical retention of microorganisms to aid colonization are present.  
Sousa et al., (2009) recently demonstrated that silicone exhibits large 
numbers of depressions and grooves, and since it is known that C. glabrata 
cells are generally smaller (1-4 µm) than C. tropicalis (4-8 µm) and C. 
parapsilosis (2.5-4 µm) (Odds, 1998) it is tempting to speculate that the 
silicone rubber coupons used in this study had a surface roughness optimal 
for C. glabrata retention.   
Initial attachment of individual cells to a substratum is closely 
followed by cell division, proliferation, and biofilm development (Ramage 
et al., 2006).  Under the conditions used in these experiments and despite 
extensive adherence of NCAC species, biofilm formation was not 
subsequently detected (Figure IV.2).  Nevertheless, it was possible to 
observe differences among the NCAC species under study regarding total 
biomass.  As found in the adhesion assays, C. glabrata colonization yielded 
a higher total biomass than that of C. parapsilosis and C. tropicalis.  It is 
known that mature Candida biofilms are organised into structured 
communities embedded within a matrix of extracellular material that is 
produced by the biofilm cells (Al-Fattani et al., 2006; Silva et al., 2009).  
Formation of mature biofilms and consequent production of matrix is 
strongly dependent on environmental conditions, such as medium 
composition, pH, oxygen, species and strains (Jain et al., 2007; Ramage et 
al., 2006).  In fact, these particular isolates are not capable of forming 
dense 3D biofilms and produce enough matrix (Figure IV.3).  However, it 
should be emphasized that only few isolates were used and it other 
isolates belonging to same species may be able to form stronger biofilms.  
Furthermore, the authors verified that, as previously recognized (Jain et al., 
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2007; Uppluri et al., 2009), an increase of sugars (which could be 
representative of diabetic patients), is a requirement for increased biofilm 
formation (data not shown).  Furthermore, fungal infections are also more 
common in patients with diabetes, particularly those involving Candida 
species, occasionally causing dramatic clinical repercussions with 
obstruction of the urinary catheter (Patterson et al., 1995).  However, it is 
important to stress that the composition of AU was formulated to mimic 
the natural urine of non-diabetic patients (pH 5.6 with a residual quantity 
of sugar).   
Enumeration of CFU and confocal observation revealed that whilst 
NCAC species were unable to form dense biofilms on the silicone in the 
presence of AU (Figure IV.3), Candida cells remained viable over the 72 h 
period of study [mean log CFU (cm biofilm)-2: 5.3 for C. parapsilosis, 5.4 for 
C. tropicalis and 6.1 for C. glabrata).  This is highly important as it implies 
that under appropriate conditions Candida can proliferate within the 
catheter environment and potentially infect vital organs in the host (such 
as bladder and kidneys).   
In summary, this work demonstrates that the tested NCAC species 
were able to colonize and survive on the silicone surface in the presence of 
AU.  Additionally, it was shown that C. glabrata strains exhibited higher 
colonization of silicone surfaces compared with C. tropicalis and C. 
parapsilosis.  This finding is potentially significant, not just for UTI in 
catheterized patients, but also for other patients who have inserted 
silicone medical devices including those patients who receive transplants 
or who are admitted into intensive care units.  Importantly, such patients 
would appear to have a higher incidence of C. glabrata colonization 
compared with other NCAC species (Guglielmo et al., 1994; Krcmery, 1997; 
Manzano-Goyasso et al., 2008).  
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Abstract 
Oral candidosis is a common problem in immunocompromised patients, and whilst 
C. albicans is regarded as the principle cause of infection, other non-Candida albicans 
Candida (NCAC) species are increasingly being recognised as human pathogens.  Relatively 
little is known about the virulence factors associated with NCAC species, and the aim of 
this study was to use a reconstituted human oral epithelium (RHOE) to examine epithelial 
infection of C. parapsilosis.  Strains originating from the oral and vaginal mucosa and from 
the urinary tract were all shown to colonize RHOE in a strain-dependent manner.  Strain 
differences were found in the colonizing morphology and in the extent of invasion of the 
RHOE.  Low invasion of RHOE was detected for strains after 12 h, whereas extensive tissue 
damage was evident after 24 h when assessed using histological examination and lactate 
dehydrogenase activity determination.  Tissue damage was reduced in the presence of 
pepstatin A, although C. parapsilosis invasion of the tissue was not inhibited.  Real-time 
polymerase chain reaction of secreted aspartyl proteinase (SAP) genes (SAPP1-3) showed 
that expression was strain dependent, with an increased expression generally occurring 
for Candida infecting RHOE compared with planktonic equivalents.  In summary, C. 
parapsilosis was not highly invasive of RHOE but did induce significant tissue damage 
which could relate to specific SAP gene expression. 
 
Keywords: Candida; candidosis; Candida parapsilosis; oral epithelium
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Introduction 
Several species of Candida can colonize human mucosal surfaces as 
harmless commensals.  Normally, infection (candidosis) does not occur 
because of efficient of the host by innate and adaptive immune responses.  
However, debilitation of the host often results in candidosis, which most 
frequently manifests as superficial infection of moist mucosal surfaces, 
such as the vagina and oral cavity.  Candida albicans is regarded as the 
most prevalent species involved in both colonization and infection.  
However, in recent years an increased incidence of infection by non-
Candida albicans Candida (NCAC) species has become evident 
(Samaranayake, 1990).  This is significant because there are often inherent 
differences in susceptibility to traditional antifungals between C. albicans 
and NCAC species. 
Candida parapsilosis is one such NCAC species that is now recognized 
as an important pathogen of debilitated individuals (Kcrmery et al., 2000; 
Bonassoli et al., 2005; Fridkin et al., 2006).  However, when compared with 
the extensively studied C. albicans (De Bernardis et al., 1995; Schaller et al., 
1998; Bartie et al., 2004; Jayatilake et al., 2005; 2006; Malic et al., 2007), 
relatively little is known about the associated virulence factors of C. 
parapsilosis (Jayatilake et al., 2006; Gácser et al., 2007).  A greater 
awareness of the virulence determinants of this species are important, as 
not only would this provide an insight into pathogenic mechanisms but 
may also promote the development of more effective management 
strategies. 
The virulence attributes of Candida species include the ability to 
adhere to host tissues, the ability to exhibit morphological alteration, and 
the ability to secrete hydrolytic enzymes, [e.g., phospholipases and 
secreted aspartyl proteinases (Saps)] (Haynes, 2001; Lerman et al., 2008; 
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Naglik et al., 2008).  The change in Candida species from being commensal 
orgamisms to becoming pathogenic and invasive has been related to 
altered expression of these virulence factors together with a debilitation in 
host defence mechanisms.  Secreted aspartyl proteinase are considered to 
be potentially important enzymes that contribute to infection by 
promoting damage to the host mucosa, facilitating invasion of the 
organism into the epithelium (Zaugg et al., 1992; Schaller et al., 1998; 
Malic et al., 2007).  Candida parapsilosis possesses at least three genes 
encoding for Saps, designated SAPP1 (Haynes, 2001), SAPP2 (Monod et al., 
1994) and SAPP3 (NCBI accession number AF339513).  
The pathogenesis of mucosal candidosis has been investigated by 
several authors using animal models and primarily with C. albicans 
(Howlett, 1976; Zaugg et al., 1992; De Benardis et al., 1995; Samaranayake 
et al., 2001; Naglik et al., 2008).  In recent years, a commercially available 
reconstituted human oral epithelium (RHOE) has successfully been used to 
investigate the in vitro mechanisms of tissue degradation caused by 
infection with Candida albicans (Schaller et al., 1998, 1999, 2002; Bartie et 
al., 2004; Jayatilake et al., 2005, 2006; Malic et al., 2007).   
The aim of the present study was to use the RHOE model, coupled 
with confocal laser scanning microscopy (CLSM) and real-time polymerase 
chain reacyion (PCR), to investigate epithelial infection with, and virulence 
of, C. parapsilosis.  Specifically, a comparison of strains originating from 
different body sites was made in terms of tissue colonization, invasion and 
SAP gene expression.  
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Materials and methods 
Organisms  
A total of six clinical isolates of C. parapsilosis, originally recovered 
from the oral cavity (strains AD and AM2), vagina (strains 491861 and 
513143), and urinary tract (strains 534638 and 553877) were used in this 
study.  A reference strain of C. parapsilosis from the American Type Culture 
Collection (ATCC 22019T, Manassas, VA, USA) was also examined.  Oral 
isolates were obtained from the Biofilm Group of the Centre of Biological 
Engineering, Minho University (Braga, Portugal) and were originally 
obtained from the Clinic of Dentistry, Congregados (Braga, Portugal).  
Isolates from the vaginal and urinary tract were obtained from the Hospital 
of S. Marcos collection, (Braga, Portugal).  The identity of all isolates was 
initially confirmed by PCR-based sequencing using specific primers (ITS1 
and ITS4) that are specific for the 5.8S subunit gene (Williams et al., 1995).   
 
Isolate preparation  
For each experiment, isolates were subcultured on sabouraud 
dextrose agar (Merck, Darmstadt, Germany) for 48 h at 37°C.  The isolates 
were then cultured in Yeast Nitrogen Base medium (BD Diagnostics, 
Cowley, UK) supplemented with 0.5 % (w/v) glucose, for 12 h at 37°C.  
After incubation, the yeast cells were harvested by centrifugation and 
washed three times with phosphate-buffered saline (PBS; pH 7).  The 
yeasts were then enumerated using an Improved Neubauer 
haemocytometer and adjusted to a concentration of 2×106 cells ml-1. 
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In vitro reconstituted human oral epihelium (RHOE) infection 
model  
Commercially available human oral epithelium (human keratinocytes 
derived from a squamous carcinoma of the buccal mucosa, cell line TR 146; 
Skinethic Laboratory, Nice, France) was placed in MCDB 153-defined 
medium (Clonetics, San Diego, USA) containing 5 µg ml-1 insulin, 1.5 mM 
CaCl2, 25 µl ml
-1 gentamicin, and 0.4 µg ml-1 hydrocortisone, in 24-well 
tissue culture plates according to the manufacturer’s instructions.  
Standardized suspensions of C. parapsilosis (1 ml of MCDB 153 defined 
medium containing 2×106 cells in) were subsequently placed directly onto 
0.5 cm2 RHOE tissue inserts.  Control samples were inoculated with 1 ml of 
medium devoid of C. parapsilosis.  Infected tissues were incubated at 37°C 
in a 5% CO2 environment with saturated humidity for 12 h or 24 h.  In 
addition, planktonic cultures of C. parapsilosis were prepared using the 
same tissue culture medium and incubation conditions, but without the 
RHOE.  These planktonic cultures were subsequently used for standardizing 
lactate dehydrogenase (LDH) activity in experiments assessing tissue 
damage and also as planktonic controls for SAP gene-expression studies. 
After incubation, the tissues were rinsed twice in PBS to remove non-
adherent C. parapsilosis and then bisected, with one half of the tissue used 
for CLSM analysis and the other for real time-PCR studies.  The culture 
medium was also analyzed for Candida-induced damage using a LDH 
activity assay.  In addition, in two separate experiments, the Sap inhibiter, 
pepstatin A (Sigma, St Louis, MO, USA), was added to selected tissue 
inserts to assess the effect of Saps on the infection process.  Briefly, 
pepstatin A was dissolved in 100% methanol and added directly to the 
prepared Candida inoculum to give a final pepstatin A concentration of 15 
Chapter V 
 
 
114  
µg ml-1.  These tissue inserts were analyzed (24 h after infection) to 
determine invasion and evaluate the production LDH.   
 
Confocal laser scanning microscopy (CLSM) 
The degree of colonization and morphological characteristics of C. 
parapsilosis on the surface of fresh tissues was assessed by CLSM following 
direct labelling of the Candida with 100 µl of concanavalin A lectin 
conjugated with Alexa 594 (Molecular Probes-Invitrogen, Paisley, UK: 25 µg 
ml-1 in PBS) for 20 min at room temperature.  Briefly, infected tissue was 
fixed in 2% (v/v) paraformaldehyde (in ultra-pure water) for 24 h at 4°C and 
embedded in paraffin wax using standard histological techniques.  Tissues 
sections (20 µm) were cut and placed onto Histobond+ -coated microscope 
slides (Raymond A. Lamb, East Sussex, UK), de-waxed, and processed 
through xylene, ethanol, and water before staining.  To visualize infection 
by C. parapsilosis, prepared sections were directly labelled with 50 µl Alexa 
594-conjugated concanavalin A lectin (25 µg ml-1 in PBS) for 20 min at 
room temperature.  For cell nucleus detection, keratinocytes within the 
RHOE sections were stained with Hoechst 33258 (Sigma-Aldrich; St Louis, 
MO, USA; 1 µg ml-1) for 30 min at room temperature before washing in 
PBS.  Tissues were then mounted using Vectashield (Vector Laboratories, 
Peterborough, UK) fade-retarding mountant.  Stained sections were 
viewed and analyzed by CLSM using a Leica TCS SP2 AOBS spectral confocal 
microscope (Leica, Wetzlar, Germany).   
 
Lactate dehydrogenase (LDH) assay  
The release of LDH from tissues into the medium was used as a 
measurement of cell damage.  The LDH concentration in the medium from 
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control and infected tissues was measured at 24 h using the CytoTox-ONE 
kit (Promega, Madison, WI, USA) according to the manufacturer’s 
instructions.  The LDH activity of Candida cells in cell culture medium 
devoid of tissue was measured and subtracted from the LDH activity of the 
tissue infected with yeast.  The LDH released during infection with the 
different C. parapsilosis strains was then expressed relative to the 
untreated control tissue.  All experiments were performed in duplicate. 
 
Analysis of SAP gene expression 
Tissues for RNA extraction were stored at 4°C in 2-ml microtubes 
containing RNAlater (Ambion, Huntington, UK) solution.  Before RNA 
extraction, lysis buffer was prepared by adding 10 μl of ß-mercaptoethanol 
per ml of RLT buffer (Qiagen, Crawley, UK).  Then, 600 μl of lysis buffer and 
glass beads (0.5 mm diameter, approximately 500 µl) were added to each 
tissue and this mix was homogenized twice for 30 s using a Mini-Bead-
Beater-8 (Stratech Scientific, Soham, UK).  After disruption of tissue, the 
RNeasy Mini Kit (Qiagen) was used to complete total RNA extraction 
according to the manufacturer’s recommended protocol.  Potential DNA 
contamination was removed by RNase-Free DNase I (Qiagen) treatment.  
RNA was also extracted, using the same approach, from C. parapsilosis 
planktonic cells grown in MCDB 153-defined medium at 37°C in a 5% CO2 
environment for 24 h.   
Primers for real time-PCR were designed using Primer3 web-based 
software (http://fokker.wi.mit.edu\cgi-bin\primer3\primer3_www.cgi) and 
are listed in Table V.1. In order to verify the specificity of each primer pair 
for its corresponding target gene, PCR products were first amplified from C. 
parapsilosis ATCC 22019T genomic DNA.  Control S14 primers were also 
used (Cairns et al., 1997) to detect human recombinant DNA. 
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Table V.1 Primers used for real time-PCR analysis of SAP and control gene 
expression 
 
 
From each sample, 10 µl of extracted RNA was used for 
complementary DNA (cDNA) synthesis.  Firstly of all, the RNA was 
incubated with 5µl (50 µg ml-1) of oligo-dT primer (Promega, Southampton, 
UK) at 70°C for 5 min.  Then, this preparation was added to a reaction 
mixture containing RT Buffer [50 mM Tris (pH 8.3), 3 mM MgCl2, 10 U of 
RNasin Plus RNase inhibitor (Promega)], 20 µM of each deoxynucleoside 
triphosphate (dNTP) and 200 U of Moloney Murine Leukaemia Virus-
Reverse Transcriptase (MMLV-RT, Promega), in a final reaction volume of 
50 µl.  Synthesis of cDNA was then performed at 42°C for 1 h.  The reaction 
was stopped by heating at 95°C for 5 min.  
Real-time PCR was used to determine the relative levels of SAPP1–3 
mRNA transcripts in the RNA samples, with ACT1 used as a reference 
candidal housekeeping gene (Rossignol et al., 2007).  A 7900HT Fast Real-
Time PCR System (Applied Biosystems, Warrington, UK) was used according 
to the manufacturer’s instructions.  Each reaction mixture consisted of the 
Sequence (5’→ 3’) Primer  Target  
PCR product size 
(bp) 
AGTGGTCGTCAAACCACTCC Forward 
SAPP1 219 
GACGGAAGCAAGCGAAATAG Reverse 
TTACTTGCCTGACAGCATCG Forward 
SAPP2 277 
CGCATAAGCGTGTCTCAAAA Reverse 
GCTCAAGGTGCTGCTATTCC Forward 
SAPP3 253 
TTGCATCAATGACCCAGAAA Reverse 
ATGATAGAGTTGAAAGTAGTTTGGTCAATA Forward 
ACT1 350 
ACTACTGCTGAAAGAGAAATTGTTAGAGAC Reverse 
CAGGTCCAGGGGTCTTGGTCC Forward 
S14 143 
GGCAGACCGAGATGAATCCTCA Reverse 
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working concentration of Power SYBR® Green PCR master mix (Applied 
Biosystems), 300 nM forward and reverse primer, and 1 μl of cDNA, in a 
final reaction volume of 20 μl.  Negative (water) controls were included in 
each run.  The relative quantification of SAPP1-3 gene expression was 
performed by the ΔCT (threshold cycle) method, using the control gene 
(ACT1) to normalize the data.  Each reaction was performed in triplicate 
and mean values of relative expression analyzed for each SAP gene.
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Results 
In vitro RHOE infection 
The surface colonization and morphology of fresh RHOE tissues was 
examined after 24 h incubation with C. parapsilosis (Figure V.1 and Table 
V.2).  The results showed that all C. parapsilosis strains were able to 
colonize the RHOE surface, although the extent of colonization was strain 
dependent.  Candida parapsilosis AD (oral strain) and C. parapsilosis 
534638 (urinary tract strain) yielded the highest level of colonization of the 
epithelial surface, whilst strain AM2 (oral) colonized the tissue to a lower 
extent (Figure V.1).  
 
 
 
 
Figure V.1 Surface colonization of Candida parapsilosis strains infecting 
reconstituted human oral epithelium after 24 h of incubation: (A) C. parapsilosis 
AD showing extensive colonization (+++), (B) C. parapsilosis 553887 showing 
moderate colonization (++) and (C) C. parapsilosis AM2 demonstrating sparse 
colonization (+).  Presence of pseudohyphal form (*).  
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Table V.2 Candida parapsilosis infection profile of reconstituted human oral epithelium (at 12 and 24 h), as assessed using confocal laser 
scanning microscopy 
 
 
 
 
C. parapsilosis 
strain 
Origin Surface colonization 
Strain morphology 
 in presence of tissue 
Invasion/integrity of RHOE  
12 h 24 h 
AD 
Oral 
+++ Yeast and pseudohyphae Moderate/undamaged Moderate/partial damage 
AM2 + Yeast None/undamaged None/undamaged 
534638 
Urinary 
++ Yeast and pseudohyphae Moderate/undamaged Moderate/partial damage 
553877 ++ Yeast Low/undamaged Moderate/damaged 
491861 
Vaginal 
+++ Yeast and pseudohyphae - Moderate/partial damage 
513143 ++ Yeast Moderate/undamaged None/partial damage 
ATCC 22019 Reference ++ Yeast and pseudohyphae - Moderate/damage 
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Moreover, the different C. parapsilosis strains presented diverse cell 
morphologies on the RHOE surface.  Candida parapsilosis AD (oral strain), 
C. parapsilosis 534638 (urinary tract strain), C. parapsilosis 491861 (vaginal 
strain) and C. parapsilosis ATCC 22019T formed a network of yeasts and 
pseudohyphae, while the other strains appeared devoid of pseudohyphae 
(Figure V.1 and Table V.2). 
To assess the invasive capability of C. parapsilosis, RHOE tissues were 
fixed, sectioned, stained, and analyzed using CLSM, 12 h and/or 24 h after 
incubation (Figures V.2, V.3; Table V.2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure V.2 Confocal laser scanning microscopy of Candida parapsilosis strains 
infecting human oral epithelium after 12 h infection.  Arrows indicate yeast cells.  
 
 
AM2 AD 
513143 534638 
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Figure V.3 Confocal laser scanning microscopy of Candida parapsilosis infecting human oral epithelium after 24 h of incubation in the absence 
(A) and presence (B) of pepstatin A.
 
 
Chapter V 
 
 
122  
Figure V.2 illustrates the ability of C. parapsilosis to invade the RHOE, 
but not through all the epithelial layers.  In fact, after 12 h incubation, it 
was only possible to detect clusters of cells within the superficial 
keratinocyte layers, never reaching deeper than the second or third cell 
layer (Figure V.2).  
After 24 h incubation (Figure V.3 and Table V.2) the majority of strains 
under study caused damage to the tissue structure. 
Infection with C. parapsilosis 553877 (urinary tract strain) and ATCC 
22019T resulted in detachment of the keratinocyte layers, leading to a loss 
of tissue integrity.  Infection with C. parapsilosis AD (oral strain) and C. 
parapsilosis 534638 (urinary tract strain) induced vacuolization between 
keratinocytes, resulting in a high level of disorganization of the epithelium 
structure.  By contrast, changes caused by C. parapsilosis 513143 and C. 
parapsilosis 491861 (both vaginal strains) were not as extensive, but still 
resulted in structural damage of the epithelium.  Tissue alteration caused 
by C. parapsilosis AM2 (oral strain) was limited, with few yeast found to 
attach to the oral epithelium and the tissue structure remaining similar to 
that of the uninfected control. 
To quantify tissue damage, the levels of LDH released were 
determined after 24 h after infection with C. parapsilosis (Figure V.4).  Co-
culture of tissue with each of the isolates caused a marked increase in the 
LDH levels compared with uninfected controls.  The LDH results showed a 
positive correlation with the extent of tissue damage seen microscopically 
(Figure V.3A and Table V.2).  Candida parapsilosis AD and C. parapsilosis 
ATCC 22019T generated the highest levels of LDH and tissue damage, 
whereas C. parapsilosis AM2 and C. parapsilosis 513153 produced 
relatively lower levels of LDH and tissue damage.   
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Figure V.4 Relative lactate dehydrogenase (LDH) activity measured in the human 
oral epithelium tissue culture supernatant after 24 h incubation with different 
Candida parapsilosis strains in absence (□) and in presence (■) of pepstatin A.  
 
 
In order to help understand how C. parapsilosis induced RHOE 
damage, the effect of the specific aspartic proteinase inhibitor pepstatin A 
was evaluated (Figures V.3B and V.4).  It was found that inclusion of 
pepstatin A markedly reduced tissue damage (as determined by the LDH 
assay) after 24 h infection (Figure V.4).  Interestingly, in some cases, such 
as for C. parapsilosis AD and C. parapsilosis 534638, tissue invasion by the 
strains was still evident (Figure 3B).  At the concentrations used, pepstatin 
A did not affect C. parapsilosis growth or the appearance of the uninfected 
RHOE.  
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SAP gene expression  
ACT1 gene expression was consistently detected in all samples.  Table 
V.3 presents the mean percentage expression, relative to ACT1, of SAP 
genes in planktonic and RHOE infecting C. parapsilosis cells, obtained by 
real time-PCR.  All C. parapsilosis strains in the planktonic form expressed 
the three SAP genes, with the exception of SAPP3 for C. parapsilosis ATCC 
22019T.  The C. parapsilosis strains studied did exhibit different SAP gene 
expression profiles after RHOE infection.  Under these conditions, SAPP2 
gene expression was not detectable for C. parapsilosis 513143 and C. 
parapsilosis 491861 (both vaginal strains), whilst SAPP3 gene expression 
was not evident for C. parapsilosis 513143 (vaginal strain) and C. 
parapsilosis ATCC 22019T.  However, there was an apparent elevation of 
most SAP genes in yeast cells infecting the RHOE compared with their 
planktonic counterparts.  The exceptions to this were SAPP1 with C. 
parapsilosis ATCC 22019T and C. parapsilosis 534638, SAPP2 with C. 
parapsilosis 491861 and C. parapsilosis 513143, and SAPP3 with C. 
parapsilosis ATCC 22019T and C. parapsilosis 513143. 
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Table V.3 Detection of secreted aspartyl proteinase (SAPP 1-3) gene expression associated with pathogenesis during planktonic culture 
and reconstituted human oral epithelium infection (at 24 h) using quantitative real time-polymerase chain reaction 
 
 
 
ND, indicates that no gene expression was detected.   
* The mean arbitrary mRNA transcript levels based upon triplicate measurements, presented as a percentage relative to the respective ACT1 transcript level.  
 
C. parapsilosis strain 
Relative expression of SAP genes* 
Planktonic cells Cells that infected RHOE 
SAPP1 SAPP2 SAPP3 SAPP1 SAPP2 SAPP3 
AD 0.097 0.025 0.204 0.318 0.101 0.497 
AM2 0.599 0.090 0.546 1.615 0.112 1.064 
534638 0.364 0.213 0.142 0.334 0.287 0.408 
553877 0.326 0.067 0.021 0.607 0.210 0.092 
491861 0.041 0.011 0.208 0.119 ND 0.248 
513143 0.039 0.088 0.139 1.426 ND ND 
ATCC 22019T 0.591 0.102 ND 0.066 0.259 ND 
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Discussion 
Candida parapsilosis is a normal commensal fungus of humans.  
Compared with C. albicans, relatively few investigations have been carried 
out to assess the virulence of C. parapsilosis, particularly within intact 
human tissues.  The oral epithelium is constantly exposed to 
microorganisms and is normally an effective barrier against microbial 
invasion.  Thus, the primary aim of this study was to investigate the pattern 
of colonization and invasion of seven C. parapsilosis strains using an in vitro 
RHOE model.  This RHOE tissue histologically resembles normal human oral 
epithelium and is considered to be a good surrogate model to animals for 
experimental oral candidosis (Schaller et al., 1998; Jayatilake et al., 2005; 
Malic et al., 2007; Naglik et al., 2008; Lerman et al., 2008). 
The results obtained (Table V.2 and Figure V.1) showed that all C. 
parapsilosis strains colonized the RHOE surface.  Furthermore, the extent 
of C. parapsilosis colonization was noticeably strain dependent.  After 12 h 
incubation, it was possible to observe clusters of yeasts within the first two 
layers of the epithelium (Figure V.2); subsequent examination of invasion 
for each isolate identified significant differences between the 12- and 24-h 
time-points, indicating progressive tissue damage relating to duration of 
infection.  Compared to the invasiveness of C. albicans, described 
previously (Schaller et al., 2002; Jayatilake et al., 2006; Malic et al., 2007), 
C. parapsilosis has not been considered as highly invasive.  However, after 
24 h incubation, C. parapsilosis induced significant disruption in the tissue 
architecture of the RHOE (compared with the uninfected controls, Figure 
V.3A).  The degree of tissue damage was further confirmed through the 
measurement of relative LDH activity (Figure V.4), which was positively 
correlated with C. parapsilosis infection and with histologically observed 
damage (Figure V.3B).  These features are similar to those described in 
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previous reports (Jayatilake et al., 2006; Gácser et al., 2007) where it was 
demonstrated that C. parapsilosis is able to cause dramatic 
histopathological tissue changes.  The results indicate that the C. 
parapsilosis strains under study produced a variable degree of pathological 
tissue damage, which was generally higher when compared with C. 
albicans (Schaller et al., 2002; Jayatilake et al., 2006; Malic et al., 2007).  
The invasive behaviour of C. albicans is often attributed to its ability to 
form hyphae (Bartie et al., 2004; Malic et al., 2007).  In the case of the 
seven C. parapsilosis strains investigated, only four were able to form 
pseudohyphae under the experimental conditions of the study (Table V.2).  
Despite the extent of damage being strain dependent, this did not appear 
to correlate with the ability of the organisms to exhibit filamentous 
growth.  Furthermore, when the isolates were grouped according to their 
clinical origin, there was no obvious association between origin and the 
ability to colonize or damage the oral epithelium.  For instance, the two 
oral isolates exhibited contrasting behaviour: C. parapsilosis AM2 was 
unable to colonize to a high level or cause damage to the epithelium with 
associated high LDH levels; C. parapsilosis AD colonized to a greater extent 
and was responsible for a high degree of structural alteration to the oral 
epithelium with a correspondingly high LDH activity.  
Treatment with pepstatin A, an inhibitor of Saps, markedly reduced 
tissue damage, indicating the potential significance of Saps in this process.  
Interestingly, and contrast to what has been reported to date (Jayatilake et 
al., 2006; Gácser et al., 2007), C. parapsilosis was able to invade the RHOE 
and this was not affected by addition of pepstatin A.  To explore, in more 
detail, the possible mechanism of tissue damage and invasion, SAP gene 
expression was assessed using real-time PCR, in all strains of Candida, 24 h 
after infection of RHOE, and expression was compared with that of 
planktonic cells treat in an identical manner.  The production of 
Chapter V 
 
 
128  
extracellular enzymes (particularly Saps), by C. albicans has been studied 
previously (Zaugg et al., 1992; Schaller et al., 1998; Schaller et al., 2000; 
Malic et al., 2007; Naglik et al., 2008; Lerman et al., 2008), although there 
still remains doubt over the role of these enzymes in the invasion of 
epithelial tissue (Schaller et al., 2000; Naglik et al., 2008; Lerman et al., 
2008).  Overall, the present study showed that expression of SAP genes by 
C. parapsilosis was strain dependent, with SAPP1 being expressed by all 
infecting isolates.  In the case of SAPP2 and SAPP3, two isolates did not 
express these genes during infection.  Interestingly for SAPP2, both non-
expressing isolates originated from vaginal infections.  Furthermore, the 
pattern of SAP gene expression was different between infecting and 
planktonically cultured Candida.  Generally, for all SAPP genes studied, 
expression was higher for cells colonizing the tissue, compared with their 
planktonic equivalents (Table V.3).  Given these findings, and the fact that 
LDH activity in the tissue was reduced as a result of incorporation of 
pepstatin A, it would appear that Sap enzymes are important instigators of 
tissue damage by C. parapsilosis, but may not be essential for the invasion 
of the tissue.  These results appear to be in agreement with previous 
studies involving C. albicans (Naglik et al., 2008; Lerman et al., 2008).  
In summary, this work confirms the effectiveness of RHOE as an in 
vitro model to study Candida virulence attributes and broadens the 
currently limited knowledge on C. parapsilosis virulence mechanisms.  The 
CLSM approach has conclusively shown that C. parapsilosis is not highly 
invasive, but can be responsible for significant changes in tissue structure.  
Furthermore to our knowledge, this is the first report of SAP gene 
expression in C. parapsilosis infecting oral epithelium and suggests a role 
for these enzymes in tissue damage but not candidal invasion. 
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Abstract 
Candida virulence attributes include the ability to colonize and invade host tissues, 
and the secretion of hydrolytic enzymes.  Although Candida albicans is regarded as the 
principal fungi causing infections in humans, other species, particularly Candida tropicalis, 
are increasingly recognised as human pathogens.  Relatively little is known, however, 
about the virulence attributes associated with C. tropicalis.   
The present study aimed to investigate epithelial infection by C. tropicalis using a 
reconstituted human oral epithelium (RHOE) together with confocal laser scanning 
microscopy (CLSM) and real-time PCR.  A comparison of clinical strains was made in terms 
of tissue colonization, invasion and C. tropicalis secreted aspartyl proteinase (SAPT) gene 
expression.  
All C. tropicalis strains were able to colonize RHOE in a strain-dependent manner.  
After 12 h of infection, C. tropicalis was found to be highly invasive, with extensive tissue 
damage occurring after 24 h.  Real-time PCR of C. tropicalis SAPT1-4 genes showed that 
expression was strain-dependent, with SAPT2-4 transcripts being frequently detected and 
SAPT1 rarely detected.  Tissue invasion and damage was not inhibited by the presence of 
pepstatin A.  Accordingly, and given that an increase in infection time was not 
accompanied with an increase in SAPT gene expression, it can be suggested that the 
proteinases are not involved in invasion and damage of RHOE by C. tropicalis.   
In summary, C. tropicalis can be considered highly invasive with the ability to 
induce significant tissue damage.  These features, however, do not appear to be related to 
specific SAPT gene expression.  
 
Keywords: Candida tropicalis; candidosis; human epithelium, secreted aspartyl 
proteinases 
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Introduction 
Many Candida species inhabit human mucosal surfaces as harmless 
commensals.  However, these organisms can cause opportunistic infections 
(candidosis), especially in compromised patients such as those individuals 
with HIV-infection and diabetes mellitus, and well as in those receiving 
steroid, broad spectrum antibiotic and cytotoxic drug therapy 
(Samaranayake, 1990).  Candida albicans is regarded as the most prevalent 
species involved in both human colonization and infection (Colombo et al., 
2006; Pfaller et al., 2007).  Nevertheless, other Candida species are 
increasingly recognized as important agents of human infection (Kcrméry 
et al., 2002; Hajjey et al., 2004; Ruhnke et al., 2006; Pfaller et al., 2007; 
Horn et al., 2009).  This may reflect the higher level of resistance often 
exhibited by these species to certain antifungal agents, (González et al., 
2008) or an association with modern drug therapies, including the more 
widespread use of immunosuppressive agents and broad spectrum 
antibiotics.  
Candida tropicalis is a species that is now recognized as an important 
pathogen of debilitated individuals (Weinberger et al., 2005; Vigouroux et 
al., 2006; Nucci et al., 2007).  However, when compared with the more 
extensively studied C. albicans (De Bernadis et al., 1995; Schaller et al., 
1998; Bartie et al., 2004; Jayatilake et al., 2006; Malic et al., 2007), 
relatively less is known about C. tropicalis and its ability to cause human 
disease (Wingard et al., 1982; Kontoyiannis et al., 2001; Zaugg et al; 2001; 
Arendrup et al., 2002; Al-Fattini et al., 2006; Bizerra et al., 2008).  Thus, a 
greater understanding of the virulence determinants of this species is 
important because not only would this provide an insight into its 
pathogenic mechanisms, but also it might promote the development of 
more effective treatment strategies. 
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Virulence attributes of Candida species include the ability to adhere 
to host tissue, exhibit morphological alteration, and the secretion of 
hydrolytic enzymes [e.g. phospholipases and secreted aspartyl proteinases 
(Saps)] (Calderone et al., 2001).  The change from a commensal to a 
pathogen has been related to altered expression of these virulence factors 
together with a debilitation in host defence mechanisms.  Moreover, Saps 
are considered to be key enzymes that contribute to candidal infection by 
promoting damage to the host mucosa, thereby facilitating invasion of the 
organism into the epithelium (Schaller et al., 1999; Zaugg et al., 2001; 
Naglik et al., 2003).  Furthermore, it is known that C. tropicalis possesses at 
least four genes encoding Saps, and these are designated SAPT1 to SAPT4 
(Togni et al., 1991; Zaugg et al., 2001).    
The pathogenesis of mucosal candidosis has been investigated in 
several studies using animal models, primarily with C. albicans (De 
Bernardis et al., 1995; Samaranayake et al., 2001).  In recent years, a 
commercially available reconstituted human oral epithelium (RHOE) has 
successfully been used to study the in vitro mechanisms of tissue invasion 
by C. albicans (Schaller et al., 1999; Bartie et al., 2004; Jayatilake et al., 
2006, 2005; Malic et al., 2007; Lerman et al., 2008; Naglik et al., 2008).  
Thus, the present study aimed to investigate the pattern of colonization 
and invasion of RHOE by C. tropicalis and to relate it with SAPs expression.  
Specifically, a comparison of clinical strains obtained from different body 
sites was made in terms of tissue colonization, invasion and SAP gene 
expression using RHOE model, together with confocal laser scanning 
microscopy (CLSM) and real-time PCR.  
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Materials and methods 
Candida tropicalis strains  
A total of six clinical isolates of C. tropicalis, originally recovered from 
the oral cavity (strains AG1 and T2.2), vagina (strains 12 and 75), and 
urinary tract (strains 519468 and 544123), were used in the present study.  
A reference strain of C. tropicalis from the American Type Culture 
Collection (ATCC 750T) was also used.  Oral isolates were originally 
obtained from patients attending the ‘Clínica dos Congregados’ (Braga, 
Portugal) and the strains isolated from urinary tract infections were 
obtained from the ‘Hospital de São Marcos’ fungal collection (Braga, 
Portugal).  Candida tropicalis strains 12 and 75 (recovered from the vaginal 
tract) were provided by the University of Maringá (Maringá, Brazil).  The 
identification of all isolates was confirmed by PCR-based sequencing using 
specific primers (ITS1 and ITS4) for the 5.8S subunit gene (Williams et al., 
1995).   
Isolates were initially cultured on sabouraud dextrose agar (SDA; 
Merck, Darmstadt, Germany) for 48 h at 37°C, followed by culture in yeast 
nitrogen base medium (BD Diagnostics, Cowley, UK), supplemented with 
0.5 % glucose (w/v), for 12 h at 37°C.  After incubation, cells were 
harvested by centrifugation and washed three times with phosphate 
buffered saline (PBS; pH 7).  The yeast cells were then counted using an 
Improved Neubauer haemocytometer (Marienfield, Land-Könicshofen, 
Germany) and adjusted to a concentration of 2×106 cells ml-1. 
 
In vitro RHOE infection model  
Tissue inserts (0.5 cm2) of commercially available (SkinEthic 
Laboratories, Nice, France) human oral epithelium, derived from a 
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squamous carcinoma of the buccal mucosa (human keratinocyte cell line 
TR 146) and formed on a support membrane, were placed in a new 24-well 
tissue culture plate.  Standardized suspensions of C. tropicalis (1 ml 
containing 2×106 cells in MCDB-153 defined medium (Clonetics, San Diego, 
USA) containing 5 µg ml-1 insulin, 1.5 mM CaCl2, 25 µl ml
-1 gentamicin and 
0.4 µg ml-1 hydrocortisone) were then added to each RHOE tissue insert.  
Control samples were inoculated with 1 ml of medium devoid of Candida 
cells.  Tissues were subsequently incubated at 37°C in a 5% CO2 
environment with saturated humidity for 12 h and 24 h.  In addition, 
planktonic cultures of C. tropicalis, used as controls, were prepared using 
the same tissue culture medium and incubation conditions, but in the 
absence of RHOE.  These planktonic cultures were subsequently used for 
standardizing lactate dehydrogenase (LDH) activity and also as controls for 
SAP gene expression studies (24 h).   
After incubation, the tissues were rinsed twice with PBS to remove 
non-adherent Candida cells and then bisected, with one half used for CLSM 
analysis and the other for RNA extraction and real time-PCR studies.  The 
culture medium was also analyzed for Candida induced damage using LDH 
assay.   
In separate experiments, the Sap inhibitor, pepstatin A (Sigma, Poole, 
UK) was added, simultaneously with the C. tropicalis inoculum, to the 
tissue inserts to assess the effect of Saps on the infection process.  Briefly, 
pepstatin A was dissolved in 100% methanol and added directly to the 
prepared Candida inoculum to achieve a final concentration of pepstatin A 
of 15 µg ml-1.  These tissue inserts were examined after 24 h for invasion of 
Candida and LDH production.   
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Confocal laser scanning microscopy (CLSM) 
Colonization and morphological characteristics of C. tropicalis on the 
surface of fresh tissues were assessed using CLSM, following direct 
labelling of Candida cells with 100 µl of concanavalin A lectin conjugated 
with Alexa 594 (Molecular Probes-Invitrogen, Paisley UK: 25 µg ml-1 in PBS) 
for 20 min at room temperature.  Briefly, infected tissue was fixed in 2% 
(v/v) paraformaldehyde (in ultrapure water) for 24 h at 4°C and embedded 
in paraffin wax using standard histological techniques.  Tissue sections (20 
µm) were cut and placed on Histobond+ coated microscope slides 
(Raymond A Lamb, Eastbourne, UK), de-waxed by processing through 
xylene, followed by immersion in ethanol and then water.  The prepared 
sections were overlaid with 50 µl of Alexa 594-conjugated concanavalin A 
lectin (Molecular Probes-Invitrogen, Paisley UK; 25 µg ml-1 in PBS) for 20 
min at room temperature.  For keratinocyte nuclear staining within the 
RHOE sections, Hoechst 33258 dye (Sigma; 1 µg ml-1) was applied for 30 
min at room temperature and then washed with PBS.  Tissues were 
mounted in Vectashield (Vector Laboratories, Peterborough, UK) fade-
retarding mountant and then observed by CLSM using a Leica TCS SP2 
AOBS spectral confocal microscope (Leica, Wetzlar, Germany).  The 
sections were scanned through full depth using appropriate settings for 
single- and double fluorescence recordings of Hoechst 33258 (laser 
excitation line 485 nm and emissions detected 410-485 nm) and Alexa 594-
conjugated concanavalin A (laser excitation line 546 nm and emissions 
detected 600-660 nm).  
 
Lactate dehydrogenase (LDH) assay  
The release of LDH from the RHOE into the culture medium was used 
as a measure of epithelial cell damage.  The LDH concentration in the 
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medium from both control and infected tissues was measured at 12 h and 
24 h (in both presence and absence of pepstatin A) using the CytoTox-
ONETM kit (Promega, Madison, USA) according to the manufacturer’s 
instructions.  A control for LDH activity was also prepared using a replicate 
preparation of Candida, cultured in medium devoid of RHOE.  The LDH 
activity of this control was subtracted from the LDH activity of the tissue 
infected with yeast.  The LDH released during infection with the different C. 
tropicalis strains was then expressed as a relative activity determined 
against the untreated control tissue.  All experiments were performed in 
duplicate. 
 
Analysis of SAP gene expression 
RNA extraction 
Tissues for RNA extraction were stored at 4°C in 2 ml microtubes 
containing RNAlater® solution (Ambion, Huntington, UK).  Prior to RNA 
extraction, lysis buffer was prepared by adding 10 μl of ß-mercaptoethanol 
per ml of RLT buffer (Qiagen, Crawley, UK).  Then, 600 μl of lysis buffer and 
glass beads (0.5 mm diameter, approximately 500 µl) were added to each 
tissue and these were homogenised twice for 30 s, using a Mini-
BeadBeater-8 (Stratech Scientific, Soham, UK).  After tissue disruption, the 
RNeasy Mini Kit (Qiagen) was used for total RNA extraction according to 
the manufacturer’s recommended protocol.  Potential DNA contamination 
was removed by RNase-Free DNase I (Qiagen) treatment.  Additionally, 
RNA was also extracted, following the same approach, from C. tropicalis 
planktonic cells (absence of RHOE) prepared and cultured in the same 
manner as RHOE infecting strains.   
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Primer Design 
Primers for real-time PCR (RT-PCR) were designed using the Primer3 
web-based software (http://frodo.wi.mit.edu\primer3) and these primer 
sequences are listed in Table VI.1.   
 
Table VI.1 Primers used for real time-PCR analysis of SAP and control gene 
expression 
 
 
 
To verify the specificity of each primer pair for its corresponding 
target gene, PCR products were first amplified from ATCC 750T genomic 
DNA.  Control S14 primers were also used (Cairns et al., 1997) to detect 
human recombinant DNA. 
 
Synthesis of cDNA 
From each sample, 10 µl of extracted RNA was used for cDNA 
synthesis.  First, the RNA was incubated with 5 µl (50 µg ml-1) of oligo-dT 
Sequence (5’→ 3’) Primer  Target  
PCR product size 
(bp) 
GGAAGATCTGATGTGCCAACTACATTGA Forward 
SAPT1 1005 
CGTGCGGCCGCTCTACAAAGCCGAGATGTCT Reverse 
TTCTTCTAGTGGTACCTGGGTCAAAG Forward 
SAPT2 762 
CATAGATCTCTAAACAATAGTGACATTAGA Reverse 
ACTTGGATTTCCAGCGAAGA Forward 
SAPT3 165 
AGCCCTTCCAATGCCTAAAT Reverse 
GTACTCGAGCTCCTACAACTTCACCTCCT Forward 
SAPT4 1130 
CATGGATCCCTATGTAAGTGGAAGTATGTT Reverse 
GACCGAAGCTCCAATGAATC Forward 
ACT1 181 
AATTGGGACAACGTGGGTAA Reverse 
CAGGTCCAGGGGTCTTGGTCC Forward Human  
GGCAGACCGAGATGAATCCTCA Reverse S14 143 
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primer (Promega, Southampton, UK) at 70°C for 5 min.  Subsequently, RNA 
was added to a reaction mixture containing RT Buffer [50 mM Tris (pH 8.3), 
3 mM MgCl2, 10 U of RNasin Plus RNase inhibitor (Promega)], 20 µM of 
each deoxynucleoside triphosphate (dNTP) and 200 U of Moloney Murine 
Leukaemia Virus-Reverse Transcriptase (MMLV-RT, Promega), in a final 
reaction volume of 50 µl.  cDNA synthesis was then performed at 42C for 
1 h.  The reaction was stopped by heating for 5 min at 95C.  
 
Real-time PCR 
Real-time PCR was used to determine the relative levels of SAPT1–4 
mRNA transcripts in the RNA samples, with ACT1 used as a reference 
housekeeping gene.  A 7900HT Fast Real-Time PCR System (Applied 
Biosystems, Warrington, UK) was used in accordance with the 
manufacturer’s instructions.  Each reaction mixture consisted of the 
working concentration of Power SYBR® Green PCR master mix (Applied 
Biosystems), 300 nM forward and reverse primer and 1 μl of cDNA, in a 
final reaction volume of 20 μl.  Negative (water) controls were included in 
each run.  The relative quantification of SAPT1-4 gene expression was 
performed by the ΔCT method, using the control gene (ACT1) to normalize 
the data.  Each reaction was performed in triplicate and mean values of 
relative expression were analysed for each SAP gene.  
 
Statistical analysis  
Results were compared using one-way analysis of variance (ANOVA) 
by applying Levene´s test of homogeneity of variance and the Tukey´s 
multiple-comparisons test, using SPSS (SPSS [Statistical Package for the 
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Social Sciences], Inc., Chicago, USA).  All tests were performed with a 
confidence level of 95%. 
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Results 
In vitro RHOE infection 
Fresh RHOE tissues were used to study surface colonization and 
candidal morphology after 12 h of incubation (Figure VI.1 and Table VI.2).  
 
 
 
Figure VI.1 Colonization profile of Candida tropicalis strains infecting human oral 
epithelium after 12 h of incubation. *Presence of filamentous forms. 
 
 
The results showed that all C. tropicalis strains were able to colonize 
the RHOE.  However, the extent of colonization was strain-dependent.  By 
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contrast to the other C. tropicalis strains, strain 544123 (urinary tract 
isolate) exhibited a low colonization level.   
Interestingly, the different C. tropicalis strains exhibited diverse and 
strain dependent-differences with respect to cell morphologies on the 
RHOE surface (Figure VI.1 and Table VI.2).  Candida tropicalis T2.2 and AG1 
(oral strains) and C. tropicalis 12 (vaginal strain) formed a network of both 
yeast and filamentous morphology.  This contrasted with C. tropicalis 
519468 (urinary isolate) and C. tropicalis ATCC 750T, whit both exhibiting 
predominantly filamentous growth on the RHOE surface.  Candida 
tropicalis 75 (vaginal isolate) and C. tropicalis 544123 (urinary tract) strains 
colonized and grew on the RHOE primarily in yeast form.   
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Table VI.2 Candida tropicalis infection profile of reconstituted human oral epithelium (at 12 and 24 h) as assessed by confocal laser 
scanning microscopy 
 
 
 
 
 
C. tropicalis strains  
Origin 
Surface 
colonisation 
(12 h) 
Strain morphology in presence  
of tissue  
(12h) 
Invasion/integrity of RHOE 
12 h 24 h 
AG1 
Oral 
+++ Yeast and filament forms  High/undamaged High/ damage 
T2.2   +++ Yeast and filament forms High/undamaged High/ damage 
519468 
Urinary 
+++ Predominantly filament forms High/undamaged High/damage 
544123 + Predominantly  yeast Low/undamaged Low/undamaged  
12 
Vaginal 
++ Yeast and filament forms High/undamaged High/damage 
75 ++ Predominantly yeast High/undamaged High/damaged 
ATCC 750T Reference +++ Predominantly filament forms High/undamaged High/undamaged 
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To assess the invasive capability of C. tropicalis, the RHOE tissues 
were fixed, sectioned, stained and observed by CLSM at 12 h and 24 h after 
infection (Figures VI.2 and VI.3; Table VI.2).   
 
 
 
Figure VI.2 Confocal laser scanning microscopy images of Candida tropicalis 
strains infecting human oral epithelium after 12 h of incubation. 
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Figure VI.3 Confocal laser scanning microscopy images of Candida tropicalis strains infecting human oral epithelium after 24 h of incubation.
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Invasion was more extensive after 24 h infection (Figure VI.3) and 
disruption of the epithelial structure was also more evident.  Infection with 
C. tropicalis AG1 and T2.2 (both oral isolates) and C. tropicalis 12 (vaginal 
isolate) induced vacuolization between keratinocytes, promoting a high 
level of disorganisation of the epithelium structure.  Tissue alteration 
caused by C. tropicalis 75 (vaginal isolate) and C. tropicalis 519468 (urinary 
isolate) resulted in the detachment of the superficial keratinocytes layer.  
Furthermore, the high number of filamentous forms of both strains 
appeared to be responsible for the detachment of the RHOE from the 
support membrane.  By contrast, changes caused by the non-invasive C. 
tropicalis 544123 (urinary isolate) and by C. tropicalis ATCC 750T were 
limited, despite the latter being able to invade the RHOE. 
To quantify tissue damage, the levels of released LDH were 
determined after 12 h and 24 h of infection (Figure VI.4).   
 
 
Figure VI.4 Relative LDH activity measured in the human oral epithelium tissue 
culture supernatant after 12 h (■) and 24 h (■) incubation with different Candida 
tropicalis strains; and in the presence of pepstatin A at 24 h (□). *Strain 
statistically different from the other strains (P<0.05). Error bars represent 
standard deviation. 
* 
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Figure VI.5 Confocal laser scanning microscopy images of Candida tropicalis strains infecting human oral epithelium after 24 h in 
presence of 15 µl ml-1 pepstatin A.
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Co-culture of tissue with each of the isolates caused a moderate 
increase in the LDH levels after 12 h incubation compared with uninfected 
controls.  Furthermore, the relative LDH activity was similar for all C. 
tropicalis strains analyzed (P>0.05).  The levels of LDH markedly increased 
(approximately 5-fold) with longer infection time (P>0.05).  The results 
obtained for LDH activity (Figure VI.4) positively correlated with the extent 
of tissue damage observed microscopically (Figure VI.3).   
Candida tropicalis 544123 caused the least histologically observed 
damage (not invasive) and also produced the lowest LDH levels, although 
this was still significantly higher than the uninfected control tissue (Figure 
VI.4 and Table VI.2).   
To provide insight into the mechanism of C. tropicalis RHOE invasion 
and induction of tissue damage, the effect of the specific aspartyl 
proteinase inhibitor, pepstatin A on the infection process was evaluated 
(Figures VI.4 and VI.5) 
Importantly, invasion of C. tropicalis was not inhibited by the 
presence of pepstatin A (Figure VI.5).  Furthermore, the inclusion of 
pepstatin A did not reduce the level of tissue damage as assessed 
histologically (Figure VI.5) and by LDH activity (Figure VI.4).  At the 
concentrations used, pepstatin A did not affect C. tropicalis colonization or 
the appearance of the uninfected RHOE. 
 
SAP gene expression  
Table VI.3 presents the mean percentage SAP gene expression levels 
relative to ACT1, for C. tropicalis infecting RHOE for 12 and 24 h, and for 
planktonic cells (after 24 h incubation using the same conditions, but in the 
absence of RHOE).   
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Table VI.3 Detection of secreted aspartyl proteinase (SAPT1-4) gene expression associated with pathogenesis during Candida tropicalis 
reconstituted human oral epithelium infection (at 12 h and 24 h) and planktonic culture using quantitative real-time polymerase chain 
reaction 
 
 
 
ND, indicates that no gene expression was detected. *Mean arbitrary messenger RNA transcript levels based upon triplicate measurements, presented 
as a percentage relative to the respective ACT1 transcript level. 
 
 
Relative expression of SAP genes* 
 Cells that infected RHOE Planktonic cells 
C. tropicalis  
strains 
12 h 24 h  24 h 
SAPT1 SAPT2 SAPT3 SAPT4 SAPT1 SAPT2 SAPT3 SAPT4 SAPT1 SAPT2 SAPT3 SAPT4 
AG1 ND 0.01±0.00 0.18±0.02 0.28±0.02 ND ND 0.32±0.15 0.06±0.02 ND 0.02±0.01 1.29±0.42 1.24±0.93 
T2.2 ND 0.04±0.02 0.48±0.15 2.70±0.64 ND ND 0.69±0.27 0.06±0.02 ND 0.03±0.00 1.59±0.16 0.30±0.08 
519468 0.03±0.02 0.22±0.14 0.45±0.13 4.57± 0.99 ND 0.22±0.09 ND 0.95±0.54 ND ND 0.86±0.07 0.16±0.02 
544123 ND 0.22±0.03 0.04±0.00 1.58±0.62 ND 0.01±0.00 0.60±0.06 0.02±0.00 ND 0.01±0.01 0.97±0.44 0.10±0.02 
12 ND ND 0.23±0.04 0.01±0.00 ND 0.01±0.01 0.20±0.02 0.05±0.03 ND ND 0.07±0.03 0.25±0.06 
75 ND ND 0.48±0.06 0.03±0.03 0.03±0.01 0.04±0.02 1.58±0.35 10.07±2.47 0.06±0.01 0.04±0.00 2.27±0.71 9.78±0.41 
ATCC 750
T
 ND ND 0.76±0.10 0.01±0.07 ND 0.13±0.07 3.92±1.17 0.21±0.07 ND 0.04±0.02 1.07±0.20 0.16±0.13 
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Real time PCR analysis revealed a wide range of expression profiles of SAP 
genes for the seven C. tropicalis strains in the three conditions examined 
(Table VI.3).  In general, SAPT2-4 transcripts were frequently detected, 
whereas SAPT1 was only rarely detected.  After 12 and 24 h of incubation, 
C. tropicalis strains exhibited different SAPT2-4 gene expression profiles.  
An increase in the expression of SAP genes with a longer incubation 
time was only evident with C. tropicalis ATCC 750T and C. tropicalis 75 
(SAPT2-4), and for C. tropicalis AG1, C. tropicalis T2.2 and C. tropicalis 
544123 (SAPT3).  Furthermore, all C. tropicalis strains growing for 24 h in 
the planktonic form expressed all the SAPT2-4 genes, with the exception of 
SAPT2 for C. tropicalis 519468 and C. tropicalis 12.  Additionally, there was 
an apparent increase in the expression of most SAPT genes for planktonic 
cells (24 h), when compared to their 24 h RHOE counterparts.  For 
example, with the oral isolate C. tropicalis AG1, real time PCR analysis 
revealed an increased expression of SAPT3 and SAPT4 genes, of 
approximately 4 and 20 times, respectively when compared with RHOE 
infecting cells. 
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Discussion 
The pathogenesis of mucosal candidosis, particularly those infections 
caused by C. albicans, has been investigated by several authors (Schaller et 
al., 1998; Bartie et al., 2004; Jayatlake et al., 2006, 2005; Malic et al., 2007; 
Lerman et al., 2008; Naglik et al., 2008) using RHOE as a successful 
surrogate model to animals.  Candida tropicalis has been recognized as an 
increasingly important pathogen of debilitated individuals (Weininberg et 
al., 2005; Vigouroux et al., 2006; Nucci et al., 2008), with several studies 
demonstrating that C. tropicalis virulence in mice can be similar to, or 
indeed higher than C. albicans (Wingard et al., 1982; Arendrup et al., 
2002).  However, compared with C. albicans, relatively few investigations 
have been performed to assess the virulence of C. tropicalis, particularly in 
human tissues (Schaller et al., 2002; Jayatilake et al., 2006, 2008).  Thus, 
the primary aim of the present study was to investigate the pattern of 
colonization and invasion of RHOE by a variety of C. tropicalis strains from 
different body sites. 
The results obtained (Figure VI.1 and Table VI.2) showed that the oral 
epithelium was successfully colonized by C. tropicalis, although the extent 
of colonization was noticeably strain dependent.  The study also revealed 
that C. tropicalis was able to develop filamentous forms on the tissue 
surface which could promote colonization.  Furthermore, CLSM images 
showed that, similary to C. albicans (Jayatilake et al., 2006, 2008; Malic et 
al., 2007) C. tropicalis was also able to invade the RHOE (Figure VI.2).  In 
this regard, invading fungal elements were found to penetrate to the 
deepest layers of the RHOE within just 12 h of infection (Table VI.2 and 
Figure VI.2).  These observations are not in total agreement with previous 
reports (Schaller et al., 2002; Jayatilake et al., 2006, 2008), where C. 
tropicalis has been described as a non-invasive species, despite having an 
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ability to colonize.  However, as revealed in the present investigation, 
strain differences in the capability to invade were apparent. 
Subsequent examination of epithelial invasion revealed significant 
differences between 12- and 24-h infection periods, indicating progressive 
tissue damage related to the duration of infection.  There was induction of 
significant tissue disruption in the tissue structure (Figure VI.3) compared 
to uninfected tissues after 24 h infection.  The degree of tissue damage 
was further evaluated quantitatively through the measurement of relative 
LDH activity (Figure VI.4), and the results obtained positively correlated 
with C. tropicalis infection temporal pattern and histologically observed 
damage.  Interestingly, after 12 h infection, the LDH activities of tissues 
infected with the different C. tropicalis strains were largely similar, 
implying equivalent degrees of the damage caused.  More pronounced 
differences were found after 24 h of infection, which might reflect a 
variation in the ability of strains to continue to grow within the epithelium 
and induce damage after initial invasion.  These features were similar to 
those described in previous reports (Jayatilake et al., 2006, 2008), where it 
was demonstrated that Candida dubliniensis, Candida glabrata, Candida 
parapsilosis, Candida krusei and particularly C. tropicalis, were causative 
agents of dramatic histopathological tissue alteration.  
Of note, the six strains classified in the present study as ‘high 
invaders’ were derived from three different superficial body sites, possibly 
indicating that strain origin is not important with respect to invade 
capability.  However, further studies involving a greater number of strains, 
including those from systemic infections, would be of benefit in confirming 
this view.  One strain (C. tropicalis 544123) did not produce extensive 
filamentous forms and, notably, this strain was the only one that was 
unable to invade the oral epithelium (Figure VI.2, Table VI.2).  This result 
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would support the view that it is the filamentous forms that facilitate 
tissue invasion.   
Secreted aspartyl proteinases (Saps) are considered hydrolytic 
enzymes contributing to Candida infection by promoting damage to the 
host mucosa, thus facilitating invasion of the epithelium (Zaugg et al., 
2001; Naglik et al., 2003).  There are at least four known genes encoding 
for Saps in C. tropicalis (Togni et al., 1991; Schaller et al., 1998; Zaugg et al., 
2001) and the expression of these C. tropicalis genes and the role of Saps in 
the infection process was assessed in this present study.  For all C. 
tropicalis strains, SAPT gene expression was assessed using real-time PCR, 
after 12 h and 24 h of infection (and after 24 h of incubation for equivalent 
planktonic preparations).  Overall, the expression of SAP genes by C. 
tropicalis was strain dependent, with SAPT1 not expressed by the majority 
of strains, suggesting its limited involvement in invasion and tissue 
damage.  Interestingly, SAP gene expression was not significantly different 
between infecting and planktonic strains of C. tropicalis.  Furthermore, the 
effect of the aspartyl proteinase inhibitor, pepstatin A, on the infection 
process was also evaluated to provide a complementary insight into 
potential involvement of Saps in C. tropicalis invasion and damage to the 
RHOE.  Pepstatin A is a specific inhibitor of acidic proteinases and has been 
widely used as an inhibitor of Candida aspartyl proteinase activity (Schaller 
et al., 1999; Naglik et al., 2008; Lerman et al., 2008).  Interestingly, 
treatment with pepstatin A did not prevent tissue invasion or apparent 
histological damage induced by C. tropicalis (Figure VI.5).  Furthermore, 
LDH activity was also not reduced by incorporation of pepstatin A, 
reinforcing the view that the extent of tissue damage was maintained even 
when Sap activity was inhibited.  It would appear therefore that Saps do 
not play a significant role in tissue invasion and damage caused by C. 
tropicalis.  These results appear to be in agreement with recent studies 
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involving C. albicans, which demonstrated that Saps were not required for 
invasion (Lerman et al., 2008), and damage to RHOE (Naglik et al., 2008).   
In summary, the present study confirms the effectiveness of RHOE as 
an in vitro model to study Candida virulence attributes and broadens our 
knowledge on C. tropicalis virulence mechanisms.  The CLSM approach has 
conclusively shown that C. tropicalis was not only capable of colonizing but 
could also invade RHOE, leading to significant damage in the tissue 
structure.  Furthermore, to our knowledge, this is the first report of C. 
tropicalis SAPT gene expression during tissue invasion, and the results 
imply a limited role of these enzymes in C. tropicalis invasion and tissue 
damage.  
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Abstract 
Candida albicans is regarded as the leading of candidosis.  However, Candida 
glabrata has emerged as an important pathogen of the oral mucosa, occurring both singly 
or in mixed species infections, often with C. albicans.  Compared with C. albicans, little is 
known about the role of C. glabrata in oral infection.  The aim of this study was to 
examine single and mixed species infection of oral epithelium involving C. glabrata and 
establish its ability to invade and damage tissue.  A reconstituted human oral epithelium 
(RHOE) was infected only with C. glabrata, or simultaneously with C. glabrata and C. 
albicans.  The ability of both species to invade the tissue was examined using species 
specific peptide nucleic acid (PNA) probe hybridisation and confocal laser scanning 
microscopy (CLSM).  Epithelial damage was assessed by measuring lactate dehydrogenase 
(LDH) activity. 
Results showed that C. glabrata strains originating from the oral, vaginal and 
urinary tract were able to colonize the RHOE in a strain dependent manner.  Single 
infection with C. glabrata after 12 h, revealed no invasion of the RHOE by any of the C. 
glabrata strains, which contrasted with extensive tissue invasion demonstrated by C. 
albicans.  Mixed infection showed that C. albicans enhanced the invasiveness of C. 
glabrata, and led to increased LDH release by the RHOE, which paralleled the observed 
histological damage.  This enhanced invasion and increased tissue damage caused by 
mixed C. glabrata and C. albicans infections has important clinical significance and 
highlights the need to identify Candida species involved in oral candidosis. 
 
Keywords: candidosis; co-infection; Candida albicans; Candida glabrata, yeast PNA 
FISH 
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Introduction 
Candidosis is a frequent opportunistic infection in 
immunocompromised individuals (Samaranayake, 1990).  Candida albicans 
remains the main etiological agent in oral candidosis, accounting for 70% 
to 80% of isolates from oral mucosal lesions (Pfaller et al., 2000; Trick et al, 
2002).  However, in recent years, Candida glabrata has emerged as a 
notable pathogenic agent of the oral mucosa, either co-infecting with C. 
albicans (Redding et al., 2000, 2002; Li et al., 2007), or occurring in single 
species infections (Pfaller et al., 2000; Redding et al., 2000, 2002; Li et al., 
2007).  Candida glabrata exhibits significant differences from C. albicans, 
including relative physical size, morphological properties and biochemistry.  
Candida glabrata cells are smaller (1-4 µm) than C. albicans yeast (4-6 µm) 
and have a much narrower spectrum of carbohydrate utilisation (Fidel et 
al., 1999).  Furthermore, in contrast to C. albicans, C. glabrata is not 
polymorphic, and only occurs in the yeast form within the oral cavity (Fidel 
et al., 1999).  One possible explanation therefore for the relatively frequent 
occurrence of co-infection of C. albicans and C. glabrata is that these 
significant differences limit the extent of inter-species competition 
allowing the organisms to occupy similar oral niches.  Importantly, C. 
glabrata-associated oropharyngeal candidosis in HIV and cancer patients 
tends to be more severe and more difficult to treat than infections caused 
solely by C. albicans (Canuto et al., 2000; Redding et al., 2000; 2002).   
An understanding of the interactions between these Candida species 
has significance for the development of strategies for oral candidosis 
management.  This is important since, although oral Candida infections are 
not associated with mortality, they are a major cause of morbidity, and 
trigger chronic pain or discomfort upon mastication, which may limit 
nutritional intake in immunocompromised or elderly individuals (Redding 
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et al., 2000; Olmos et al., 2005).  In addition, oral carriage of Candida has 
also been proposed to be a predisposing factor for systemic infection in 
severely immunocompromised patients (Miranda et al., 2009).    
Fluorescent in situ hybridization (FISH) is rapidly becoming 
established as a valuable research and diagnostic tool in molecular 
pathology laboratories, having previously been used to detect and 
differentiate microorganisms in histological sections (Hayden et al., 2001, 
2002; Malic et al., 2009).  Peptide nucleic acid (PNA) probes are synthetic 
equivalents of nucleic acids where the phosphate–sugar polynucleotide 
backbone has been substituted with a peptide polymer which provides the 
basis for linking nucleobases.  Unlike DNA, the peptide backbone of PNA 
probes is not charged and this offers greater stability in nucleic acid-probe 
hybridisation.  Furthermore, PNA probes are more resistant to degradation 
from nuclease and protease activity.  Given such advantages, it is not 
surprising that PNA probes have emerged as valuable tools in the study of 
infectious diseases and represent a new generation of therapy-directed 
diagnostics (Oliveira et al., 2002; Guimarães et al., 2007; Malic et al., 2009).  
To exemplify this, the Yeast Traffic Light PNA FISHTM (YTL, AdvanDx, Inc., 
Woburn MA) is a newly developed and commercialized PNA probe kit for 
the rapid detection and distinction of the five most common and clinically 
relevant Candida species (Reller et al., 2007; Shepard et al., 2008).   
Previously, a reconstituted human oral epithelium (RHOE) was 
successfully used to investigate colonization and infection of tissue by 
Candida (Bartie et al., 2004; Jayatilake et al., 2006; Malic et al., 2007; Silva 
et al., 2009).  Coupled with species specific PNA probes and confocal laser 
scanning microscopy (CLSM), co-infection of RHOE using C. glabrata and C. 
albicans can therefore be readily examined.   
The aim of this study was to generate single and mixed species 
infections of RHOE with C. albicans and C. glabrata and ascertain the role 
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of C. glabrata in the infection using species specific PNA probes, CLSM and 
lactose dehydrogenase activity (as a measure of tissue damage) in infected 
tissue. 
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Materials and methods 
Organisms 
A total of six clinical isolates of C. glabrata, originally recovered from 
the oral cavity (strains D1 and AE2), vagina (strains 534784 and 585626) 
and urinary tract (strains 562123 and 513100) were used in this study.  A 
reference strain of C. glabrata from the American Type Culture Collection 
(ATCC 2001) was also included.  Oral isolates were obtained from the 
biofilm group of the Centre of Biological Engineering, Minho University 
(Braga, Portugal).  Strains isolated from urinary and vaginal infections were 
kindly provided from the culture collection of the Hospital of São Marcos 
(Braga, Portugal).  An oral isolate of C. albicans (strain 324LA/94) from the 
culture collection of Cardiff Dental School (Cardiff, UK) was selected based 
on its ability to invade RHOE (Malic et al., 2007).  The identity of all isolates 
was initially confirmed by PCR-based sequencing using specific primers 
(ITS1 and ITS4) for the 5.8S subunit gene (Williams et al., 1995).  
 
Growth conditions  
For each experiment, isolates were cultured on sabouraud dextrose 
agar (SDA) (Merck, Darmstadt, Germany) for 48 h at 37°C.  Isolates were 
then subcultured in yeast nitrogen base medium (YNB; BD Diagnostics, 
Cowley, UK) supplemented with 0.5% glucose (w/v) for 12 h at 37°C.  After 
incubation, cells were harvested by centrifugation and washed three times 
with Phosphate Buffered Saline (PBS; pH 7).  The yeasts were then 
enumerated using an Improved Neubauer haemocytometer and adjusted 
to a concentration of 2×106 cells ml-1 in MCDB-153 defined medium 
(Clonetics, San Diego, USA).  
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Reconstituted human oral epithelium (RHOE) infection 
To investigate in vitro single- and mixed species infection of oral 
mucosal by C. glabrata and C. albicans strains, a reconstituted human oral 
epithelium (RHOE; human keratinocytes derived from a squamous 
carcinoma of the buccal mucosa, cell line TR 146, SkinEthic Laboratories, 
Nice, France) model was used.  RHOE tissue inserts (0.5 cm2) were placed 
in 24-well tissue culture plates with MCDB 153-defined medium containing 
5 µg m-1 insulin, 1.5 mM CaCl2, 25 µl ml
-1  gentamicin, and 0.4 µg ml-1 
hydrocortisone, according to the manufacturer’s instructions.  For single 
species infection, 1 ml of standardized suspensions (2×106 cells ml-1) of C. 
glabrata or C. albicans was placed directly onto the RHOE tissue inserts.  
For mixed species infection, 500 µl of C. glabrata (2×106 cells ml-1) was 
combined with 500 µl of C. albicans (2×106 cells ml-1) suspension and this 
preparation placed onto the RHOE tissue inserts.  Control samples were 
inoculated with 1 ml of medium devoid of Candida.  Infected tissues were 
incubated at 37°C in a 5% CO2 environment with saturated humidity for 12 
h.  After 12 h incubation, the maintenance medium was removed and the 
RHOE tissues rinsed twice with PBS to remove non-adherent Candida cells.  
The RHOE specimens were then fixed in 2% (v/v, in ultrapure water) 
paraformaldehyde for 24 h, at 4°C and embedded in paraffin wax using 
standard histological techniques.  Tissue sections (20 µm) were cut and 
placed onto Histobond+ coated microscope slides (Raymond A Lamb, East 
Sussex, UK), de-waxed and processed through xylene, ethanol and water.   
 
Peptide nucleic acid fluorescent in situ hybridization  
The Yeast Traffic Light PNA FISHTM (YTL-PNA FISH) kit (AdvanDx Inc., 
Woburn MA, USA) was used to examine invasion of the RHOE by C. 
glabrata and C. albicans.  The Candida PNA FISH assay was performed 
Candida glabrata and Candida albicans co-infection
 
171  
according to the manufacturer’s instructions with some modifications 
(Reller et al., 2007; Shepard et al., 2008).  Sections of RHOE were prepared 
as described above and then washed briefly in pre-warmed 1× wash 
solution.  Hybridization with PNA probes was performed using 1 drop of C. 
albicans/C. glabrata PNA probe mixture and the overlay incubated in the 
dark in a humidified chamber for 90 min at 55°C.  After probe 
hybridization, excess PNA probe was removed by immersion of the slides 
into pre-warmed 1× wash solution (55°C) for 30 min.  For nuclear staining, 
keratinocytes within the RHOE sections were counterstained with Hoechst 
33258 for 30 min at room temperature, before washing in 1× wash 
solution.  The preparation was then mounted using Vectashield® fade-
retarding mountant (Vector Laboratories, Peterborough, UK).   
 
Confocal laser scanner microscopy (CLSM) 
Sections hybridized with PNA probes were observed by CLSM using a 
Leica TCS SP2 AOBS spectral confocal microscope (Leica, Wetzlar, 
Germany).  The sections were scanned through the full depth using 
appropriate settings for single, double or triple channel fluorescence 
recordings.  Fluorescein-labeled PNA was used for detection of C. albicans 
(laser excitation line 492 nm and emissions detected 520 nm), Tamara-
labeled PNA was used for detection of C. glabrata (laser excitation line 565 
nm and emissions detected 580 nm) and Hoechst 33258 (laser excitation 
line 485 nm and emissions detected 410-485 nm) for nuclear context of 
keratinocytes.  For multi-channel recordings, fluorochromes were scanned 
sequentially to eliminate spectral overlap between probes.  Selected 
images were presented either as single confocal optical sections or 
maximum intensity type constructions.  Candida glabrata and C. albicans 
were identified by red and green coloration respectively, whilst 
keratinocytes were depicted blue.  
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Lactate dehydrogenase (LDH) activity  
The release of LDH from RHOE into the culture medium was used as a 
measure of epithelial cell damage.  The LDH concentration in the medium 
from control and infected tissues was determined after 12 h using the 
CytoTox-ONETM kit (Promega, Madison, WI, USA) according to the 
manufacturer’s instructions.  The LDH activity of Candida cells in cell 
culture medium devoid of tissue was subtracted from the LDH activity of 
the tissue infected with yeasts.  The LDH released during single or co-
infection with the different C. glabrata strains and C. albicans was then 
expressed in relation to the untreated control tissue.  All experiments were 
performed in duplicate. 
 
Statistical analysis  
Results were compared using one-way analysis of variance (ANOVA) 
by applying Levene´s test of homogeneity of variance and the Tukey 
multiple-comparisons test, using SPSS software (SPSS [Statistical Package 
for the Social Sciences], Inc., Chicago, USA).  All tests were performed with 
a confidence level of 95%. 
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Results 
Candida glabrata and Candida albicans single species RHOE 
infection 
The ability of C. glabrata and C. albicans strains to colonize and 
invade human oral epithelium was examined after 12 h of infection using 
the RHOE model (Figure VII.1 and Table VII.1). 
 
 
 
Figure VII.1 Confocal laser scanning microscopy of Candida strains after 12 h of RHOE 
single infection, using YTL PNA FISH
TM
.  C. glabrata cells are depicted red, C. albicans are 
green, and keratinocytes nuclei are blue.  (A) C. glabrata D1 showing sparse colonization 
(+) and no invasion; (B) C. glabrata 513100 showing moderate colonization (++) and 
moderate invasion; (C) C. glabrata 534784 showing extensive colonization (+++) and no 
invasion; (D) C. albicans showing extensive colonization (+++) and high invasion.  
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Results showed that all strains colonized the RHOE surface, although 
the extent of colonization was highly strain dependent.  Candida glabrata 
534784 and 585626 (both vaginal strains) and C. albicans exhibited the 
highest level of RHOE colonization, whilst C. glabrata D1 and AE2 (both oral 
strains) and 562123 (urinary isolate) colonized the tissue to a lower extent 
(Figure VII.1).  
In general, after 12 h of infection, only clusters of C. glabrata yeast 
were detected at the surface of the keratinocyte layers (Figure VII.1A, C).  
Furthermore, strains of C. glabrata were generally unable to invade the 
epithelium, although C. glabrata 513100 (urinary isolate), was found within 
the upper (second or third epithelial cell layer) region of the RHOE (Figure 
VII.1B).  In contrast, C. albicans showed a greater ability to invade the 
RHOE with hyphal elements completely penetrating all the epithelial layers 
(Figure VII.1D).  Histological examination of the RHOE after infection with 
C. albicans, demonstrated noticeable changes (Figure VII.1D) compared 
with tissue infected with C. glabrata (Figure VII.1A, B, C).  It was evident 
that C. albicans RHOE infection induced superficial detachment of 
keratinocyte layers (Figure VII.1D). 
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Table VII.1 Candida glabrata and C. albicans single and co-infection profile of reconstituted human oral epithelium (at 12h ), as assessed 
using confocal laser scanning microscopy and peptide nucleic acid probe hybridisation  
 
 
(+) sparse colinization; (++) moderate colonization; (+++) extensive colonization 
 
Candida  Origin 
Single infection Co-infection 
Colonization Invasion Invasion 
C. glabrata (D1) 
Oral 
+ None Moderate 
C. glabrata (AE2) + None Moderate  
C. glabrata (562123) 
Urinary 
+ None Moderate 
C. glabrata (513100) ++ Moderate High  
C. glabrata (534784) 
Vaginal 
+++ None Moderate 
C. glabrata (585626) +++ None High 
C. glabrata (ATCC 2001) Reference ++ None High 
C. albicans (324LA/94) Oral +++ High - 
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In order to quantify tissue damage, the levels of LDH released by 
epithelial cells after infection were measured (Figure VII.2) and this showed 
that infection with C. albicans produced higher relative levels of LDH 
activity (P<0.05) compared with C. glabrata strains.  Furthermore, a 
moderate but statistically significant increase in relative LDH activity levels 
was induced by C. glabrata strains compared with uninfected controls 
(P<0.05).  Statistical differences with respect to LDH activity released from 
the RHOE was not evident for C. glabrata RHOE infection (P>0.05).   
 
 
 
Figure VII. 2 Relative lactate dehydrogenase (LDH) activities measured in the 
RHOE supernatant after 12 h of single infection (■) and co-infection (■) with C. 
glabrata and C. albicans.  Control was performed without Candida cells.  Error 
bars represent standard deviation.  * LDH activity of Candida albicans single 
infection is statistically different from C. glabrata strains single infections.  ** LDH 
activity of co-infection is statistically different from the respective single infection 
by each C. glabrata strain.  ϮLDH activity of C. albicans single infection is 
statistically different from co-infection values. 
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Candida glabrata and Candida albicans RHOE mixed species 
infection 
Tissues simultaneously infected with C. glabrata and C. albicans were 
subjected to appropriate histological procedures, and the Candida species 
differentiated by hybridization with specific C. glabrata/C. albicans PNA 
probes.  The relative pattern of infection and ability to invade the RHOE 
was then observed by CLSM.  Contrary to C. glabrata single species 
infection (Figure VII.1 and Table VII.1), when co-infected with C. albicans, 
the majority of C. glabrata strains were found to invade the RHOE (Figure 
VII.3 and Table VII.1).  
Yeast of oral isolates (C. glabrata D1 and AE2), the urinary isolate (C. 
glabrata 562123) and the vaginal isolate (C. glabrata 534784) penetrated 
to the third epithelial layer of the RHOE (Figure VII.3A).  In the case of C. 
glabrata 513100 (urinary isolate), C. glabrata 585626 (vaginal isolate) and 
the reference strain (C. glabrata ATCC 2001) penetration to the lowest 
epithelium layers (Figure VII.3B) was evident.  Within the tissue, C. glabrata 
yeast were observed in close proximity to C. albicans hyphal elements 
(Figure VII.4A and C) and localized close to vacuolized tissue portions 
(Figure VII.4B).  
For several strains, the LDH levels released by the RHOE epithelial 
cells infected by both species increased significantly compared to single 
species infection (Figure VII.2).  Specifically, for tissues co-infected with C. 
albicans and the oral isolates (C. glabrata D1 and AE2), the vaginal isolate 
C. glabrata 585626 and the reference strain (C. glabrata ATCC 2001) the 
levels of LDH increased approximately two-fold, whilst a slightly lower (1.5- 
fold) increase was evident with C. glabrata 562123 (urinary isolate).  This 
increase in LDH activity was found to be significant (P<0.05).   
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Figure VII.3 Single (A) and co-infection (B) of C. glabrata and C. albicans of RHOE 
after 12 h, assessed by CLSM and YTL PNA FISHTM.  Candida glabrata cells are 
stained red, C. albicans green, and keratinocytes nucleus blue.  Candida glabrata 
AE2 presents moderate invasion while C. glabrata ATCC 2001 presents high 
invasion both in the presence of C. albicans.  
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Figure VII.4 Candida glabrata/Candida albicans co-infection of RHOE after 12 h, assessed by CLSM and YTL PNA FISHTM.  Panel A shows 
the presence of C. glabrata yeast at a vacuolized tissue portion (see arrow), panel B illustrates the importance of C. albicans hyphal 
elements on the invasion of C. glabrata cells (see arrow) and panel C shows the adhesion and co-aggregation of C. glabrata cells on 
hyphal forms of C. albicans (see arrow). 
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However, no statistically differences were found in the LDH activity 
released by single and co-infection of C. glabrata 513100 (urinary isolate) 
and C. glabrata 534784 (vaginal isolate).  Furthermore, an increase on the 
levels of LDH activity was verified between C. albicans single infection and 
co-infection concerning both oral isolates (C. glabrata D1 and AE2), one 
vaginal isolate (C. glabrata 585626), one urinary isolate (C. glabrata 
562123) and the reference strain (C. glabrata ATCC 2001) (P<0.05).  This 
augment in activity was not found for C. albicans co-infecting with one 
urinary isolate (C. glabrata 513100) and one vaginal isolate (C. glabrata 
534784) (P>0.05). 
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Discussion 
Candida species can colonize human oral mucosal surfaces and are 
frequently present in the oral cavity as harmless commensals (Pfaller et al., 
2000; Trick et al., 2002).  However these organisms can cause opportunistic 
infections which are increasingly seen in compromised patients with HIV 
infection, diabetes mellitus, and in indivudals receiving broad spectrum 
antibiotics and cytotoxic drug therapies (Samaranayake, 1990; 
Samaranayake et al., 2002; Rüping et al., 2008).   
Although, C. albicans is the most frequently encountered pathogen 
(Pfaller et al., 2000; Trick et al., 2002), several other species, and especially 
C. glabrata, have recently emerged as oral pathogens either found singly or 
in combination with C. albicans (Redding et al., 2000, 2002).  Candida 
glabrata is unable to grow in filamentous forms and is therefore only seen 
as relatively small yeast cells in humans (Fidel et al., 1999).  In contrast, C. 
albicans is polymorphic being able to grow as yeast, pseudohyphae and 
hyphae (Odds, 1998).  In terms of tissue invasion, the ability of C. albicans 
to generate hyphae is seen as advantageous as such filamentous growth 
form enable migration of the fungal element from the point of adherence.  
Thigmotropic movement is also a property of Candida hyphae (Gow, 2009) 
which could promote invasion of the epithelium (Schaller et al., 2002; 
Malic et al., 2007; Gow, 2009).  The morphological differences and 
potentially different patterns of growth exhibited by C. albicans and C. 
glabrata could allow these species to occupy the same location within the 
oral cavity with limited competition for space.  Furthermore, the fact that 
C. albicans and C. glabrata also differ significantly in terms of carbohydrate 
assimilation profiles (Li et al., 2007) is an additional factor that reduces 
potential inter-species competition at oral sites, thereby allowing co-
existence in many instances.   
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In recent years, C. albicans pathogenesis in mucosal candidosis has 
been investigated by several authors (Bartie et al., 2004; Jayatilake et al., 
2006; Schaller et al., 2006; Malic et al., 2007) using a reconstituted human 
oral epithelium (RHOE) as a surrogate model to animals.  Since mixed 
infection with both C. albicans and C. glabrata species has often been 
reported in the mouth (Redding et al., 2000, 2002), we aimed to examine 
for the first time the effect of mixed infections in the RHOE model.  This in 
turn would indicate the possible pathogenic significance of mixed infection 
in the oral cavity.  
Initially, the colonization patterns and invasion of RHOE by several C. 
glabrata strains originating from different body sites were examined.  The 
results obtained (Table VII.1, Figure VII.1A-C and Figure VII.3A) showed that 
the surface of the RHOE was successfully colonized by all C. glabrata strains 
tested, although this was noticeably strain dependent.  Furthermore, CLSM 
revealed that C. glabrata were generally unable to invade the RHOE (Figure 
VII.2).  One exception was the urinary isolate C. glabrata 513100 which 
appeared to invade the superficial epithelial layers of the RHOE.  These 
results highlight the diversity of C. glabrata strains in colonization and 
invasiveness capability, and mirror those previously reported for C. 
parapsilosis (Silva et al., 2009), C. tropicalis (Silva et al., 2010) and C. 
albicans (Malic et al., 2007).  Schaller et al., (2002) and Jayatilake et al., 
(2006) have both previously classified C. glabrata strains as being non-
invasive in RHOE infection.   
It is important to note that six of the seven strains analysed in this 
present study and classified as ‘non invaders’ were sourced from different 
body sites, possibly indicating that strain origin is not an important aspect 
in C. glabrata colonization and invasion of oral epithelium.  For example, 
the oral isolates (AE2 and D1) exhibited a lower ability to colonize the 
RHOE, compared with vaginal isolates (534784 and 585626).  
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Generally, most C. albicans isolates infecting the RHOE model exhibit 
histological signs of hyphal invasion (Odds, 1998; Schaller et al., 2002; 
Bartie et al., 2004; Malic et al., 2007).  This current study also confirmed 
the high invasiveness of C. albicans (Figure VII.1D) and particularly so when 
compared with C. glabrata (Figure VII.1 A-C and Figure VII.3A).  In fact, 
after 12 h of infection, invasion of the RHOE by hyphal elements of C. 
albicans was clearly evident, leading to marked disorganization of RHOE 
and detachment of superficial layers of the tissue from the insert (Figure 
VII.1 D); this was in contrast to the lower level of damage caused by C. 
glabrata strains (Figure VII.1 A-C and Figure VII.3 A).  The extent of tissue 
damage was quantitatively assessed by measurement of relative LDH 
activity (Figure VII.2).  The results were in accordance with the extent of 
Candida colonization and tissue damage observed histologically (Figure 
VII.1).  The levels of LDH released during single species infection was 
highest for C. albicans which was expected given the previous histological 
observations and considering that this species is generally the most 
virulent Candida species (Jayatilake et al., 2006; Schaller et al., 2006).  
Interestingly, mixed species infection revealed (Table VII.1 and Figure 
VII.3B) that C. albicans promoted the invasiveness of C. glabrata.  In fact, 
six of the seven C. glabrata strains classified as ‘non-invaders’ in single 
infection studies were found to penetrate the oral epithelium in the 
presence of C. albicans.  It is known that C. albicans hyphal formation is a 
critical determinant in invasive pathogenesis especially in comparison with 
non-Candida albicans Candida species, and it has been shown that C. 
albicans with mutations in genes involved in promoting hyphal 
development were less invasive than wild type strains (Jayatilake et al., 
2006).    
The exact mechanism of how C. albicans might promote C. glabrata 
penetration of the oral epithelium remains unclear.  Damage to the 
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integrity of the epithelial surface caused by the growing tips of the C. 
albicans hyphae (Figure VII.4 A-B) could provide access to lower epithelial 
layers for C. glabrata yeast.  It is tempting to speculate that the C. glabrata 
yeast could adhere to C. albicans hyphae and be transported in this 
adhered form to deeper tissue layers.  In this context, Ez-Azizi et al. (2004) 
showed the efficient adherence of C. albicans to a pre-formed C. glabrata 
biofilm in a catheter model and suggested the possibility of co-aggregation 
of these two species in vivo.  RHOE infection studies presented here 
confirmed adherence of C. glabrata cells to hyphal C. albicans elements 
(Figure VII.4C).   
The increased LDH activity (Figure VII.2) reported after mixed 
infection with C. albicans and C. glabrata supports a finding of enhanced 
pathogenicity.  Of additional concern is that strains of C. glabrata often 
have higher resistance to azoles antifungal agents compared with many 
other Candida species, including C. albicans (Redding et al., 2000, 2002; 
Bagg et al., 2003).  In such instances, mixed infection would not only 
exhibit enhanced pathogenicity, but would also be more problematic to 
treat.  Many diagnostic laboratories are limited in the identification of 
mixed Candida infection, particularly when non differential primary 
isolation agars such as sabouraud dextrose agar are used.  The importance 
of recognising the occurrence of such mixed infection is however 
highlighted by the results of this study and represents an area that should 
be considered by both diagnostic laboratories and clinicians alike. 
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Concluding remarks 
Infections caused by Candida species have increased greatly over 
recent years, mainly due to increasing numbers of immunocompromised 
patients, the ageing population, and the increasing use of indwelling 
medical devices.  Candida albicans is the major causative agent of human 
candidosis, however, and possibly due to new screening techniques other 
Candida species (NCAC) are increasingly being identified.  
The virulence aspects of NCAC species, namely C. parapsilosis, C. 
tropicalis and C. glabrata, remain poorly understood.  As a consequence 
this work aimed to examine the expression of some of the more relevant 
virulent factors for NCAC species, such as adhesion and biofilm formation 
ability, secretion of aspartly proteinases and its role on invasion and 
damage of an in vitro human oral epithelium model.  
All NCAC strains (C. parapsilosis, C. tropicalis, and C. glabrata), 
assessed in this study were able to form biofilm in the presence of a rich 
culture medium (SDB) and on polystyrene surfaces.  The extent of biofilm 
formation was however both species and strain dependent.  Specifically, C. 
glabrata strains were less able to form biofilms than C. parapsilosis and C. 
tropicalis.  SEM images, indeed, revealed structural and morphological 
differences for the biofilms of studied NCAC species and strains.  However, 
in general, biofilms of C. glabrata presented a more compact biofilm than 
other species.  Concerning, matrix composition, significant and consistent 
differences were found for the biofilms of different species.  Matrices of C. 
parapsilosis biofilms consisted of high amounts of carbohydrate and small 
amounts of proteins, whilst C. tropicalis biofilms were low in both 
carbohydrate and protein content.  Regarding metabolic activity of 
biofilms, it was possible to conclude that, there were intrinsic differences 
in terms of metabolic activity amongst biofilms of NCAC strains, which 
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could have important implications in terms of species relative virulence.  
The total metabolic activities of biofilms were also strongly species and 
strain dependent.  Furthermore, C. glabrata biofilms exhibited the lowest 
biofilm metabolic activity which was comparable with the lowest value of 
biofilm or planktonic metabolic activity.  Moreover, the absence of a 
correlation, between cultivable cells number, total biofilm activity and total 
biofilm biomass, raises the question over which parameter was the most 
appropriate for in vitro assessment of biofilms and their consequent 
potential clinical significance, stressing out the importance of the use of 
two or more methodologies together.  
In order to better approach and mimic human body conditions, 
namely those found in urinary catheters (which is the source of severe 
nosocomial Candida infections), adhesion and biofilm formation of NCAC 
species (urinary isolates) was assessed using silicone and artificial urine 
(AU).  Interestingly, the results showed that all isolates under study were 
able to adhere to silicone in the presence of AU, but again this was in a 
species and strain dependent manner.  In contrast to the biofilm formation 
ability studies on SDB and polystyrene, in the presence of AU, C. glabrata 
showed the highest levels of adhesion to silicone when compared with C. 
parapsilosis and C. tropicalis.  These findings therefore highlighted the 
importance of varying experimental conditions on biofilm development 
studies.  Additionally, it was also evident that differences in adhesion could 
not be correlated with cell surface properties since all strains examined 
presented similar degree of hydrophobicity and exhibited a similar zeta 
potential.  Furthermore, despite the high number of cultivable cells 
recovered after 72 h of incubation in AU, extensive biofilms were not 
observed and CLSM showed an absence of extracellular polymeric material 
for all species.  It was therefore shown that these NCAC species were able 
to adhere and survive on silicone in the presence of urine and the high 
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levels of C. glabrata colonization could be an explanation for the increasing 
of infections caused by this species in hospitalized and catheterized 
patients.  Furthermore, it is possible to conclude that the virulence factors 
of NCAC species, such as adhesion and biofilm formation, were strongly 
dependent not only on the strain type but also the environmental 
conditions.  
In terms of characterization of C. parapsilosis and C. tropicalis 
infection of an in vitro oral human epithelium (RHOE), it was possible to 
conclude that all strains from different body sites (oral, vaginal and urinary 
tract) were able to colonize this epithelium.  However, this again was in a 
strain dependent manner.  Strains differences were found in the 
colonization morphology and in the extent of invasion of the RHOE.  Low 
invasion of RHOE was detected for C. parapsilosis strains after 12 h, 
whereas extensive tissue damage occurred after 24 h when assessed using 
histological examination and lactate dehydrogenase (LDH) activity 
determination.  Conversely, C. tropicalis strains presented higher 
invasiveness after 12 h of infection, with extensive tissue damage occurring 
after 24 h.  Molecular analysis (real time-PCR) of SAP genes, for C. tropicalis 
and C. parapsilosis showed that SAP expression was strain dependent for 
both species.  Also, the results suggested that the proteinases were not 
involved in invasion of RHOE by C. tropicalis and C. parapsilosis.  In 
addition, pepstatin A was unable to inhibit the invasion of oral epithelium 
by both species.  Furthermore, after 24 h of infection it was evident that a 
reduction of tissue damage occurred in the presence of pepstatin A in the 
case of C. parapsilosis, but not in case of C. tropicalis strains.  These 
findings therefore suggest that Saps could play an important role in tissue 
damage induced by C. parapsilosis. 
Regarding, C. glabrata and C. albicans single and co-infection of 
RHOE, it was possible to conclude that C. glabrata strains originating from 
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the oral, vaginal and urinary tract were able to colonize the epithelium, 
again in a strain dependent manner.  Single infection with C. glabrata after 
12 h, generally revealed, no invasion of the RHOE in contrast to tissue 
invasion caused by C. albicans, C. tropicalis and C. parapsilosis.  
Interestingly, mixed infection (C. glabrata and C. albicans) showed that C. 
albicans actually enhanced the invasiveness of C. glabrata, and led to an 
increased LDH release by the epithelial cells, which correlated with the 
observed histological damage.  This enhanced invasion and increased 
tissue damage caused by mixed C. glabrata and C. albicans infections could 
have important clinical significance, especially in oral infections where C. 
glabrata (highly resistant to antifungal agents) is often isolated, 
highlighting the need to a better identification of Candida species involved 
in oral candidosis.   
In summary, this work highlights both species and strains differences 
in terms of the most relevant virulence factors, concerning C. glabrata, C. 
parapsilosis and C. tropicalis.  Furthermore, this work also demonstrated 
that the virulence factors assessed did not vary with the body origin of the 
respective strain under study.  Candida glabrata is the most genetically 
distinct species compared with C. tropicalis and C. parapsilosis and this 
appeared to be reflected by its heterogeneity compared to other to species 
in terms of the adhesion, biofilm formation, and colonization and invasion 
of oral epithelium.  Since many genes and virulence factors ultimately 
determine the pathogenicity of opportunistic pathogens and given the 
increasing incidence of candidosis caused by NCAC species, it remains 
essential to continue to increase our knowledge base concerning the 
pathogenic mechanisms of NCAC species.  Whilst this study has 
contributed to this process further work is warranted (see future 
perspectives).  With the advent of new experimental methodology such as 
CLSM and molecular analysis as utilized in the present study, the further 
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elucidation of such virulence mechanisms should be an achievable and 
realistic goal. 
Chapter VIII 
 
196  
Future perspectives 
The work described in this thesis provided a useful insight into 
several aspects of NCAC species pathogenecity, leading to interesting new 
questions for further research.  Some of the suggestions that should be 
taken into consideration for future investigations are: 
a)  Assessment of the extension of colonization ability by the 
same several NCAC strains of reconstituted vaginal epithelium 
(RHVE).  Consequently, stressing the differences among 
different epithelia and colonization/infection mode. 
b) Evaluation of co-infection processes, not only crossing all 
NCAC species but also using important bacteria, since the 
great majority of the infections are caused by more than one 
microorganism.   
 
c) Assessment of the role of other enzymes (phospholipases, 
lipases and hemolysins) in Candida pathogenesis a genomic 
approach by analyzing the levels of gene expression during 
tissue interaction and through analysis of the respective 
deletion mutants.  
 
d) Proteomic approaches could be used with the aim to identify 
cell wall proteins (CWPs) and other proteins located at the cell 
surface of NCAC species.  Since, CWPs play a crucial role in the 
initial contacts and interactions between pathogen and host.  
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e) Adressing the host inflammatory response caused by NCAC 
species. Since, a more comprehensive study of Candida 
transition from commensalism into a pathogenic state is only 
possible by addressing the host inflammatory responses. 
Furthermore, to date, there is still limited knowledge 
regarding the inflammatory responses to NCAC species.  
 
Summarizing, the recognition of genes and corresponding proteins 
involved in Candida-host interaction as well as the inflammatory response, 
with the aim to contribute to the elucidation of the underlying molecular 
mechanisms, and to disclose new potential targets for development of 
therapeutics against clinically relevant NCAC species fungal pathogens, can 
be proposed for future work. 
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